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“As our circle of knowledge expands,  
so does the circumference of darkness surrounding it.” 
 
A. Einstein 
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Abstract 
 
Chapter 1 gives a brief introduction to supramolecular chemistry, metallosupramolecular 
chemistry and 2,2':6',2''-terpyridine-based ligands and their complexes.  
 
Chapter 2 discusses the synthesis and characterization of new ditopic ligands L1-L4 and 
L6-L7. These ligands are based on a benzene unit connected to two 4'-substituted-
2,2':6',2''-terpyridine moieties through polyethyleneoxy spacers. The variability of this 
group of compounds was achieved by using different length ethyleneoxy chains and 
changing the substitution position on the benzene unit. The ligands were also preliminary 
studied for interactions with Group 1 metals. 
 
Chapter 3 describes the synthesis and characterization of heteroleptic dinuclear 
ruthenium(II) complexes formed with ligands L1-L2, L4 and L6-L7. 
 
Chapter 4 describes the synthesis and characterization of a homoleptic mononuclear 
zinc(II) complex with a ditopic 4'-substituted- 2,2':6',2''-terpyridine ligand L4. 
 
Chapter 5 discusses the synthesis and characterization of ligand L5 which contain three 
2,2':6',2''-terpyridine metal-binding domains as well as the synthesis and characterization 
of a heteroleptic trinuclear ruthenium(II) complex of this ligand. Three 2,2':6',2''- 
terpyridine domains on the ligand L5 are linked at their 4'-positions to a benzene unit 
through diethylene glycol spacers. 
 
Chapter 6 describes the synthesis and characterization of homoleptic mononuclear 
europium(III) and terbium(III) complexes of tritopic 4'-substituted- 2,2':6',2''-terpyridine 
ligand L5. 
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Abbreviations 
 
Cl-tpy  4'-chloro-2,2':6',2"-terpyridine 
COSY  correlated spectroscopy 
CV  cyclic voltammetry 
bpy  2,2'-bipyridine 
br  broad 
d  doublet 
δ  chemical shift 
DCM  dichloromethane 
DEPT distortionless enhancement by polarisation transfer 
DMF  N,N'-dimethylformamide 
DMSO  dimethylsulfoxide 
ε  molar extinction coefficient 
ESI  electrospray ionisation 
EtOH  ethanol 
Fc  ferrocene 
Fc+  ferrocenium 
HMBC heteronuclear multiple bond correlation 
HMQC heteronuclear multiple quantum correlation 
HPLC high performance liquid chromatography 
Hz hertz, s-1 
IR infrared spectroscopy 
IUPAC International Union of Pure and Applied Chemistry 
J coupling constant 
λ wavelength 
LC ligand centred 
m multiplet or medium (IR) 
M molarity 
M  parent ion mass 
MALDI matrix assisted laser desorption ionisation 
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MC metal centred 
MLCT metal to ligand charge transfer 
m.p. melting point 
MS mass spectrometry 
m/z mass to charge ratio 
ν frequency (cm-1 or Hz) 
NMR nuclear magnetic resonance spectroscopy 
NOESY nuclear overhauser effect spectroscopy 
ppm  parts per million 
RT  room temperature 
REOSY Rotating frame nuclear Overhauser effect spectroscopy 
s  singlet or strong (IR) 
t  triplet 
td  triplet of doublets 
τ  lifetime of emission 
TOF  time of flight 
tpy  2,2':6',2''-terpyridine 
UV-Vis ultra-violet visible spectroscopy 
w weak (IR) 
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General experimental 
 
Microwave reactor 
Microwave reactions were carried out in a Biotage Initiator 8 reactor with sealed tubes 
allowing pressures of up to 20 bars. 
 
NMR spectroscopy 
NMR spectra were recorded on Bruker AM250 (250 MHz), Bruker AVANCE 300 (300 
MHz), Bruker DPX400 (400 MHz) and Bruker DRX500 (500 MHz). For full 
assignments COSY, DEPT, HMBC, HMQC and NOESY experiments were recorded on 
the Bruker DRX500. 1H and 13C spectra were recorded at 25 °C and chemical shifts are 
relative to residual solvent peaks (1H: CDCl3 7.24 ppm, acetonitrile-d3 1.94 ppm; 13C: 
CDCl3 77.00 ppm, acetonitrile-d3 1.39 ppm). 
 
Mass spectrometry 
Electrospray ionisation (ESI) mass spectra were measured using Finnigan MAT LCQ or 
Bruker esquire 3000plus instruments. MALDI-TOF mass spectra were recorded with a 
PerSeptive Biosystems Voyager mass spectrometer, using a supporting matrix (sinapinic 
acid or α-cyano-4-hydroxycinnamic acid). 
 
Infrared spectroscopy 
IR spectra were recorded on a Shimadzu FTIR-8400S spectrophotometer with neat 
samples using a golden gate attachment.  
 
Melting points 
Melting points were determined on a Stuart Scientific melting point apparatus SMP3. 
 
UV-Vis spectroscopy 
UV-visible absorption spectra were measured in 1-cm quartz cuvettes on a Varian Cary 
50 spectrophotometer. Baseline correction was applied for all spectra.  
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Emission spectroscopy 
Emission (Fluorescence, phosphorescence and excitation) spectra were recorded on a 
Varian Cary Eclipse Fluorimeter. Quartz cells with a 1 cm path length from Hellma were 
used for these measurements. The temperature was kept constant throughout the 
measurements by using a thermostated unit block 
 
Microanalysis 
The microanalyses were performed with a Leco CHN-900 microanalyser by W. Kirsch. 
 
Electrochemistry 
Electrochemical measurements were done on an Eco Chemie Autolab PGSTAT 20 using 
a glassy carbon working electrode, a platinum mesh for the counter electrode, and a silver 
wire as the reference electrode. The redox potentials (E1/2ox, E1/2red [V]) were determined 
by cyclic voltammetry (CV) and by square wave and differential pulse voltammetry. The 
compounds were dissolved and measured in dry and degassed acetonitrile in the presence 
of 0.1 M [n-Bu4N][PF6] unless otherwise stated. The scanning rate for the CV was 100 
mV·s-1 in all cases and ferrocene (Fc) was added as an internal standard at the end of 
every experiment. 
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CHAPTER 1 
 
Introduction 
 
In this chapter, a brief introduction to this thesis is presented. The three most important 
subjects are described below: supramolecular chemistry, metallosupramolecular 
chemistry and 2,2':6',2''-terpyridine-based molecules in supramolecular chemistry. 
 
1.1   Supramolecular chemistry 
 
Stoddart has defined chemistry as follows:1 
Chemistry can be likened to “language”. The atoms are the “letters”. The molecules are 
the “words”. Assemblies of molecules make up the ”sentences”. The sets of assembled 
molecules or supermolecules are the “paragraphs”. The ways in which the molecular 
assemblies and supramolecular arrays contain and express information are the 
“chapters”. The manner in which this information is conveyed at both a molecular level 
is the “book”. Ultimately, chemistry has to tell a “story”. 
Chemists are writing their own “stories”. They know how to produce the “words”. They 
are still learning how to write the ”sentences”. The “grammar” they use has been 
dictated by the nature of the noncovalent bond. 
 
Supramolecular chemistry was defined by Jean-Marie Lehn as "chemistry beyond the 
molecule, bearing on the organized entities of higher complexity that result from the 
association of two or more chemical species".2-4 
 
Supramolecular chemistry is an interdisciplinary field of science which covers the 
chemical, physical, and biological features of chemical species. In contrast to molecular 
chemistry which is based on the covalent bond, supramolecular chemistry is the 
chemistry of molecular assemblies and of the intermolecular (noncovalent) bond. All 
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weak intermolecular interactions can be used in supramolecular chemistry: electrostatic 
interactions, hydrogen bonds, van der Waals forces, π-π stacking, charge transfer 
interactions and hydrophobic interactions.5 
 
There are two probable mechanisms which work together and lead to supramolecules: 
molecular recognition and self-assembly. Molecular recognition is a process involving 
both binding and selection of substrate by a given receptor molecule.6 Self-assembly is a 
spontaneous assembly of molecules into structured, stable, non-covalently joined 
aggregates.3 
 
One of the most known examples of a supramolecule comes from nature and is 
deoxyribonucleic acid (DNA). The double helix form of DNA is based on hydrogen 
bonds between complementary bases in two oligonucleotides. The structure of DNA 
became an inspiration for some chemists to synthesize similar systems. Lehn and his 
group have reported bpy-based double helices held by three copper(I) metal ions (Figure 
1.1).7,8 
                                           
 
Figure 1.1. Self assembly interactions between three copper(I) ions and two tris(2,2'-
bipirydyne) ligands.7,8 
 
Jean-Marie Lehn found his interest in the supramolecular chemistry field more than 20 
years before he published copper(I) double helices.7,8 Everything started in the 1960's 
with cryptands3,4 and Pedersen joined him with his studies of crown ethers.9 Since then 
supramolecular chemistry became one of the biggest and fastest developing field of 
studies.  
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1.2   Metallosupramolecular chemistry 
 
Introducing metals into supramolecular chemistry appeared to be one of the best ideas. 
Metallosupramolecules are based on strong metal-ligand bonds, ~ 200 kJ/mol. The 
ligands can be described as the building blocks, which form larger structures and the 
metal ions are like molecular "glue", which hold these structures together. The number 
and orientation of the coordination sites of ligand and coordination number and geometry 
of metal ion allows very often to design a large number of various highly directional and 
geometrically well-defined species.  
 
One of the most simple examples of metallosupramolecules are 2-dimensional molecular 
squares. The geometry of these systems is well defined by platinum(II) or palladium(II) 
ions acting as 90 degree corners. Fujita, Yazaki, and Ogura have reported self-assembling 
molecular squares based on metal coordination chemistry. When [M(en)(NO3)2] (M = Pt, 
Pd) is treated with bipyridine, a cyclic tetrameric macrocycle - a molecular square - is 
formed as the thermodynamically preferred product (Figure 1.2).10,11 
 
 
Figure 1.2. Tetrameric bipyridine macrocycles.10,11 
 
Hupp and co-workers have prepared a number of molecular squares which have been 
used as catalysts.12 Figure 1.3 shows a structure in which manganese(II) porphyrin is 
encapsulated in a square built from four zinc(II) porphyrins and four rhenium complexes. 
It has been suggested that this could act as an artificial enzyme. 
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Figure 1.3. A molecular square with an encapsulated Mn(II) porphyrin, prepared by 
Hupp.12 
 
The supramolecular structures containing copper ions and bidentate or tridentate ligands 
are very good examples to demonstrate how important the metal ion geometry is and the 
number of the coordination sites of ligand. The Cu(I) ion has a d10 electron configuration 
and it prefers a coordination number of 4 and a tetrahedral geometry13 whereas the Cu(II) 
ion has a d9 electron configuration and prefers to be octahedral or 5-coordinate.14 There 
are a lot of examples of the use of preferences of metal ions to direct the assembly of 
multi-component structures.  
 
                            
                                                                          a                                                                                     b 
Figure 1.4. 4-Coordinated copper(I) (a) and 5-coordinated copper(II) (b).14 
 
Rotaxanes are a class of molecules in which a dumbbell shaped component is encircled 
by a macrocycle; the two components are linked mechanically rather than by a covalent 
bond. A generally accepted method for the synthesis of rotaxanes is threading.15 The 
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complex formed between these two species can then be modified with blocking groups to 
produce the [2]rotaxane.15 
 
Sauvage has reported a rotaxane in which the thread contains two different ligand 
domains: 1,10-phenanthroline and 2,2':6',2''-terpyridine, whereas the ring is built out of a 
bidentate 1,10-phenathroline unit.16,17 The system can be switched from a four-coordinate 
Cu(I) to a five-coordinate Cu(II) and back, by oxidizing and reducing the metal (Figure 
1.5).18 
 
 
Figure 1.5. The molecular motion of the rotaxane driven by reduction and oxidation.18  
 
 
 
 
Figure 1.6. The first X-ray crystal structure of a catenate, prepared by Sauvage et al.25 
 20 
The efficient synthesis of interlocked or catenated molecules19-24 requires that one ring be 
threaded by the precursor of the second ring, and that this assembly be held together as 
the second ring is formed, simply: one macrocycle must act as a template for the 
formation of the second macrocycle. One of the very first Cu(I) based catenates was 
prepared in the Sauvage group.25 The X-ray structure has confirmed the structure of the 
product (Figure 1.6). 
 
The Sauvage group has also shown that catenates could be extended to multinuclear 
systems substituted with multiple bridged porphyrin groups (Figure 1.7).26 
 
Figure 1.7. An example of catenate containing porphyrin groups.26 
 
From the above examples, we understand how important it is to design ligands with the 
correct number and orientation of the coordination sites as well as a choice of metal ions 
with the correct coordination number and geometry. Figure 1.8 shows that smaller 
molecules can be used as tools, to template the formation of larger systems. Sanders and 
co-workers have investigated the flexible bisporphyrin receptors.27,28 In a directed self-
assembly process, novel porphyrin-containing macrocycles could be obtained. Although 
the macrocyclic porphyrin trimer (Figure 1.8) can be synthesized by untemplated 
oxidative coupling of the diacetylenic porphyrin monomer (Figure 1.8), the yield is 
relatively low (47%). If the monomer (Figure 1.8) is oxidatively coupled in the presence 
of s-2,4,6-tri-4-pyridyltriazine, the amount of cyclic trimer formed is dramatically 
enhanced. The s-2,4,6-tri-4-pyridyltriazine acts as a “negative template”: it promotes 
trimer formation passively by inhibiting dimer formation actively.29,30 
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Figure 1.8. Trimeric macrocyclic porphyrin array prepared by Sanders et al.29,30 
 
Many metal complexes contain more than one metal centre. Some of these dinuclear or 
multinuclear complexes exhibit electron transfer and energy transfer properties.  
Anderson has studied the porphyrin-based macrocycles and that led him to present 
successful syntheses of electron transporting molecular wires (Figure 1.9).31,32 He also 
reported new pi-conjugated porphyrin nanorings33 (Figure 1.10), which could be obtained 
by bending and connecting these molecular wires. 
           
Figure 1.9. Electron transporting molecular wires.31,32 
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Figure 1.10. Template-directed synthesis of a pi-conjugated porphyrin nanoring.33 
 
Lehn and co-workers have explored the use of metal coordination for the construction of 
molecular racks, ladders, and grids (Figure 1.11).34-38 After mixing the ligand presented 
in Figure 11 with 1.5 eq. of AgSO3CF3, a three-by-three molecular grid self-assembles 
spontaneously from nine Ag(I) ions and six ligands (Figure 1.11). 
 
                  
Figure 1.11. Rack (a), ladder (b), and grid structures (c) and self-assembled molecular 
grid with Ag(I) ions prepared by Lehn.34-38 
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1.3   2,2':6',2"-Terpyridine in Supramolecular chemistry 
 
2,2':6',2"-Terpyridine (tpy) and its derivatives are some of the most popular chelating 
ligands in supramolecular chemistry. This ligand forms very stable octahedral complexes 
with a large variety of metal ions.39,40 In contrast to the bidentate analogue 2,2'-bipyridine 
(bpy), {M(tpy)2}n+ complexes are achiral (provided that only non-substituted or 
symmetrically substituted tpy ligands are used). The {M(bpy)3}n+ complexes exist in two 
enantiomeric forms: Λ and ∆.  
 
 
Figure 1.12. The Λ and ∆ enantiomers of {M(bpy)3}n+ (top) and an achiral {M(tpy)2}n+ 
with symmetrical ligands (bottom). 
 
Tpy can be functionalized at several different positions, such as the 4' position of the 
central ring and the 6 and 6" positions of the terminal pyridine rings, but the most known 
and studied are the 4'-substituted tpy derivatives.  
Constable and Housecroft have reported many different 2,2':6',2"-terpyridine ligands 
substituted with functional groups in 4'-position. Azacrown41,42 (Figure 1.13) and 
fullerene43,44 (Figure 1.14) functionalized ligands have been synthesized, as well as their 
metal complexes. These have been studied further of or their electronic and luminescent 
properties.  
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Figure 1.13. Azacrown functionalized tpy ligands.41,42 
 
                     
                                                                                            n=0,1 
Figure 1.14. Fullerene functionalized tpy ligands.43,44 
 
A cyclopentadiene functionalized tpy was used to synthesize the corresponding ferrocene 
tpy ligand45 (Figure 1.15 a). The 4'-cyclodextrin functionalized46-48 (Figure 1.15 b) and 
anthryl substituted49 (Figure 1.15 c) tpy ligands have been also synthesized. Their 
ruthenium and osmium complexes have been studied.  
 
 
                                                    a                                                                              b                                                c 
Figure 1.15. Ferrocene (a), cyclodextrin (b) and anthryl (c) substituted tpy.45-49 
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Other functional groups have also been used in the syntheses of the 4'-substituted tpy 
ligands: 2,2'-bipyridine50, diphenylphosphine51,52, porphyrins53-56, thienyl groups57,58, 
sugars59 and much more. 
2- and 3-furyl and thiophene have been used to synthesize 4'-substituted tpy ligands and 
then have been studied for their potential application in anticancer therapy (Figure 
1.16).60,61 
 
Figure 1.16. Furyl and thiophene substituted tpy ligands.60,61 
 
The other well-studied substitution position is the 6-position of the terminal pyridine ring. 
A series of 6-substituted tpy ligands has been synthesized62-64: 6-bromo tpy (Figure 1.17 
a), chiral 6-bornyloxy tpy ligands (Figure 1.17 b-e) and quaterpyridine ligand (Figure 
1.17 f), synthesized in coupling reaction65. A chiral cobalt(II) complex of 6-bromo tpy 
(Figure 1.17 a) has been well studied in Constable group.66 In contrast to cobalt(II) 
complexes of 4'-substituted tpy, [Co(II)(6-bromo tpy)2] complex is a high spin system. 
 
 
                                           a                                                          b                                                        c  
 
                                                  d                                              e                                                                             f  
Figure 1.17. 6-Bromo tpy (a), chiral 6-bornyloxy tpy ligands (b-e) and quaterpyridine 
ligand (f).62-66 
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More than one 2,2':6',2"-terpyridine domain can be used to synthesize different groups of 
ligands. There is great interest in studying ligands containing two or more tpy units, these 
are called "bridged" ligands. A variety of ligands with two 2,2':6',2"-terpyridine groups 
linked with different spacers have been reported. An introduction of the spacer into a 
molecule allows one to control the supramolecular structure, distances and angles, and/or 
to control transfer of electrons or energy through the bonds. Depending on the type of the 
spacer, either rod-like67-78 or macrocyclic79-82 complexes are preferred.  
 
Figure 1.18. Ditopic bis(2,2':6',2"-terpyridine) ligands with rigid phenylene-based 
spacers.67-78 
 
Figure 1.19. Ditopic bis(2,2':6',2"-terpyridine) ligands with naphthalene spacers.79-82 
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Figure 1.20 shows bridged ligands containing three (a), four (b) and six tpy (c) domains. 
These kind of ligands have been used as the core for the synthesis of metallostars83,84 and 
metallodendrimers.85 
 
                                                        a                                          b                                                 c  
Figure 1.20. Tpy based ligands with three, four and six tpy domains.83-85 
 
The triruthenium complex (Figure 1.21) has been reacted with 
hexakis(bromomethyl)benzene to give the desired octadecanuclear complex (Figure 
1.21). The center of the complex is built from six tpy domains – dendrimeric core, and 
therefore is a very similar to that presented on Figure 1.20 c.86 
 
Figure 1.21. Reaction scheme for the synthesis of the octadecaruthenium complex.86 
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A first generation tetranuclear complex has been synthesized by reacting together 
pentaerythritol functionalised with 2,2′:6′,2″-terpyridine and ruthenium(III) complex. For 
a second generation dendrimer, the tetranuclear metal species has been coupled with a 
[Ru(tpy)(Cl-tpy)]2+ complex (Figure 1.22).85 
               
 
Figure 1.22. Reaction scheme for the synthesis of metallodendrimers.85 
 
Metallodendrimers and metallostars pictured in Figure 1.21 and 1.22 are examples of 
typical examples of the use of tpy-based ligands, as the building blocks for larger 
systems, namely – metal complexes. Due to the photophysical properties (they absorb a 
significant portion of the visible spectrum, have relatively long-lived excited states (>1 
µs) and exhibit good photochemical stability),87 ruthenium(II) tpy complexes have been 
the focus of big research interest. From all of the enormous possible applications only 
two of the most spectacular are mentioned here: light-powered molecular machines88,89 
and dye sensitized solar cells (Grätzel cells).90-95 
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As already mentioned, ligands with two or more 2,2':6',2"-terpyridine units, depending on 
the type of the spacer used, allows one to obtain basically two types of different 
complexes, either rod-like67-78 (or sometimes linear polymeric) or macrocyclic.79-82 Some 
examples of the linear multinuclear complexes are shown on Figure 1.23. 
Metallomacrocyclic iron(II) complexes shown in Figure 1.24 are the thermodynamic 
products although the initial kinetic products are oligomeric. 
 
 
 
Figure 1.23. Linear multinuclear complexes.67-78 
 
 
Figure 1.24. Macrocyclic multinuclear iron(II) complexes.79-82 
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1.4   Aims of this thesis 
 
The aim of this thesis is to synthesize and characterize a series of ligands containing two 
or three 2,2':6',2"-terpyridine domains, linked by flexible oligo(ethylene glycol) chains 
separated additionally with a phenyl spacer. These ditopic 2,2':6',2"-terpyridine – based 
ligands (L1 – L4, L6 - L7) are the building blocks for heteroleptic dinuclear 
ruthenium(II) as well as homoleptic mononuclear zinc(II) complexes.  
The tritopic 2,2':6',2"-terpyridine ligand (L5) is also a template for binding ruthenium(II) 
into trinuclear complex but due to its flexibility and higher number of coordination sites 
(9), this particular ligand can be used for binding europium(III) and terbium(III).  
All of these complexes, containing a number of metal centers can be further investigated 
for the applications in the energy transfer processes between metal centers. 
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CHAPTER 2 
 
Synthesis of ditopic 4'-substituted- 2,2':6',2''-tpy ligands and 
preliminary study of interactions with Group 1 metals 
 
2.1   Introduction 
 
2,2':6',2''-Terpyridine contains three pyridine rings connected through the α carbon atoms 
with respect to the nitrogen atoms. There are two major methodologies for the synthesis 
of the 2,2':6',2"-terpyridine ligand and its derivatives: ring assembly (Scheme 2.1) and 
cross-coupling procedures (Scheme 2.2).96 In the first method an intermediate diketone 
undergoes a ring closing reaction in the last step in the presence of ammonium acetate 
and ethanol.  
 
Scheme 2.1. The ring-coupling procedure for the synthesis of tpy. 
 
 
Scheme 2.2. The cross-coupling procedure for the synthesis of tpy, R – alkyl or aryl. 
 
The coupling reaction can also be used to prepare "back-to-back" ditopic terpyridine 
ligands,97-100 some examples are shown in Scheme 2.3. A range of 2,5-diethynyl-3,4-
dibutylthiophene-bridged "back-to-back" terpyridine ligands have been prepared by the 
Ziessel group.101 
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Scheme 2.3. "Back-to-back" ditopic tpy ligands.97-101 
 
In this chapter the syntheses of several new ditopic ligands (L1-L4, L6-L7) based on a 
benzene unit connected to two 4'-substituted-2,2':6',2''-terpyridine moieties through 
polyethyleneoxy spacers are discussed. The variability of this group of compounds was 
achieved by using different length ethyleneoxy chains and changing the substitution 
position on the benzene unit (Scheme 2.4).  
 
 
Scheme 2.4. Ditopic ligands L1-L4, L6-L7. 
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2.2   Synthesis 
 
All of the ligands were prepared in two steps by nucleophilic substitution reactions. For 
ligands L1-L4 and L6, firstly the appropriate benzene functionalized with two ethylene 
glycol chains was obtained (L1a-L4a, L6a) by nucleophilic substitution of the 
dibromobenzene derivative (Schemes 2.6, 2.8, 2.10). In the second step a nucleophile 
was generated by deprotonation of the terminal hydroxyl groups, this was then reacted 
further with Cl-tpy (Schemes 2.7, 2.8, 2.11). L7 was synthesized by two nucleophilic 
substitution reactions. In both steps deprotonated hydroxyl groups were reacted with 
electrophilic halogenated reagents.  
4'- Chloro-2,2':6',2"-terpyridine (Cl-tpy) was prepared as previously reported in the 
literature102 (Scheme 2.5). 
 
 
Scheme 2.5. Synthesis of Cl-tpy102 : (i) NaH, MeOCH2CH2OMe; (ii) [NH4][O2CMe], 
EtOH; (iii) PCl5, POCl3. 
 
The syntheses of the ditopic 4'-substituted-2,2':6',2''-terpyridine based ligands (L1-L4, 
L6-L7) are described below. The syntheses of three intermediate products: 2,2'-((((1,3-
phenylenebis(methylene))bis(oxy))bis(ethane-2,1-diyl))bis(oxy))diethanol (L1a), 1,1'-
(1,3-phenylene)bis(2,5,8,11,14,17-hexaoxanonadecan-19-ol) (L2a) and 2,2'-((((((1,3-
phenylenebis(methylene))bis(oxy))bis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl))bis 
(oxy))diethanol (L3a) are shown in Scheme 2.6.  
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Scheme 2.6. Syntheses of L1a-L3a. 
 
L1a-L3a were prepared from 1,3-bis(bromomethyl)benzene, which was heated under 
reflux in the appropriate (n+1)ethylene glycol with sodium hydroxide overnight. 
In the next step, after deprotonation of two terminal hydroxyl groups with KOH in hot 
DMSO, intermediate product (L1a/L2a/L3a) was reacted further with Cl-tpy. After three 
days the desired products were obtained in 55-70% yield after work up. 
 
 
Scheme 2.7. Syntheses of L1-L3. 
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Scheme 2.8. Synthesis of L4a. 
 
L4a was prepared from 1,4-bis(bromomethyl)benzene, under reflux, overnight. The 
hydroxyl groups of 2,2'-oxydiethanol (diethylene glycol) were deprotonated with sodium 
hydroxide. Diethylene glycol was playing in this reaction a double role: as a reagent and 
as the solvent (Scheme 2.8). L4a was then reacted as described above for L1a-L3a 
(Scheme 2.9), yielding 68% of a yellow powder after work up. Other tpy containing 
products were not isolated. 
 
 
Scheme 2.9. Synthesis of L4. 
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Scheme 2.10. Synthesis of L6a. 
 
In the synthesis of L6a, 1,2-bis(bromomethyl)benzene (o-xylylene dibromide) was mixed 
with deprotonated diethylene glycol overnight (Scheme 2.10). The intermediate was then 
reacted with Cl-tpy, followed by purification by column chromatography on alumina with 
CHCl3 resulting in 65% of L6, as a yellow oil (Scheme 2.11). 
 
 
Scheme 2.11. Synthesis of L6. 
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Scheme 2.12. Synthesis of L7a. 
 
The synthesis of L7a required a different strategy than preparations of the previous 
intermediate products, L1a-L4a and L6a. Both of the hydroxyl groups of the 1,2-
dihydroxybenzene were deprotonated with potassium carbonate and 2-(2-
chloroethoxy)ethanol was added to the reaction mixture (Scheme 2.12). L7a was reacted 
further as described previously with Cl-tpy in DMSO. After column chromatography 
(Al2O3, CHCl3), L7 in 63% yield was obtained as a yellow powder. Other tpy containing 
products were not isolated. 
 
 
Scheme 2.13. Synthesis of L7. 
 38 
2.3   1H NMR spectroscopy 
 
All of the intermediate products L1a-L4a, L6a-L7a (Scheme 2.14) and the ligands L1-
L4, L6-L7 (Scheme 2.15) were characterized by 1H NMR spectroscopy in CDCl3. The 
1H NMR spectra of intermediates L1a-L4a, L6a-L7a compare well with those of similar 
crown ether systems8-10 and they are almost identical with each other (Table 2.1). 
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Scheme 2.14. Labeling for L1a-L4a, L6a-L7a intermediates. 
 
The HP protons from compound L1a-L3a and L7a appear in the 1H NMR spectrum as a 
multiplet. Only the HP proton from L6a shows a different multiplicity (singlet), due to 
the higher symmetry of the compound. All of the signals corresponding to the ethylene 
glycol chain HG1-G4/G6/G12 can be found, as expected in the aliphatic region 3.55-3.80 
ppm. The signal around 4.55 ppm is assigned to HF from the -CH2- bridge connecting the 
benzene ring to the ethylene glycol chain. 
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Table 2.1. 1H NMR spectroscopic data, δH [ppm], (400 MHz, 295 K, CDCl3) for L1a-
L4a, L6a-L7a (see page 38 for scheme of labeling). 
 
 
Ditopic intermediates L1a-L4a, L6a-L7a were considered as closely related to crown 
ethers (especially benzo-crown ethers); for this reason all of the spectroscopic data were 
compared with the literature and gave very good agreement with these.103-105 L1a 
intermediate has been already discibed in literature103 and its 1H NMR spectrum matched 
that reported. 
 
 
 
 
 
 
 
 
 
 
 
L HG2-G4/G6/G12 HG1 HF HOH HP 
L1a 3.59–3.76 (m) 3.57 (m) 4.56 (s) 3.34 (br) 
7.18-7.39 
(m) 
L2a 3.60–3.77 (m) 3.55 (m) 4.55 (s) 3.32 (br) 
7.18-7.40 
(m) 
L3a 3.55–3.75 (m) 3.59 (m) 4.57 (s) 3.36 (br) 
7.20-7.40 
(m) 
L4a 3.59–3.77 (m) 3.57 (m) 4.57 (s) 3.36 (br) 7.32 (s) 
L6a 3.59–3.76 (m) 3.55 (m) 4.58 (s) 3.35 (br) 
7.18-7.39 
(m) 
L7a 3.60–3.80 (m) 3.58 (m)  3.34 (br) 
7.18-7.39 
(m) 
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Upon substitution of the free hydroxyl groups on the ethylene glycol chain with chloro-
tpy a lot of changes in chemical shifts can be observed. Table 2.2 shows chemical shifts 
for the protons on ethylene glycol chains HG1-G4/G6/G12 and the -CH2-bridge HF. The 
aromatic protons from tpy and the phenyl spacer are shown in Table 2.3. 
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Scheme 2.15. Labeling for L1-L4, L6-L7 ligands. 
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Table 2.2. 1H NMR spectroscopic shift data, δH [ppm], (500 MHz, 295 K, CDCl3) for 
L1-L2, L4, L6-L7. As an exception L3 was measured at 400 MHz, 295 K, CDCl3. 
 
 
Table 2.3. 1H NMR spectroscopic shift data, δH [ppm], (500 MHz, 295 K, CDCl3) for 
L1-L2, L4, L6-L7. As an exception L3 was measured at 400 MHz, 295 K, CDCl3. 
L HG4/-G6/-G12 HG3 HG2 HG1 HF 
L1 3.63 (m) 3.75 (m) 3.91 (m) 4.37 (m) 4.54 (s) 
L2 3.50-3.65 (m) 3.69 (m) 3.86 (m) 4.32 (m) 4.47 (s) 
L3 3.45-3.75 (m) 
3.45-3.75 
(m) 3.87 (m) 4.34 (m) 4.49 (s) 
L4 3.62 (t) J 5.0 Hz 
3.73 (t) 
J 5.0 Hz 
3.91 (t) 
J 5.0 Hz 
4.38 (t) 
J 5.0 Hz 4.53 (s) 
L6 3.27 (m) 3.34 (m) 3.48 (m) 3.94 (m) 4.26 (s) 
L7 4.17 (m) 3.92 (m) 3.96 (m) 4.34 (m) ─ 
L HT5/HP HT4 HT3' HT3 HT6 
L1 
7.27-7.31 (m)/ 
7.21-7.27(m), 
7.27-7.31 (m) 
7.81 (td) 
J 1.5, 7.8 Hz 8.02 (s) 
8.58 (d) 
J 8.0 Hz 
8.65 (d) 
J 4.1 Hz 
L2 7.15-7.30 (m)/ 7.15-7.30 (m) 
7.76 (t) 
J 7.7 Hz 7.98 (s) 
8.54 (d) 
J 8.0 Hz 
8.61 (d) 
J 4.2 Hz 
L3 7.15-7.30 (m)/ 7.15-7.30 (m) 
7.79 (td) 
J 1.7, 7.8 Hz 7.99 (s) 
8.55 (d) 
J 8.0 Hz 
8.62 (d) 
J 3.9 Hz 
L4 7.30 (m)/ 7.29 (s) 
7.81 (td) 
J 1.8, 7.7 Hz 8.02 (s) 
8.58 (d) 
J 8.0 Hz 
8.66 (d) 
J 4.7 Hz 
L6 
6.92 (m)/ 
6.88 (m), 
7.01 (m) 
7.44 (t) 
J 7.6 Hz 7.65 (s) 
8.20 (d) 
J 8.0 Hz 
8.28 (d) 
J 3.9 Hz 
L7 
7.25 (m)/ 
6.84-6.88 (m), 
6.88-6.92 (m) 
7.77 (td) 
J 1.6, 7.8 Hz 7.99 (s) 
8.54 (d) 
J 7.9 Hz 
8.62 (d) 
J 4.7 Hz 
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3.63.84.04.24.44.67.17.37.57.77.98.18.38.58.7
*
HG1 HG2 HG3 HG4
HF
HP2,P3,P5,P6
HT5H
T4
HT3
HT6
HT3’
L4
Figure 2.1. 1H NMR spectrum (500 MHz, 295 K) of L4 in CDCl3. The signal marked 
with * is the signal for CHCl3. 
 
The 1H NMR spectrum of ligand L4 shows six signals in the aromatic region: five signals 
for the protons on tpy: HT5, HT3, HT3', HT4, HT5 and the sixth signal comes from the 
protons on the phenyl spacer. Due to the symmetrical substitution on the benzene ring all 
of the phenyl protons are equivalent and give rise to a singlet (Figure 2.1).  
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Figure 2.2. Aliphatic region of the 1H-1H COSY spectrum (500 MHz, 295 K) of L4 in 
CDCl3. 
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In the aliphatic region, in the NMR spectrum of ligand L4, there is one singlet for the HF 
proton and four well separated triplets from the HG protons on the diethylene glycol 
chains. The signal for HG1 is the strongest shifted downfield due to its close proximity to 
the tpy unit. The assignment of the HG1, HG2, HG3 and HG4 protons of the L4 ligand was 
made using the COSY technique (Figure 2.2). The signal for HG1 gives a COSY cross 
peak to the signal HG2 at δ 3.91 ppm (Figure 2.2). The signal for HG3 gives a COSY 
cross peak to the signal at δ 3.62 ppm, and this signal is assigned to HG4 (Figure 2.2). 
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Figure 2.3. 1H NMR spectra (500 MHz, 295 K) of L6 (above) and L1 (below) in CDCl3. 
The signal marked with * is the signal for CHCl3. Spectrum exhibits some residues of the 
starting material, which could not be removed by column chromatography or other 
purification methods. 
 
In Figure 2.3 the 1H NMR spectra of ligands L6 and L1 are compared. Both spectra have 
the usual features of this group of terpyridine ligands and are almost identical to each 
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other, but the signals for protons of L6 are all shifted upfield. The reason for these 
changes in the NMR spectrum is most probably the ortho- substitution on the benzene 
ring in ligand L6. 
*
HG1 HG2
HG3-HG6
HG3
HF
HT4H
T3HT6
HT3’
HP, HT5
HG1 HG2
HG4-HG12
HF
HT4H
T3HT6
HT3’
HP,  HT5
*
HG1 HG2 HG3H
T4HT3HT6
HT3’
HT5
HP HG4
L3
L2
L7
O
O
O
O
O
O
P3P6
P4P5
P2P1
F
O
G1
G2 G3
G4 G5
G6
T3
T2
T6
T4
T5
T3'
T2'
T4'
O
N
N
N
N
N
N
O
O
O
O
O
O
G1
P3P6
P4P5
P2P1
F
G4
G2 G3
O
O
O
O
O
O
O
O
G5
G6 G7
G8 G9
G10 G11
G12
N
N
N
N
N
N
T3
T2
T6 T4
T5
T3'
T2'
T4'
P1
P2
P3
P4
P5P6
G1
G2 G3
G4
T3
T2
T6
T4
T5
T3'
T2'
T4'
O
OO
OO
O
N
N
N
N
N
N
 
 
Figure 2.4. 1H NMR spectra (500 MHz, 295 K, for L3 400 MHz, 295 K) of L3 (above), 
L2 (middle) and L7 (below) in CDCl3. The signal marked with * is the signal for CHCl3. 
 
The ligands L2 and L3 have the longest glycol spacers with six and three -CH2-CH2- 
groups respectively. Most of the protons HG from the ethylene glycol chains of ligand L2 
and ligand L3 overlap on the 1H NMR spectrum and can be found together as one 
multiplet between δ 3.40-3.80 ppm. The signal at δ 4.47 ppm, for ligand L2 and at δ 4.49 
ppm, for ligand L3 is assigned to proton HF. There are six signals excluding the signal 
for CHCl3, in the aromatic region for both ligands L2 and L3: HT6, HT3, HT3', HT4, HP 
and HT5 are overlapping.  
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The 1H NMR spectrum of ligand L7 looks very different from those discussed above 
(Figure 2.4). Ligand L7 has two flexible glycol chains directly attached to the benzene 
ring through the oxygen, unlike ligands L1-L4, L6, in which the glycols are attached 
through a -CH2- bridge. This does not affect any of the protons on the terpyridine: HT6, 
HT3, HT3', HT4, HT5 of ligand L7, but has a strong influence on the HP protons on the 
phenyl ring. From the NOESY spectrum (Figure 2.5), the two multiplets at δ 6.84-6.88 
and 6.88-6.92 ppm can be assigned to HP3/P4 and HP2/P5. Both signals, from protons 
HP3/P4 and HP2/P5, give cross peaks to the signal for HG4 at δ 4.17 ppm, which is the 
closest glycol proton to the benzene ring. Due to the ortho- substitution on the benzene 
ring proton HP3 is equivalent to proton HP4, and proton HP2 to HP5.  
 
 
HG4
HP2/P5 HP3/P4
 
Figure 2.5. NOESY spectrum (500 MHz, 295 K) of L7 in CDCl3. 
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From the 1H-1H COSY spectrum, all of the protons in the aliphatic region can be 
assigned. As in the other ligands L1-L4 and L6, proton HG1 of the glycol chains of ligand 
L7 is most shifted downfield, influenced by the tpy substituent. Proton HG1 gives a 
COSY cross peak to the signal for HG2 at δ 3.96 ppm. The signals for HG3 and HG4 
couple with each other giving a cross peak in the COSY spectrum. In comparison with 
the ligands L1-L4 and L6, the signals for both HG3 and HG4 are downfield shifted, which 
is an effect of the phenyl ring and the lack of the -CH2- bridge.  
HG1 HG2 HG3H
G4
HG1
HG2
HG3
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Figure 2.6. Part of the COSY spectrum (500 MHz, 295 K) of L7 in CDCl3 showing the 
aliphatic region. Spectrum exhibits some residues of the starting material, which could 
not be removed by column chromatography or other purification methods. 
 
 
 
 
2.4   13C NMR spectroscopy 
 
Table 2.4 shows the ethylene glycol CG, CF and phenyl CP carbon signals for L1-L4 and 
L6-L7 in CDCl3 solution. All of the terpyridine carbon signals are shown in the Table 
2.5. The assignments were made using HMQC and HMBC techniques. 
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L CG1 CG2 CG3 C
G4/ 
CG5-G12 C
F
 
CP/ 
(#)CP 
(quaternary) 
L1 68.0 69.8 71.2 69.7 73.4 
127.2 
127.3 
128.7 
(#)138.6 
L2 67.8 69.5 71.0 
69.4/ 
70.6 
70.6 
70.7 
73.2 
127.0 
127.1 
(#)138.4 
L4 67.7 69.7 71.2 68.0 73.3 128.0 (#)137.7 
L6 67. 0 68.5 70.1 68.9 70.0 
126.9 
127.9 
(#)135.7 
L7 68.0 69.8 70.3 69.2 ─ 
115.2 
121.9 
(#)149.2 
 
Table 2.4. 13C NMR spectroscopic shift data, δC [ppm], (125 MHz, 295 K, CDCl3) for 
L1-L2, L4, L6-L7 (see page 40 for scheme of labeling). 
 
 
 
Table 2.5. 13C NMR spectroscopic shift data, δC [ppm], (125 MHz, 295 K, CDCl3) for 
L1-L2, L4, L6-L7 (see page 40 for scheme of labeling). 
L CT3' CT3 CT5 CT4 CT6 CT2 CT2' CT4' 
L1 107.7 121.5 124.0 136.9 149.2 156.3 157.3 167.2 
L2 107.5 121.3 123.9 136.8 149.1 156.0 157.1 167.0 
L4 107.6 121.5 124.0 137.00 149.2 156.3 157.3 167.1 
L6 106.5 120.5 123.3 136.1 148.3 155.0 156.2 166.1 
L7 107.6 121.4 123.9 136.8 149.2 156.1 157.2 167.1 
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Figure. 2.7. Part of the HMQC spectrum (500 MHz, 295 K) of L1 in CDCl3. 
 
In the Figure 2.7 the cross peaks of the aliphatic protons of the ligand L1 : HG1-4 and HF 
to the direct carbons signal are shown. The signals could be easily assigned using the 
HMQC spectrum. The HMBC spectrum (Figure 2.8) exhibits the expected cross-peaks 
consistent with the proposed molecular structure. The signal for HG3 is coupling with the 
signals for carbon CG2 and CG4 and the for HG4 is coupling with the signals for carbon 
CG3 and CF.  
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Figure. 2.8. Part of the HMBC spectrum (500 MHz, 295 K) of L1 in CDCl3. 
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Figure 2.9. Part of the HMBC spectrum (500 MHz, 295 K) of L4 in CDCl3. 
 
In the HMBC spectrum, the signal for the quaternary carbons CP1,P4 of ligand L4 couples 
over two bonds to the HF proton. Using this method, this small peak could be assigned 
(Figure 2.9). In Figure 2.10 two carbon-proton cross peaks for HP2,P3,P5,P6 to CP2,P3,P5,P6 
and H T5 to CT5 are shown. 
*HP2,P3,P5,P6
HT5
CP2,P3,P5,P6
CT5
 
Figure 2.10. Part of the HMQC spectrum (500 MHz, 295 K) of L4 in CDCl3. 
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Figure 2.11. Part of the HMQC spectrum (500 MHz, 295 K) of L6 in CDCl3. 
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Figure 2.12. Part of the HMQC spectrum (500 MHz, 295 K) of L6 in CDCl3. 
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As already observed for the proton signals of ligand L6 the carbon signals are also shifted 
upfield (Table 2.4 and 2.5). In the aliphatic region there are some additional changes in 
comparison to the other ligands. The carbon CF is influenced very strongly and shifted 
upfield, to the frequency even lower than carbon CG3. The signal for CG2 carbon is 
shifted upfield more than one ppm and in contrast to the other ligands it is shifted to the 
lower energy than carbon CG4 (Figure 2.11). In Figure 2.12 the assignments for the 
carbon signals for tpy and phenyl are shown. The missing signal for quaternary carbons 
CP1,P6 were observed next to the carbon CT4.  
 
For the ligand L7 only carbon signals for CG3 and CG4 protons are upfield shifted (Table 
2.4). These are the carbons the closest to the phenyl ring and this is most probably an 
effect of the lack of the -CH2- bridge. In the HMBC spectrum there is the cross peak for 
the proton HG4 to the carbon CT5, which suggests that signal for quaternary carbons 
CP1,P6 must be overlapping with signal for carbon CT5 (Figure 2.13). In the same figure 
one can observe that the proton HG1 couples over three bonds to carbon CT4'. Both carbon 
signals for phenyl protons CP2/P5 and CP3/P4 could be assigned using the HMQC 
technique (Figure 2.14).  
HG1 HG2 HG3HG4
CP1,P6
and
CT5
CT4’
 
Figure 2.13. Part of the HMBC spectrum (500 MHz, 295 K) of L7 in CDCl3. Spectrum 
exhibits some residues of the starting material, which could not be removed by column 
chromatography or other purification methods. 
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Figure 2.14. Part of the HMQC spectrum (500 MHz, 295 K) of L7 in CDCl3. 
 
 
 
 
2.5   Mass spectrometric characterization 
 
Electrospray ionization (ESI) and MALDI-TOF mass spectrometry, both in positive 
mode, were used to characterize intermediates L1a-L4a and L6a-L7a and ligands L1-L4 
and L6-L7. Normally, the [L+H]+ peak was found as the major peak. In some 
measurements [L+Na]+ could also be observed. Scanning with a laser in the MALDI-
TOF method is a harder method and can cause fragmentation of some compounds (for 
example fragmentation on one or both of the glycol chains). 
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2.6   NMR titrations of ligand L1 with alkali metal ions: Na+ 
and Li+ 
 
Despite the important role of alkali metal ions in biological and material sciences,107,108 
their coordination chemistry, especially with classical ligands, has received little 
attention, in comparison with transition metal ions.109 Although the discovery of crown 
ethers110 and cryptands111 opened a new era in coordination chemistry of the alkali metal 
ions, their complexes with more conventional ligands have remained much less 
investigated. Pedersen reported in 1967, thirty-three cyclic polyethers, derived from 
aromatic vicinal diols and containing from 9 to 60 atoms including 3 to 20 oxygen atoms 
in the ring. Many of those containing five to ten oxygen atoms form stable complexes 
with some or all of the cations of: Li, Na, NH4, RNH3, K, Rb, Cs, Ag(I), Au(I), Ca, Sr, 
Ba, Cd, Hg(I), Hg(II), La(III), Tl(I), Ce(III) and Pb(II).110 Most of the attempts to study 
these alkali metals complexes were focused on the isolation of the solid adducts of the 
alkali metal salts with a variety of chelating and non-chelating ligands.109 Morita and co-
workers have prepared a number of complexes with dicyano-monoalkyl-tetraaza 
macrocycles with lithium salts and the properties of resulting macrocycle complexes 
were examined in detail by means of 1H NMR spectroscopy.112 An unsymmetrical 
macrocycle has exhibited intriguing features, such as high selectivity for binding to the 
Li+ ion. The unusual Li+ complexation reactions have their origin in the unique properties 
of the metal free macrocycle, due to the fact that macrocycle has a strong intramolecular 
hydrogen bond in the macrocyclic ring and the highly strained macrocyclic ring by 
unsymmetrical structure consisting of nonplanar and planar moieties.112 Recently Baulin 
and Kurochkina have reported the sodium, calcium and potassium complexes of benzo-
15-crown-5-substituted terpyridines.113 In the Ishimori group, highly effective and 
selective synergistic extraction of Li+ has been found using 2-naphthoyltrifluoroacetone 
(Hnta) as an acidic chelating agent and 2,9-dimethyl-1,10-phenanthroline (dmp) or 2,9-
dimethyl-4,7-diphenyl-1,10-phenanthroline (dmdpp) as a neutral coligands.114 The 
electronic and steric effects of the methyl groups at 2,9-positions of phen on the 
thermodynamic functions of adduct formation as well as the high lithium selectivity were 
quantitatively elucidated.114 Starova and Denisova have been investigating the solid 
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phase formed in acetone at a 1,10-phenanthroline (phen):LiClO4 concentration ratio close 
to 2: 1. According to X-ray diffraction data, the molecular structure of bis(1,10-
phenanthroline)lithium perchlorate consists of a flattered tetrahedron Li(phen)2+ cation. 
The IR spectral data show that the complex dissociates in acetone to a 1:1 complex and a 
phen molecule.115 The role of nitrogen in the charge transfer and storage capacity of 
lithium-intercalated heterocyclic oligophenylenes was investigated using photoelectron 
spectroscopy by Doherty and Friedlein. The development of new occupied states at low 
binding energies in the valence band region, as well as core level chemical shifts at both 
carbon and nitrogen sites, demonstrates partial charge transfer from lithium atoms to the 
organic component during formation of the intercalated compound. In small compounds, 
i.e., biphenyl and bipyridine derivatives, the position of the nitrogen heteroatom 
significantly affects the spacing between gap states in the Li-intercalated film; yet it has 
minimal effects on the charge storage capacity. In larger, branched systems, the presence 
of nitrogen in the aromatic system significantly enhances the charge storage capacity 
while the Li-N bond strength at high intercalation levels is significantly weakened 
relative to the nitrogen-free derivative. These observations have important implications 
for improved deintercalation processes in organic electrodes in lithium-ion batteries.116 A 
new sodium tetrafluoroborate bridged neutral helical coordination polymer, formulated as 
[Na(1,10-phenanthroline)BF4](n), has been synthesized and characterized by Huang, W. 
and H. F. Qian. X-ray single crystal determination reveals that the Na center has hexa-
coordinate distorted octahedron coordination geometry and the BF4- anion serves as a 
multidentate bridging ligand coordinated to three adjacent sodium cations forming an 
infinite one-dimensional single-strand helix. Mostly likely this complex is an 
unprecedented type of helical structure in which only coordinated alkali metal sodium 
and bridging tetrafluoroborate are present.117 Sauvage has reported a compound in which 
Li+ is used as an assembling centre to generate a double-stranded helical complex from 
two linear coordinating fragments, each containing three 1,10-phenanthroline units and 
bearing terminal olefins at their ends; ruthenium-catalyzed ring-closing metathesis on the 
helical precursor leads to a 4-crossing [2]-catenane in 30% yield, making the procedure 
reasonably preparative (Figure 2.15).118  
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Figure 2.15. Synthesis of a dilithium catenate.118 
 
A few attempts have been made to study such alkali complexes in solutions, and 
particularly in nonaqueous solutions.119,120 The reason for such a low interest in the 
solution studies is the fact that the interactions of conventional ligands with alkali metal 
ions are relatively weak and most of the physicochemical techniques are not sensitive 
enough. 
 
In this section we report an NMR study of the complexation of Na+ and Li+ ions with the 
new ditopic 4'-substituted- 2,2':6',2''-terpyridine ligand L1 in acetonitrile. 
 
To determine conditional stability constants, NMR titrations of ligand L1 with NaClO4 
and LiClO4 solutions were performed. A 1.3×10-2 M solution of ligand L1 was titrated 
with 1 M NaClO4 and 1H NMR spectra were recorded after each addition of Na+ starting 
from 0.8 eq up to a total concentration ratio R = Na+/L1 = 12. For titration with LiClO4, 
to 1.3×10-2 M ligand L1 solution 0.5 M Li+ was added and 1H NMR spectra were 
recorded after each addition of metal solution starting from 0.2 eq up to a total 
concentration ratio R = Li+/L1 = 4.6. All of the titrations were conducted in CD3CN 
solution (Figures 2.16, 2.17. 2.18 and 2.19).  
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Figure 2.16. Part of the 1H NMR spectra (500 MHz, 295 K) of L1 (bottom spectrum) 
with increasing amount of NaClO4 (from bottom up) in CD3CN. 
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Figure 2.17. Aromatic region of the 1H NMR spectra (500 MHz, 295 K) of L1 (bottom 
spectrum) with increasing amount of NaClO4 (from bottom up) in CD3CN. 
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Addition of the NaClO4 solution results in a few significant changes in the 1H NMR 
spectrum of ligand L1 (Figures 2.16 and 2.17). In the aromatic region, signals assigned 
to the protons HT6 and HT3' of ligand L1 are both strongly shifted upfield. Also the 
multiplet for protons HP is shifted upfield and additionally is changing its multiplicity to 
a singlet. This suggests that upon addition of NaClO4, the geometry of the created species 
changes in such a way that all of the protons on the benzene ring are equivalent. In the 
aliphatic region of the 1H NMR spectrum of ligand L1, after addition of the NaClO4, only 
small changes are observed. The signal at δ 4.54 ppm which is assigned to HF from the -
CH2- bridge connecting the benzene ring to the ethylene glycol chain is slightly shifted 
upfield. After addition of the 8 equivalents of NaClO4, further addition resulted in no 
more significant changes in the 1H NMR spectrum being observed.  
 
 
The addition of the LiClO4 results in more marked changes in the 1H NMR spectrum of 
ligand L1 (Figures 2.18 and 2.19). In the aromatic region, the signal assigned to proton 
HT3 is slightly shifted downfield. Proton HT6 is shifted strongly upfield and after the 
addition of 1.5 equivalents of LiClO4, overlaps with a triplet from proton HT4. The most 
affected by the addition of LiClO4 is the signal for proton HT3', this signal is shifted 
upfield from δ 8.02 ppm to δ 7.17 ppm, at the end of the titration. Also the signal for 
protons HP is shifted upfield and this multiplet separates to two signals. In the aliphatic 
region of the 1H NMR spectrum of ligand L1 after addition of LiClO4, similar changes to 
the titration with NaClO4 can be observed, namely the signal at δ 4.54 ppm from proton 
HF is slightly shifted upfield. After the addition of 1.5 equivalents of LiClO4 salt, no 
more significant changes in the 1H NMR spectrum are observed.  
 
The signal at δ 7.58 ppm is the signal for chloroform. A small amount of this solvent was 
used to dissolve ligand. 
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Figure 2.18. Part of the 1H NMR spectra (500 MHz, 295 K) of L1 (bottom spectrum) 
with increasing amount of LiClO4 (from bottom up) in CD3CN. 
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Figure 2.19. Aromatic region of the 1H NMR spectra (500 MHz, 295 K) of L1 (bottom 
spectrum) with increasing amount of LiClO4 (from bottom up) in CD3CN. 
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All of the changes in chemical shifts in 1H NMR spectra after addition of NaClO4 
(Tabele 2.6) or LiClO4 (Tabele 2.7) are shown below. As one can notice from tables, the 
less affected by metal addition proton signals are HG, HT4 and HT6. In contrast, the most 
sensitive to increasing amounts of sodium or lithium perchlorate is proton HT3'.  
The changes in chemical shifts of HT3' (∆δ HT3' [ppm]) as a function of added NaClO4 or 
LiClO4 are shown in Figures 2.20 and 2.21.  
 
 
1H Before addition [ppm] 
After addition 
[ppm] ∆δ 
HG4 3.63 3.60 -0.03 
HG3 3.75 3.69 -0.06 
HG2 3.91 3.86 -0.05 
HG1 4.37 4.32 -0.05 
HF 4.54 4.38 -0.19 
HP 7.24 7.09 -0.15 
HT5 7.29 7.42 0.13 
HT4 7.81 7.89 0.07 
HT3' 8.02 7.62 -0.40 
HT3 8.58 8.18 -0.40 
HT6 8.65 8.67 0.02 
 
Table 2.6. Changes in chemical shifts of 1H (∆δ H) after addition of NaClO4 (12 eq). 
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1H Before addition [ppm] 
After addition 
[ppm] ∆δ 
HG4 3.63 3.70 0.07 
HG3 3.75 3.82 0.07 
HG2 3.91 3.90 -0.01 
HG1 4.37 4.20 -0.17 
HF 4.54 4.15 -0.39 
HP 7.24 6.46 6.77 
-0.78 
-0.47 
HT5 7.29 7.56 0.27 
HT4 7.81 7.89 0.08 
HT3' 8.02 7.17 -0.85 
HT3 8.58 7.89 -0.69 
HT6 8.65 8.77 0.12 
 
Table 2.7. Changes in chemical shifts of 1H (∆δ H) after addition of LiClO4 (4.6 eq). 
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Figure 2.20. Changes in chemical shifts of HT3' (∆δ HT3' [ppm]) as a function of added 
NaClO4 [eq] together with best fit curve.  
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Figure 2.21. Changes in chemical shifts of HT3' (∆δ HT3' [ppm]) as a function of added 
LiClO4 [eq] together with best fit curve. 
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The stability of the resulting complexes were evaluated from non-linear least-squares 
fitting of the chemical shift-mole ratio data of the 3' proton to appropriate equations by 
using WinEQNMR2 (Version 2.00 by Michael J. Hynes, National University of Ireland, 
Galway). 
 
Na+   +   L1 ↔ [NaL1] +                    logΚ 
 
Li+   +   L1 ↔ [LiL1] +                      logΚ 
 
 
 LogΚa 
Na+ 1.03 
Li+ 2.69 
 
Table 2.8. Conditional stability constants for [NaL1]+ and [LiL1]+ in CD3CN. a esd 
values on calculated K values were 15 (Li) and 0.6 (Na). 
 
 
The overall stability of the resulting Li+ complex with the ditopic 4'-substituted- 
2,2':6',2''-terpyridine ligand L1 is higher than that of the corresponding Na+ complex 
(Table 2.6). The lithium ion, with a higher charge density and harder character, is 
expected to form more stable complex with tpy ligands. 
 
It seems reasonable to assume that the nitrogen atoms of tpy substituent act as more 
effective donating groups than the oxygen atoms of the glycol chains for Li+ and Na+ 
ions. 
 
For comparison conditional stability constant values of sodium and lithium complexes 
with bpy and phen in acetonitrile and with tpy and bpy in nitromethane are shown in 
Table 2.9. The orders of magnitude of logK values are comparable to the conditional 
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stability constants found for [NaL1]+ and [LiL1]+ in CD3CN. It is imported to notice that 
conditional stability constant of tpy complex with lithium in nitromethane is higher than 
this of [LiL1]+ in acetonitrile by almost one order of the magnitude and conditional 
stability constant of tpy complex with sodium in nitromethane is slightly smaller than this 
of [NaL1]+ in acetonitrile. 
 
 
 LogΚ1 
bpy + Na+ (in acetonitrile) 1.31(7)121 
bpy + Li+ (in acetonitrile) 2.11(7)121 
phen+ Na+ (in acetonitrile) 1.55(7)121 
phen + Li+ (in acetonitrile) 2.28(7)121 
bpy + Na+ (in nitromethane) 2.39(7)121 
bpy + Li+ (in nitromethane) 2.44(7)121 
tpy + Na+ (in nitromethane) 1.67(7)121 
tpy + Li+ (in nitromethane) 3.24(6)121 
 
Table 2.9. Conditional stability constants for some 1:1 Na+ and Li+ complexes.121 
 
 
In Table 2.10 conditional stability constant of transition metals tpy complexes are shown. 
All of the presented in table transition metals are binding tpy ligands much stronger, from 
two to six times, than the alkali metal ions: Li+ and Na+. 
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 LogK1 LogK2 
tpy + Fe2+ 7.1(4)122 12.9(5)122 
tpy + Co2+ 8.4(4)122 9.9(3)122 
tpy + Mn2+ 4.4(5)122 - 
tpy + Cd2+ 5.1(2)122 - 
tpy + Ni2+ 10.7(5)122 11.1(2)122 
tpy + Zn2+ 6.0(1)122 - 
 
Table 2.10. Conditional stability constants for transition metal tpy complexes.122 
 
 
 
 
2.7   Conclusion 
 
In this chapter, several new ditopic intermediates L1a-L4a, L6a-L7a and ligands L1-L4, 
L6-L7, which are based on a benzene unit connected to two 4'-substituted- 2,2':6',2''-
terpyridine moieties through different polyethyleneoxy spacers were synthesized and 
characterized by 1H and 13C NMR spectroscopy, mass spectrometry (ESI-MS and 
MALDI-TOF), IR spectroscopy, UV-Vis spectroscopy and elemental analysis. The 
ligands were also preliminary studied for interactions with Group 1 metals. 
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2.8   Experimental 
 
 1,3-Bis(7-hydroxy-2,5-dioxaheptyl)benzene (L1a) 
 1,3-Bis(19-hydroxy-2,5,8,11,14,17-hexaoctanonadecyl)benzene (L2a) 
 1,3-Bis(10-hydroxy-2,5,8-trioxadecyl)benzene (L3a) 
 1,4-Bis(7-hydroxy-2,5-dioxaheptyl)benzene (L4a) 
 1,2-Bis(7-hydroxy-2,5-dioxaheptyl)benzene (L6a) 
 1,3-Bis(6-hydroxy-1,4-dioxahexyl)benzene (L7a) 
 
 
4'- Chloro-2,2':6',2"-terpyridine was prepared as previously reported in the literature.102 
 
 
 
 
 1,3-Bis(7-hydroxy-2,5-dioxaheptyl)benzene (L1a) 
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General procedure for ditopic intermediates L1a-L4a, L6a-L7a 
 
The intermediates were only characterized in a crude form by 1H NMR spectroscopy and 
MALDI MS. 
 
1,3-Bis(bromomethyl)benzene (97%, Alfa Aesar) (1.0 g, 3.8 mmol) was added to a hot 
suspension of NaOH (0.35 g, 8.8 mmol) in 50 mL diethylene glycol. The reaction 
mixture was stirred overnight at 125 °C under nitrogen. After 10 h the reaction mixture 
was cooled to room temperature and quenched with 100 mL water, then extracted with 
CHCl3 (4x100 mL). The organic layer was dried (MgSO4) filtered and the solvent was 
removed in vacuo. The product L1a was collected as a yellow oil (0.95 g, 3.0 mmol, 
80%) after column chromatography (Al2O3, CHCl3).  
 
The reaction could be also performed in a microwave reactor at 125 °C for 15 minutes 
but on a much smaller scale. 1,3-Bis(bromomethyl)benzene (97%, Alfa Aesar) was 
reacted with NaOH (0.040 g, 0.88 mmol) in 10 mL diethylene glycol. After work up, the 
product L1a was obtained in 50% yield (0.063 g, 0.19 mmol). Other tpy containing 
products were not isolated. Despite the lower yield, this method allowed the reaction time 
to be shortened from 10 hours to 15 minutes. 
 
1H NMR (400 MHz, CDCl3) δH 3.34 (br, 2H, HOH), 3.57 (m, 4H, HG1), 3.59–3.76 (m, 
12H, HG2-G4), 4.56 (s, 4H, HF), 7.18-7.39 (m, 4H, HP2, P3, P4, P6). 
 
MS (MALDI-TOF, sinapinic acid): m/z = 337.5 [L1a+Na]+ (calc. 337.5), 315.5 
[L1a+H]+ (calc. 315.5). 
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 1,3-Bis(19-hydroxy-2,5,8,11,14,17-hexaoctanonadecyl)benzene (L2a) 
 
Br Br
NaOH, ref lux, overnight1,3-bis(bromomethyl)
benzene
Molecular formula: C32H58O14
Molecular weight: 666.79
O
O
O
O
O
O
G1
P3
P6
P4
P5
P2
P1
F
G4
G2
G3
O
O
O
OH
O
O
O
HO
G5
G6
G7
G8
G9
G10
G11
G12
1,3-bis(19-hydroxy-2,5,8,11,14,17-
hexaoctanonadecyl)benzene (L2a)
3,6,9,12,15-pentaoxa
heptadecane-1,17-diol
(haxaethylene glycol)
 
 
Compound L2a was synthesized according to general procedure for ditopic intermediates 
with 1,3-bis(bromomethyl)benzene (97%, Alfa Aesar) (1.0 g, 3.8 mmol), NaOH (0.35 g, 
8.8 mmol) and hexaethylene glycol (2.2 g, 7.6 mmol) in 50 mL DMSO. The product L2a 
was collected as a yellow oil (2.1 g, 3.1 mmol, 82%) after column chromatography 
(Al2O3, CHCl3). 
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1H NMR (400 MHz, CDCl3) δH 3.32 (br, 2H, HOH), 3.55 (m, 4H, HG1), 3.60–3.77 (m, 
44H, HG2-G12), 4.55 (s, 4H, HF), 7.18-7.40 (m, 4H, HP2, P3, P4, P6). 
 
MS (MALDI-TOF, sinapinic acid): m/z = 667.8 [L2a+H]+ (calc. 667.5). 
 
 
 
 
 
 1,3-Bis(10-hydroxy-2,5,8-trioxadecyl)benzene (L3a) 
 
 
 
Compound L3a was synthesized according to general procedure for ditopic intermediates 
with 1,3-bis(bromomethyl)benzene (97%, Alfa Aesar) (1.0 g, 3.8 mmol) and NaOH (0.35 
g, 8.8 mmol) in 50 mL triethylene glycol. The product L3a was collected as a yellow oil 
(1.2 g, 3.0 mmol, 80%) after column chromatography (Al2O3, CHCl3). 
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The reaction could be also performed in a microwave reactor at 125 °C for 15 minutes 
but on a much smaller scale. 1,3-Bis(bromomethyl)benzene (97%, Alfa Aesar) was 
reacted with NaOH (0.040 g, 0.88 mmol) in 10 mL diethylene glycol. After work up, the 
product L3a was obtained in 50% yield (0.076 g, 0.19 mmol). Despite the lower yield, 
this method allowed the reaction time to be shortened from 10 hours to 15 minutes. 
 
1H NMR (400 MHz, CDCl3) δH 3.36 (br, 2H, HOH), 3.59 (m, 4H, HG1), 3.55–3.75 (m, 
20H, HG2-G6), 4.57 (s, 4H, HF), 7.20-7.40 (m, 4H, HP2, P3, P4, P6). 
 
MS (MALDI-TOF, sinapinic acid): m/z = 425.5 [L3a+Na]+ (calc. 425.5), 403.5 
[L3a+H]+ (calc. 403.5). 
 
 
 
 
 
 1,4-Bis(7-hydroxy-2,5-dioxaheptyl)benzene (L4a) 
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Compound L4a was synthesized according to general procedure for ditopic intermediates 
with 1,4-bis(bromomethyl)benzene (97%, Alfa Aesar) (1.0 g, 3.8 mmol) and NaOH (0.35 
g, 8.8 mmol) in 50 mL diethylene glycol. The product L4a was collected as a yellow oil 
(1.1 g, 3.4 mmol, 90%) after column chromatography (Al2O3, CHCl3). 
 
The reaction could be also performed in a microwave reactor at 125 °C for 15 minutes 
but on a much smaller scale. 1,4-Bis(bromomethyl)benzene (97%, Alfa Aesar) was 
reacted with NaOH (0.040 g, 0.88 mmol) in 10 mL diethylene glycol. After work up, the 
product L4a was obtained in 60% yield (0.072 g, 0.23 mmol). Despite the lower yield, 
this method allowed the reaction time to be shortened from 10 hours to 15 minutes. 
 
1H NMR (400 MHz, CDCl3) δH 3.36 (br, 2H, HOH), 3.57 (m, 4H, HG1), 3.59–3.77 (m, 
12H, HG2-G4), 4.57 (s, 4H, HF), 7.32 (s, 4H, HP2, P3, P5, P6). 
 
MS (MALDI-TOF, sinapinic acid): m/z = 315.4 [L4a+H]+ (calc. 315.5). 
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 1,2-Bis(7-hydroxy-2,5-dioxaheptyl)benzene (L6a) 
 
 
Compound L6a was synthesized according to general procedure for ditopic intermediates 
with 1,2-bis(bromomethyl)benzene (97%, Alfa Aesar) (1.0 g, 3.8 mmol) and NaOH (0.35 
g, 8.8 mmol) in 50 mL diethylene glycol. The product L6a was collected as a yellow oil 
(1.0 g, 3.2 mmol, 85%) after column chromatography (Al2O3, CHCl3). 
 
The reaction could be also performed in a microwave reactor at 125 °C for 15 minutes 
but on a much smaller scale. 1,2-Bis(bromomethyl)benzene (97%, Alfa Aesar) was 
reacted with NaOH (0.040 g, 0.88 mmol) in 10 mL diethylene glycol. After work up, the 
product L6a was obtained in 50% yield (0.063 g, 0.19 mmol).  
 
1H NMR (400 MHz, CDCl3) δH 3.35 (br, 2H, HOH), 3.55 (m, 4H, HG1), 3.59–3.76 (m, 
12H, HG2-G4), 4.58 (s, 4H, HF), 7.18-7.39 (m, 4H, HP2, P3, P4, P5). 
 
MS (MALDI-TOF, sinapinic acid): m/z = 327.5 [L6a+Na]+ (calc. 327.5), 315.5 
[L6a+H]+ (calc. 315.5). 
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 1,3-Bis(6-hydroxy-1,4-dioxahexyl)benzene (L7a) 
 
 
 
1,2-Dihydroxybenzene (>98%, Fluka) (1.0 g, 9.1 mmol) was added to a hot mixture of 
K2CO3 (3.5 g, 25 mmol) and 2-(2-chloroethoxy)ethanol (2.5 g, 20 mmol) in 50 mL DMF. 
The reaction mixture was stirred overnight at 70 °C under nitrogen. After 10 h the 
reaction mixture was cooled to room temperature and quenched with 100 mL water, then 
extracted with CHCl3 (4x100 mL). The organic layer was dried (MgSO4) filtered and the 
solvent was removed in vacuo. The product L7a was collected as a yellow oil (2.1 g, 7.3 
mmol, 80%) after column chromatography (Al2O3, CHCl3).  
 
1H NMR (400 MHz, CDCl3) δH 3.34 (br, 2H, HOH), 3.58 (m, 4H, HG1), 3.60–3.80 (m, 
12H, HG2-G4), 7.18-7.39 (m, 4H, HP2, P3, P4, P5). 
 
MS (MALDI-TOF, sinapinic acid): m/z = 289.3 [L7a+H]+ (calc. 289.5). 
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 1,3-Bis(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)benzene (L1) 
 1,3-Bis(20-(4'-(2,2':6',2''-terpyridyl))-2,5,8,11,14,17,20-heptaoxaeikosyl)benzene 
(L2) 
 1,3-Bis(11-(4'-(2,2':6',2''-terpyridyl))-2,5,8,11-tetraoxaundecyl)benzene (L3) 
 1,4-Bis(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)benzene (L4) 
 1,2-Bis(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)benzene (L6) 
 1,2-Bis(7-(4'-(2,2':6',2''-terpyridyl))-1,4,7-trioxaheptyl)benzene (L7) 
 
 
 
 
 
 1,3-Bis(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)benzene (L1) 
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General procedure for ditopic ligands L1-L4 and L6-L7 
 
Compound L1a (0.50 g, 1.6 mmol) and finely powdered potassium hydroxide (0.31 g, 
5.0 mmol) were stirred in 20 mL DMSO at 75 °C under nitrogen for 1 hour. Cl-tpy (1.4 
g, 5.0 mmol) was added to the suspension and the mixture was stirred for 3 days at 75 °C. 
The reaction mixture was cooled to room temperature and quenched with 200 mL water, 
then extracted with CHCl3 (3x200 mL). The organic layer was dried (MgSO4), filtered 
and the solvent was removed. After column chromatography (Al2O3, CHCl3), L1 (0.85 g, 
1.1 mmol, 68%) was obtained as a yellow oil. Other tpy containing products were not 
isolated. 
 
1H NMR (500 MHz, CDCl3) δH 3.63 (m, 4H, HG4), 3.75 (m, 4H, HG3), 3.91 (m, 4H, HG2), 
4.37 (m, 4H, HG1), 4.54 (s, 4H, HF), 7.21-7.27 (m, 2H, HP2/P4 or HP3 and HP6), 7.27-7.31 
(m, 6H, HT5 and HP2/P4 or HP3 and HP6), 7.81 (td, J 1.5, 7.8 Hz, 4H, HT4), 8.02 (s, 4H, 
HT3'), 8.58 (d, J 8.0 Hz, 4H, HT3), 8.65 (d, J 4.1 Hz, 4H, HT6). 
 
13C NMR (125 MHz, CDCl3) δC 68.0 (CG1), 69.7 (CG4), 69.8 (CG2), 71.2 (CG3), 73.4 (CF), 
107.7 (CT3'), 121.5 (CT3), 124.0 (CT5), 127.3 (CP2/P4 or CP3 or CP6), 127.3 (CP2/P4 or CP3 or 
CP6), 128.7 (CP2/P4 or CP3 or CP6), 136.9 (CT4), 138.6 (CP1,P5), 149.2 (CT6), 156.3 (CT2), 
157.3 (CT2'), 167.2 (CT4').  
 
MS (ESI) m/z = 777.8 [L1+H]+ (calc. 777.5). 
 
IR (oil, ν∼/cm-1): 2864w, 1599m, 1582s, 1562s, 1556s, 1504m, 1468m, 1441s, 1406s, 
1367m, 1348m, 1323m, 1292w, 1252w, 1203m, 1123s, 1091s, 1058s, 1038s, 991s, 
971m, 963m, 941m, 929s, 903m, 845m, 791s, 743s, 733s, 697s, 656s, 646m, 621m. 
 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (56.7 x 103), 279 (55.4 x 103). 
 
Elemental Analysis : Found: C, 64.21; H, 5.83; N, 9.45. Calc. for C46H44N6O6·2H2O· 
0.5CHCl3: C, 64.00; H, 5.60; N, 9.63%. 
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 1,3-Bis(20-(4'-(2,2':6',2''-terpyridyl))-2,5,8,11,14,17,20-heptaoxaeikosyl)benzene 
(L2) 
1. KOH, DMSO, 75 °C, 1 h
2. Cl-tpy, 75 °C, 3 days
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1,3-bis(20-(4'-(2,2':6',2''-terpyridyl))
-2,5,8,11,14,17,20-heptaoxaeikosyl)benzene (L2)
Molecular formula: C62H76N6O14
Molecular weight:1129.31
 
 
Compound L2 was synthesized according to general procedure for ditopic ligands with 
intermediate L2a (0.50 g, 0.75 mmol), finely powdered potassium hydroxide (0.31 g, 5.0 
mmol) and Cl-tpy (1.4 g, 5.0 mmol). After column chromatography (Al2O3, CHCl3), L2 
(0.55 g, 0.49 mmol, 65%) was obtained as a yellow oil. Other tpy containing products 
were not isolated. 
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1H NMR (500 MHz, CDCl3) δH 3.50-3.65 (m, 36H, HG4-G12), 3.69 (m, 4H, HG3), 3.86 (m, 
4H, HG2), 4.32 (m, 4H, HG1), 4.47 (s, 4H, HF), 7.15-7.30 (m, 8H, HT5, HP2/P4 and HP3/P6), 
7.76 (t, J 7.7 Hz, 4H, HT4), 7.98 (s, 4H, HT3'), 8.54 (d, J 8.0 Hz, 4H, HT3), 8.61 (d, J 4.2 
Hz, 4H, HT6). 
 
13C NMR (125 MHz, CDCl3) δC 67.8 (CG1), 69.4 (CG4), 69.5 (CG2), 70.6 (CG5-G12), 70.6 
(CG5-G12), 70.7 (CG5-G12), 71.0 (CG3), 73.2 (CF), 107.5 (CT3'), 121.3 (CT3), 123.9 (CT5), 
127.0 (CP2/P4 or CP3 or CP6), 127.1 (CP2/P4 or CP3 or CP6), 136.8 (CT4), 138.4 (CP1,P5), 149.1 
(CT6), 156.0 (CT2), 157.1 (CT2'), 167.0 (CT4').  
 
MS (ESI) m/z = 1130.3 [L2+H]+ (calc. 1130.5). 
 
IR (oil, ν∼/cm-1): 1598m, 1581s, 1563s, 1501m, 1467m, 1441m, 1404s, 1368s, 1348m, 
1323s, 1291w, 1254w, 1205m, 1124s, 1091s, 1059m, 1038s, 991s, 971m, 963m, 943s, 
931s, 905m, 844m, 789m, 744s, 735m, 697s, 656s, 645m, 621m. 
 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (56.5 x 103), 279 (55.5 x 103). 
 
Elemental Analysis : Found: C, 63.27; H, 6.38; N, 7.15. Calc. for C62H76N6O14·0.5CHCl3: 
C, 63.14 H, 6.49; N, 7.07%. 
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 1,3-Bis(11-(4'-(2,2':6',2''-terpyridyl))-2,5,8,11-tetraoxaundecyl)benzene (L3) 
 
L3a
Molecular formula: C50H52N6O8
Molecular weight: 864.98
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1,3-bis(11-(4'-(2,2':6',2''-terpyridyl))-2,5,8,11-
tetraoxaundecyl)benzene (L3)
1. KOH, DMSO, 75 °C, 1 h
2. Cl-tpy, 75 °C, 3 days
 
 
Compound L3 was synthesized according to general procedure for ditopic ligands with 
intermediate L3a (0.50 g, 1.2 mmol), finely powdered potassium hydroxide (0.31 g, 5.0 
mmol) and Cl-tpy (1.4 g, 5.0 mmol). After column chromatography (Al2O3, CHCl3), L3 
(0.58 g, 0.67 mmol, 56%) was obtained as a yellow oil. Other tpy containing products 
were not isolated. 
 
1H NMR (400 MHz, CDCl3) δH 3.45-3.75 (m, 16H, HG3-G6), 3.87 (m, 4H, HG2), 4.34 (m, 
4H, HG1), 4.49 (s, 4H, HF), 7.15-7.30 (m, 8H, HT5, HP2/P4 and HP3/P6), 7.79 (td, J 1.7, 7.8 
Hz, 4H, HT4), 7.99 (s, 4H, HT3'), 8.55 (d, J 8.0 Hz, 4H, HT3), 8.62 (d, J 3.9 Hz, 4H, HT6). 
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MS (MALDI-TOF, sinapinic acid): m/z = 866.0 [L3+H]+ (calc. 866.0). 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (54.5 x 103), 279 (55.5 x 103). 
 
 
 
 
 
 1,4-Bis(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)benzene (L4) 
 
L4a
Molecular formula: C46H44N6O6
Molecular weight: 776.88
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1,4-bis(8-(4'-(2,2':6',2''-terpyridyl))
-2,5,8-trioxaoctyl)benzene (L4)
1. KOH, DMSO, 75 °C, 1 h
2. Cl-tpy, 75 °C, 3 days
 
 
Compound L4 was synthesized according to general procedure for ditopic ligands with 
intermediate L4a (0.50 g, 1.6 mmol), finely powdered potassium hydroxide (0.31 g, 5.0 
mmol) and Cl-tpy (1.4 g, 5.0 mmol). After column chromatography (Al2O3, CHCl3), L4 
(0.85 g, 1.1 mmol, 68%) was obtained as a yellow oil. Other tpy containing products 
were not isolated. 
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1H NMR (500 MHz, CDCl3) δH 3.62 (t, J 5.0 Hz, 4H, HG4), 3.73 (t, J 5.0 Hz, 4H, HG3), 
3.91 (t, J 5.0 Hz, 4H, HG2), 4.38 (t, J 5.0 Hz, 4H, HG1), 4.53 (s, 4H, HF), 7.29 (s, 4H, HP2, 
P3, P5, P6), 7.30 (m, 4H, HT5), 7.81 (td, J 1.8, 7.7 Hz, 4H, HT4), 8.02 (s, 4H, HT3'), 8.58 (d, J 
8.0 Hz, 4H, HT3), 8.66 (d, J 4.7 Hz, 4H, HT6). 
 
13C NMR (125 MHz, CDCl3) δC 67.7 (CG1), 68.0 (CG4), 69.7 (CG2), 71.2 (CG3), 73.3 (CF), 
107.6 (CT3'), 121.5 (CT3), 124.0 (CT5), 128.0 (CP2,P3,P5,P6), 137.0 (CT4), 137.7 (CP1,P4), 
149.2 (CT6), 156.3 (CT2), 157.3 (CT2'), 167.1 (CT4'). 
 
MS (ESI) m/z = 777.9 [L4+H]+ (calc. 778.0). 
 
m.p.: 97-100 °C 
 
IR (oil, ν∼/cm-1): 1599m, 1582m, 1555m, 1466w, 1441w, 1406m, 1348w, 1325m, 1294w, 
1277w, 1252w, 1236w, 1202m, 1124m, 1086m, 1049m, 1038m, 1022m, 989m, 968m, 
930m, 868m, 847m, 835m, 814m, 791m, 771m, 733m, 700m, 660w, 621w. 
 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (56.8 x 103), 279 (55.3 x 103). 
 
Elemental Analysis . Found: C, 66.57; H, 5.48; N, 10.35. Calc for C46H44N6O6·0.5CHCl3: 
C, 66.76; H, 5.36; N, 10.05%. 
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 1,2-Bis(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)benzene (L6) 
 
L6a
Molecular formula: C46H44N6O6
Molecular weight: 776.88
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1,2-bis(8-(4'-(2,2':6',2''-terpyridyl))
-2,5,8-trioxaoctyl)benzene (L6)
1. KOH, DMSO, 75 °C, 1 h
2. Cl-tpy, 75 °C, 3 days
 
 
Compound L6 was synthesized according to general procedure for ditopic ligands with 
intermediate L6a (0.50 g, 1.6 mmol), finely powdered potassium hydroxide (0.31 g, 5.0 
mmol) and Cl-tpy (1.4 g, 5.0 mmol). After column chromatography (Al2O3, CHCl3), L6 
(0.78 g, 1.0 mmol, 65%) was obtained as a yellow oil. Other tpy containing products 
were not isolated. 
 
1H NMR (500 MHz, CDCl3) δH 3.27 (m, 4H, HG4), 3.34 (m, 4H, HG3), 3.48 (m, 4H, HG2), 
3.94 (m, 4H, HG1), 4.26 (s, 4H, HF), 6.88 (m, 2H, HP2/P5 or HP3/P4), 6.92 (m, 4H, HT5), 
7.01 (m, 2H, HP2/P5 or HP3/P4), 7.44 (t, J 7.6 Hz, 4H, HT4), 7.65 (s, 4H, HT3'), 8.20 (d, J 8.0 
Hz, 4H, HT3), 8.28 (d, J 3.9 Hz, 4H, HT6). 
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13C NMR (125 MHz, CDCl3) δC 67. 0 (CG1), 68.5 (CG2), 68.9 (CG4), 70.0 (CF), 70.0 (CG3), 
106.5 (CT3'), 120.5 (CT3), 123.3 (CT5), 126.9 (CP2/P5 or CP3/P4), 127.9 (CP2/P5 or CP3/P4), 
135.7 (CP1,P6), 136.1 (CT4), 148.3 (CT6), 155.0 (CT2), 156.2 (CT2'), 166.1 (CT4'). 
MS (ESI) m/z = 777.9 [L6+H]+ (calc. 778.0). 
 
IR (oil, ν∼/cm-1): 1598m, 1583s, 1563s, 1556s, 1503s, 1468m, 1443s, 1404s, 1368m, 
1348m, 1323m, 1291m, 1252w, 1205m, 1123s, 1091s, 1059s, 1037s, 991s, 973s, 967m, 
941m, 929s, 904m, 847s, 791s, 743m, 733s, 697m, 655s, 644m, 621m. 
 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (56.5 x 103), 279 (55.6 x 103). 
 
Elemental Analysis . Found: C, 65.60; H, 5.80; N, 9.55. Calc. for 
C46H44N6O6·H2O·0.5CHCl3: C, 65.35; H, 5.48; N, 9.83%. 
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 1,2-Bis(7-(4'-(2,2':6',2''-terpyridyl))-1,4,7-trioxaheptyl)benzene (L7) 
 
 
 
Compound L7 was synthesized according to general procedure for ditopic ligands with 
intermediate L7a (0.50 g, 1.8 mmol), finely powdered potassium hydroxide (0.31 g, 5.0 
mmol) and Cl-tpy (1.4 g, 5.0 mmol). After column chromatography (Al2O3, CHCl3), L7 
(0.82 g, 1.1 mmol, 63%) was obtained as a yellow oil. Other tpy containing products 
were not isolated. 
 
1H NMR (500 MHz, CDCl3) δH 3.92 (m, 4H, HG3), 3.96 (m, 4H, HG2), 4.17 (m, 4H, HG4), 
4.34 (m, 4H, HG1), 6.84-6.88 (m, 2H, HP3/P4), 6.88-6.92 (m, 2H, HP2/P5), 7.25 (m, 4H, 
HT5), 7.77 (td, J 1.6, 7.8 Hz, 4H, HT4), 7.99 (s, 4H, HT3'), 8.54 (d, J 7.9 Hz, 4H, HT3), 8.62 
(d, J 4.7 Hz, 4H, HT6). 
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13C NMR (125 MHz, CDCl3) δC 68.0 (CG1), 69.2 (CG4), 69.8 (CG2), 70.3 (CG3), 107.6 
(CT3'), 115.3 (CP2/P5), 121.4 (CT3), 121.9 (CP3/P4), 123.9 (CT5), 136.8 (CT4), 149.2 (CT6 and 
CP1/P6), 156.1 (CT2), 157.2 (CT2'), 167.1 (CT4'). 
MS (ESI) m/z = 749.9 [L7+H]+ (calc. 750.0). 
 
m.p.: 99-102 °C 
 
IR (oil, ν∼/cm-1): 1599m, 1582s, 1556s, 1504m, 1468m, 1441s, 1404s, 1369m, 1350s, 
1323m, 1300w, 1292w, 1254s, 1234m, 1202s, 1124s, 1097s, 1090s, 1053s, 1039s, 991s, 
972m, 962m, 941m, 928s, 905m, 866s, 845m, 823m, 790s, 741s, 730s, 698s, 657s, 646m, 
621m. 
 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (57.5 x 103), 279 (55.6 x 103). 
 
Elemental Analysis : Found: C, 61.67; H, 5.47; N, 9.75. Calc. for 
C44H40N6O6·2H2O·0.75CHCl3: C, 61.47; H, 5.16; N, 9.61%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 85 
CHAPTER 3 
 
Synthesis of heteroleptic dinuclear ruthenium(II) complexes of 
ditopic 4'-substituted- 2,2':6',2''-terpyridine ligands 
 
3.1   Introduction 
 
The photochemical and photophysical properties of ruthenium(II) complexes of 2,2'-
bipyridine (bpy) and its derivatives have been widely studied over the past 30 years.123-138 
Most widely investigated are their redox properties, luminescence intensities and excited 
state lifetimes.123,124,139 Despite the fact that ruthenium(II) complexes of 2,2':6',2''-
terpyridine derivatives show lower luminescence intensities and shorter excited state 
lifetimes at room temperature than those of 2,2'-bipyridine and its derivatives, they are 
still of great interest, due to their synthetic and structural advantages (see Section 
1.3).124,139,140 Their potential applications as energy- and electron- transmitters has been 
explored in details.141-159  
 
2,2':6',2''-Terpyridine derivatives can form metal complexes with a variety of transition 
metal ions. When tridentate tpy-based ligands react with ruthenium(II) ions, achiral 
octahedral complexes are usually formed (Scheme 3.1).160 Ruthenium(II) is a d6 ion, in 
the low-spin state. Its complexes are kinetically inert and relatively stable. 
 
Scheme 3.1. Reaction of 2,2':6',2''-terpyridine with RuCl3x3H2O in reducing enviroment. 
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In this chapter, heteroleptic dinuclear ruthenium(II) complexes of ditopic 4'-substituted- 
2,2':6',2''-terpyridine ligands are discussed (Scheme 3.2).  
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Scheme 3.2. Ruthenium(II) complexes of ditopic 4'-substituted- 2,2':6',2''-terpyridine 
ligands studied in this chapter.  
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3.2   Synthesis 
 
Heteroleptic dinuclear ruthenium(II) complexes of ligands L1, L2, L4, L6 and L7 were 
prepared stepwise in a Biotage microwave reactor. First one equivalent of RuCl3·3H2O 
and one equivalent of p-ttpy (for complex with ligand L1) (Scheme 3.3) or tpy (for 
complexes with ligands L2, L4, L6 and L7) (Scheme 3.4) were heated under microwave 
conditions in ethanol at 135 °C for 15 minutes. Then 0.5 equivalent of ditopic ligand (Lb) 
and the reducing agent N-ethylmorpholine (NEM) were added and the mixture was again 
treated as described above. Red ruthenium(II) complexes were precipitated from solution 
with excess aqueous NH4PF6 and then filtered and collected. The yield of [(X-
tpy)Ru(Lb)(Ru)(X-tpy)][PF6]4 complexes ranged from 89-93%. 
 
 
 
Scheme 3.3. Synthesis of [(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4. 
 
 
 
Scheme 3.4. The general synthesis of [(tpy)Ru(Lb)(Ru)(tpy)][PF6]4, where Lb = L2, L4, 
L6, L7. 
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3.3   1H NMR spectroscopy 
 
All of the complexes were characterized by 1H NMR spectroscopy in CD3CN solution. 
The 1H NMR spectra of the complexes were similar to those of other related 
bis(terpyridine) systems. The terpyridine proton signals, from both types of tpy units – 
from ditopic ligand L and the monotopic tpy ligand - are very similar or almost identical 
in all complexes (Tables 3.1 and 3.2).  
The aromatic part of the 1H NMR spectrum of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 in CD3CN is 
shown in Figure 3.1. The proton signals from rings A and B of the unsubstituted tpy are 
highlighted in green, the proton signals from ligand L4 in red. 
HC5
HP2,P3,P5,P6
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HA3 HC3
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[(tpy)Ru(L4)(Ru)(tpy)][PF6]4
 
Figure 3.1. Aromatic region of the 1H NMR spectrum (500 MHz, 295 K) of 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 in CD3CN. Signals for HA3 and HC3 overlap to give in 
experiment triplet (see experimental for integrations).  
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Scheme 3.5. Labeling for ruthenium(II) complexes of ditopic 4'-substituted- 2,2':6',2''-
terpyridine ligands studied in this chapter.  
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HB4 or 
HE3,E3 
8.34-
8.40 (m) 
8.30-
8.45 (m) 
8.33-
8.45 (m) 
8.35-
8.45 (m) 
8.35-
8.43 (m) 
HD3 
8.33 (s) 
8.30-
8.45 (m) 
8.34 (s) 
8.34 (s) 
8.34 (s) 
HB3 
8.72 (d) 
J 8.2 Hz 
8.72 (d) 
J 8.1 Hz 
8.72 (d) 
J 8.1 Hz 
8.73 (d) 
J 8.2 Hz 
8.72 (d) 
J 8.2 Hz 
HF 
4.63 (s) 
4.56 (s) 
4.54 (s) 
4.70 (s) 
─ 
HG1 
4.66 (m) 
4.67 (m) 
4.67 (m) 
4.67 (m) 
4.72 (m) 
HG2 
4.02 (m) 
4.06 (m) 
4.06 (m) 
4.06 (m) 
4.15 (m) 
HG3 
3.79 (m) 
3.80 (m) 
3.80 (m) 
3.83 (m) 
4.03 (m) 
HG4/-G12 
3.72 (m) 
3.65-
3.75 (m) 
3.69 (m) 
3.75 (m) 
4.26 (m) 
 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
  
Table 3.1. 1H NMR spectroscopic data, δH [ppm], (500 MHz, 295 K, CD3CN) for ruthenium(II) complexes of ligands L1, 
L2, L4, L6 and L7 (see page 89 for scheme of labeling). 
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HA6 
7.25-
7.45 (m) 
7.41 (d) 
J 4.9 Hz 
7.41 (d) 
J 5.4 Hz 
7.43 (d) 
J 5.6 Hz 
7.42 (d) 
J 5.3 Hz 
 
HA5 
7.16 (m) 
7.17 (m) 
7.17 (m) 
7.15 (m) 
7.16 (m) 
 
HA4 
7.75-
7.95 (m) 
7.82-
7.94 (m) 
7.82-
7.94 (m) 
7.85-
7.95 (m) 
7.85-
7.95 (m) 
 
HA3 
8.46 (d) 
J 9.0 Hz 
8.45-
8.50 (m) 
8.47 (d) 
J 8.0 Hz 
8.47 (d) 
J 9.2 Hz 
8.43-
8.51 (m) 
 
HC6 
7.25-
7.45 (m) 
7.29 (d) 
J 5.3 Hz 
7.29 (d) 
J 5.5 Hz 
7.30 (d) 
J 5.3 Hz 
7.29 (d) 
J 5.3 Hz 
 
HC5 
7.11 (m) 
7.11 (m) 
7.11 (m) 
7.11 (m) 
7.10 (m) 
 
HC4 
7.75-
7.95 (m) 
7.82-
7.94 (m) 
7.82-
7.94 (m) 
7.85-
7.95 (m) 
7.85-
7.95 (m) 
 
HC3 
8.45 (d) 
J 9.0 Hz 
8.45-
8.50 (m) 
8.46 (d) 
J 8.0 Hz 
8.46 (d) 
J 9.2 Hz 
8.43-
8.51 (m) 
 
 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
 
Table 3.2. 1H NMR spectroscopic data, δH [ppm], (500 MHz, 295 K, CD3CN) for ruthenium(II) complexes of ligands L1, 
L2, L4, L6 and L7 (see page 89 for scheme of labeling). 
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*
HG1 HG2 HG3 HG4
HF
HP2,P3,P5,P6
HT5
HT4H
T3HT6
HT3’
L4
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4
HG1 HG2 HG3 HG4
HF
HC5
HP2,P3,P5,P6
HC6HC4
HD3
HC3
 
Figure 3.2. 1H NMR spectra (500 MHz, 295 K) of L4 in CDCl3 (below) and 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 in CD3CN (above). Spectra exhibit some residues of the 
starting material, which could not be removed by purify. 
 
Figure 3.2 shows how the 1H NMR spectrum of ligand L4 changes, after complexation 
with ruthenium(II). All of the signals are influenced by addition of the ruthenium(II) to 
the system but most changed is the proton signal HT6 of ligand L4, which is shifted 1.37 
ppm upfield (HC6). The proton signals for HT3' and HG1 of ligand L4 are both shifted 
around 0.3 ppm downfield in the 1H NMR spectrum of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4.  
 
The proton signals in the aliphatic region for heteroleptic ruthenium(II) complexes of 
ligands L1 and L2 exhibit the same behavior as ligand L4. However, the signal assigned 
to the HF proton of the complex with ligand L7 is shifted much further downfield than 
the signal from the HF proton of any other complex. Also the HG proton signals of ligand 
L7 are all shifted downfield in comparison to other complexes (Table 3.1). 
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3.4   13C NMR spectroscopy 
 
Table 3.3 shows the ethylene glycol CG, CF and phenyl CP carbon signals for 
heteroleptic dinuclear ruthenium(II) complexes of ligands L1-L2, L4 and L6-L7 in 
CD3CN solution. All of the terpyridine carbon signals, from both types of tpy units – 
from ditopic ligand L and the monotopic tpy ligand - are shown in Tables 3.4 and 3.5. 
The assignments were made using HMQC and HMBC techniques. The terpyridine 
carbon signals are similar in all of the complexes and comparable to other related 
bis(terpyridine) systems79-82.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
94
 
CE 
128.5, 
138.9 
─ 
─ 
─ 
─ 
 
CP 
quatern. 
138.9 
139.0 
139.0 
139.0 
149.9 
 
CP 
128.5 
128.5 
128.8 
128.7, 
129.6 
115.7, 
124.8 
 
CF 
68.6 
73.5 
73.5 
71.6 
─ 
 
CG1 
70.7 
70.9 
70.9 
70.9 
70.8 
 
CG2 
69. 8 
70.0 
70.0 
70.0 
70.2 
 
CG3 
71.9 
71.69 
71.69 
71.3 
70.9 
 
CG4/-G12 
70.3 
70.5, 
70.6, 
70.6, 
70. 7 
70.6 
70.7 
69.7 
 
 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
 
Table 3.3. 13C NMR spectroscopic data, δH [ppm], (125 MHz, 295 K, CD3CN) for ruthenium(II) complexes of ligands L1, 
L2, L4, L6 and L7 (see page 89 for scheme of labeling). 
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CD4 
167.2 
167.3 
167.3 
167.3 
167.3 
 
CD3 
112.1 
112.0 
112.2 
112.2 
112.2 
 
CD2 
159.0 
159.1 
159.1 
159.1 
159.1 
 
CC6 
153.8 
153.8 
153.8 
153.7 
153.8 
 
CC5 
128.5 
128.5 
128.5 
128.5 
128.5 
 
CC4 
138.9 
138.9 
138.9 
138.9 
138.9/ 
139.0 
 
CC3 
125.5 
125.5 
125.5 
125.5 
125.4 
 
CC2 
157.0 
157.0 
157.0 
157.0 
157.0 
 
 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
 
Table 3.4. 13C NMR spectroscopic data, δH [ppm], (125 MHz, 295 K, CD3CN) for ruthenium(II) complexes of ligands L1, 
L2, L4, L6 and L7 (see page 89 for scheme of labeling). 
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CB4 
136.3 
136.3 
136.3 
136.3 
136.3 
 
CB3 
124.7 
124.6 
124.7 
124.7 
124.7 
 
CB2 
159.3 
159.3 
159.3 
159.3 
159.2 
 
CA6 
153.3 
153.3 
153.3 
153.3 
153.3 
 
CA5 
128.5 
128.5 
128.5 
128.5 
128.5 
 
CA4 
138.9 
138.9 
138.9 
138.9 
138.9/ 
139.0 
 
CA3 
125.3 
125.3 
125.3 
125.3 
125.3 
 
CA2 
156.9 
156.9 
156.9 
156.9 
156.9 
 
 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
 
Table 3.5. 13C NMR spectroscopic data, δH [ppm], (125 MHz, 295 K, CD3CN) for ruthenium(II) complexes of ligands L1, 
L2, L4, L6 and L7 (see page 89 for scheme of labeling). 
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3.5   Mass spectroscopic characterization 
 
Electrospray ionization mass spectroscopy (ESI) was used to characterize the new 
heteroleptic dinuclear ruthenium(II) complexes. The peaks are observed as the ratio of 
mass to the charge of the species (m/z). All of the peaks show the typical isotope 
distribution of two ruthenium atoms. Normally, the [M-2PF6]2+ peak was found as the 
major peak for these dinuclear ruthenium(II) complexes but [M-3PF6]3+and [M-4PF6]4+ 
can be also observed. Charge on the ion was confirmed by the peak separations in each 
peak-envelope, as shown in Figure 3.3 for a 2+ ion. 
 
 [M-2PF6]2+ [M-3PF6]3+ [M-4PF6]4+ 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 958.2 590.5 ─ 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 1044.2 ─ 449.6 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 868.3 530.5 361.7 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 868.1 530.4 ─ 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 854.1 521.1 354.6 
 
Table 3.6. The ESI-MS data for ruthenium(II) complexes with L1, L2, L4, L6 and L7  
 
In Figure 3.3 the ESI-MS spectrum of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 is shown. The major 
signal is a peak at m/z 530.5 and was assigned to [M-3PF6]3+. The other two signals at 
m/z 868.3 and 361.7 correspond to [M-2PF6]2+ and [M-4PF6]4+, respectively. The inset 
shows an expansion of the  peak at m/z 868.3 ([M-2PF6]2+). The observed isotope pattern 
matches that of the simulated spectrum.  
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Figure 3.3. ESI-MS spectrum of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4. 
 
 
 
 
3.6   Electrochemical studies 
 
The redox properties of the ruthenium(II) complexes have been investigated using the 
cyclic voltammetry method (CV). One typical example is shown in Figure 3.4 for the 
cyclic voltammogram of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 in degassed acetonitrile solution. 
The oxidation of ruthenium(II) in the complexes introduced in this chapter typically 
occurs around 830 mV (Table 3.7). There are three reduction processes, two of them are 
reversible, around -1.69 and -1.92 V, one is irreversible, at -2.44 V (Table 3.7). The 
potentials were measured versus Ferrocene0/Ferrocenium+ (Fc/Fc+). 
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Figure 3.4. Cyclic voltammogram of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 (1 mM) in degassed 
acetonitrile containing 0.1 M [nBu4N][PF6], scan rate = 100 mVs-1. 
 
Potential [V] vs Fc/Fc+  
oxidation reduction 
[(Ru)(tpy)2][PF6]2 0.92a -1.67a, -1.92a 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 0.83a -1.69a, -1.92a, -2.44b 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 0.83a -1.69a, -1.92a, -2.44b 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 0.83a -1.69a, -1.92a, -2.44b 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 0.83a -1.69a, -1.92a, -2.44b 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 0.83a -1.69a, -1.92a, -2.44b 
 
Table 3.7. Redox potentials measured for ruthenium(II) complexes in argon-purged 
solutions of acetonitrile. E1/2 values are given for reversible processes (a) from the cyclic 
voltammetry and for irreversible processes (b) from square wave.  
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For comparison, in Table 3.7 oxidation and reduction potentials for the homoleptic 
ruthenium(II) complex [(Ru)(tpy)2][PF6]2 are also shown This homoleptic complex 
shows the Ru(II)/Ru(III) process at higher reduction/oxidation potential than the 
ruthenium(II) complexes introduced in this chapter. This indicates that these substituents 
in the 4'-position of the terpyridine ligands (L1-L2, L4 and L6-L7) have higher electron 
donating properties than a hydrogen atom in the 4'-position of 2,2':6',2''-terpyridine.160 
 
 
 
 
3.7   Absorption spectroscopic characterization 
 
The electronic spectra of the heteroleptic dinuclear ruthenium(II) complexes were 
recorded in HPLC grade acetonitrile solution. The very intense bands in the UV region 
are assigned to the ligand-centered (LC) pi* ← pi transitions (Table 3.8). The 
ruthenium(II) complexes exhibit a low energy metal-to-ligand charge transfer (MLCT) 
transition with λmax at 480 nm (Table 3.8). The MLCT transitions occur when an electron 
is transferred from the metal-centered d orbital to an unfilled ligand-centered pi* orbital.  
 
For comparison, in Table 3.8 electronic spectroscopic data for the homoleptic 
ruthenium(II) complex [(Ru)(tpy)2][PF6]2 are also shown The MLCT bands of 
heteroleptic ruthenium(II) complexes are red shifted in comparison to the homoleptic 
[(Ru)(tpy)2][PF6]2 complex. Balzani and Constable et al.161 have reported that there is a 
red shift of the MLCT band of ruthenium(II) complexes irrespective of whether the 
substituent at the 4'-position of the terpyridine ligand is electron-donating or electron-
accepting. 
 
It seems that there is no influence on the absorption data when the length of the linkage is 
changed, nor when the substitution position on the benzyl ring is altered. 
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λmax/nm (εmax/103 M-1 cm-1)  
 LC MLCT 
[(Ru)(tpy)2][PF6]2 268 (67), 305 (111) 473 (25) 
[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 241 (110), 269 (115), 305 (140) 480 (40) 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4 241 (107), 269 (116), 305 (141) 480 (41) 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 241 (108), 269 (116), 305 (140) 480 (40) 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4 241 (108), 269 (115), 305 (139) 480 (39) 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4 241 (105), 269 (113), 305 (139) 480 (38) 
 
Table 3.8. Electronic spectroscopic data for the ruthenium(II) complexes in acetonitrile 
solution. 
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Figure 3.3. Absorption spectra of ligand L4 in CH2Cl2 (in green) and 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 in CH3CN (in violet). 
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In Figure 3.3 absorption spectra of ligand L4 (in green) and 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 (in violet) are shown for comparison. In contrast to the 
absorption spectrum of [(tpy)Ru(L4)(Ru)(tpy)][PF6]4, for uncomplexed ligand L4 there 
are only two bands in the high energy UV region, assigned to ligand-centered (LC) pi* ← 
pi and/or pi* ← n transitions with λmax at 241 and 279 nm. Both bands are only half as 
intense as the LC bands for [(tpy)Ru(L4)(Ru)(tpy)][PF6]4, (εmax/103 M-1 cm-1 : 56.8 and 
55.3). 
 
 
 
 
3.8   Conclusion 
 
The heteroleptic dinuclear ruthenium(II) complexes of the ditopic 4'-substituted-
2,2':6',2''-terpyridine ligands L1-L2, L4 and L6-L7, which are based on a benzene unit 
connected to two 4'-substituted-2,2':6',2''-terpyridine moieties through different 
polyethyleneoxy spacers, have been synthesized. The complexes were characterized by 
1H and 13C NMR spectroscopy, mass spectrometry (ESI-MS), IR spectroscopy, UV-Vis 
spectroscopy, cyclic voltammetry and elemental analysis. 
 
The microanalitical data for many of these compounds required the inclusion of NaPF6 in 
the material. This is not unexpected in view of the affinity of Group 1 metal ions for 
poly(oxethylene) chains and we have recently reported a crystallographically 
characterized example of a compound capturing serendipitous sodium ions.154 
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3.9   Experimental 
 
 [(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
 [(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
 [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
 [(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
 [(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
 
 
 
L1, L2, L4, L6 and L7 were prepared as described in Chapter 2. RuCl3·3H2O and 
NH4PF6 are commercially available compounds and were used as received. 
 
 
 
 
 
 
 
 
 [(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4 
 
General procedure for [Ru(p-ttpy)Cl3] and [Ru(tpy)Cl3] complexes 
 
RuCl3·3H2O (0.011 g, 0.043 mmol, 1.0 eq ) and p-ttpy (for complex with ligand L1, 
0.014 g, 0.043 mmol, 1.0 eq) or tpy (for complexes with ligands L2, L4, L6 and L7, 
0.010 g, 0.043 mmol, 1.0 eq) were heated under microwave conditions in 15 mL ethanol 
at 135 °C for 15 minutes. The crude product was used for the next step reactions. 
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General procedure for ruthenium(II) complexes 
 
Compound L1 (0.015 g, 0.019 mmol, 1.0 eq ) and [Ru(p-ttpy)Cl3] (0.021 g, 0.038 mmol, 
2.0 eq) with a few drops of N-ethylmorpholine (NEM) were heated at 135 °C in 15 mL 
ethanol in a microwave reactor for 30 minutes. Excess of solid ammonium 
hexafluorophosphate was added to give a red precipitate. This was collected by filtration 
through celite, washed with water and diethyl ether, then redissolved in acetonitrile. The 
solvent was removed in vacuo to give a red solid (0.038 g, 0.017 mmol, 90%). 
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[(p-ttpy)Ru(L1)(Ru)(p-ttpy)][PF6]4
Molecular formula: C90H78F24N12O6P4Ru2
Molecular weight: 2206.28
P1
P2
P3
P4
P5
P6
F
G1
G2
G3
G4
3
2
6
4
5
3
2
4
O O
O O
O O
N N
N N
N
N
NN
N Ru
N
N
N
Ru
[PF6]4
A
B
C D
2 23
3
4
4
5 6
E
2
3
1
4
 
 
1H NMR (500 MHz, CD3CN) δH 2.46 (s, 6H, HMes), 3.72 (m, 4H, HG4), 3.79 (m, 4H, 
HG3), 4.02 (m, 4H, HG2), 4.63 (s, 4H, HF), 4.66 (m, 4H, HG1), 7.11 (m, 4H, HC5), 7.16 (m, 
4H, HA5), 7.25-7.45 (m, 12H, HC6, HP2/P4, HP3, HP6, HA6), 7.75-7.95 (m, 8H, HC4 and HA4), 
8.33 (s, 4H, HD3), 8.34-8.40 (m, 8H, HE2 and HE3), 8.45 (d, J 9.0 Hz, 4H, HC3), 8.46 (d, J 
9.0 Hz, 4H, HA3), 8.72 (d, J 8.2 Hz, 4H, HB3). 
 
13C NMR (125 MHz, CD3CN) δC 16.0 (CMes), 68.6 (CF), 69.8 (CG2), 70.3 (CG4), 70.7 
(CG1), 71.9 (CG3), 112.1 (CD3), 124.7 (CB3), 125.3 (CA3), 125.5 (CC3), 128.5 (CA5, CC5, 
CP2/P4, CP3, CP6 and CE2, CE3), 136.3 (C B4), 138.9 (CA4, CC4, CE1, CE4 and CP1/P5), 153.3 
(CA6), 153.8 (CC6), 156.9 (CA2), 157.0 (CC2), 159.0 (CD2), 159.3 (CB2), 167.2 (CD4). 
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MS (ESI) m/z = 958.2 [M-2PF6]2+ (calc. 958.0), 590.5 [M-3PF6]3+ (calc. 590.5). 
 
IR (solid, ν∼/cm-1): 3661w, 2923w, 2867w, 2833w, 1956w, 1700w, 1669w, 1613m, 
1605m, 1560w, 1490w, 1467m, 1448m, 1420m, 1388m, 1350w, 1285w, 1209m, 1162w, 
1130w, 1116w, 1090m, 1065m, 1045m, 1029m, 1019w, 987w, 964w, 926w, 877w, 824s, 
820s, 786s, 765s, 750s, 735s, 725s, 696s, 673m, 665m, 645m, 638m, 617w. 
 
Cyclic voltammetry data (CH3CN, 0.1 M [nBu4N][PF6], Fc/Fc+): +0.83 V, - 1.69 V, 
-1.92 V, -2.44 V. 
 
UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 241 (110 x 103), 269 (115 x 103), 305 (140 x 
103), 480 (40 x 103). 
 
Elemental Analysis . Found: C, 47.76; H, 3.61; N, 7.62. Calc. for C90H78F24N12O6P4Ru2· 
1/3NaPF6: C, 47.80; H, 3.48; N, 7.43%. 
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 [(tpy)Ru(L2)(Ru)(tpy)][PF6]4 
 
[(tpy)Ru(L2)(Ru)(tpy)][PF6]4
Molecular formula: C92H98F24N12O14P4Ru2
Molecular weight: 2378.40
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Complex [(tpy)Ru(L2)(Ru)(tpy)][PF6]4 was synthesized according to general procedure 
for ruthenium(II) complexes with L2 (0.015 g, 0.013 mmol, 1.0 eq ) and [Ru(tpy)Cl3] 
(0.012 g, 0.027 mmol, 2.0 eq). The product was collected by filtration through celite, as a 
red solid (0.029 g, 0.012 mmol, 93%). 
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1H NMR (500 MHz, CD3CN) δH 3.65-3.75 (m, 36H, HG4-G12), 3.80 (m, 4H, HG3), 4.06 
(m, 4H, HG2), 4.56 (s, 4H, HF), 4.67 (m, 4H, HG1), 7.11 (m, 4H, HC5), 7.17 (m, 4H, HA5), 
7.29 (d, J 5.3 Hz, 4H, HC6), 7.30-7.40 (m, 4H, HP2, P3, P4, P6), 7.41 (d, J 4.9 Hz, 4H, HA6), 
7.82-7.94 (m, 8H, HC4 and HA4), 8.30-8.45 (m, 6H, HB4 and HD3), 8.45-8.50 (m, 8H, HC3 
and HA3), 8.72 (d, J 8.1 Hz, 4H, HB3). 
 
13C NMR (125 MHz, CD3CN) δC 70.0 (CG2), 70.5 (CG4), 70.6 (CG5-G12), 70.6 (CG5-G12), 
70.7 (CG5-G12), 70.9 (CG1), 71.6 (CG3), 73.5 (CF), 112.0 (CD3), 124.6 (CB3), 125.3 (CA3), 
125.5 (CC3), 128.5 (CA5, CC5 and CP2,P3,P4,P6), 136.3 (C B4), 138.9 (CA4 and CC4), 139.0 
(CP1/P5), 153.3 (CA6), 153.8 (CC6), 156.9 (CA2), 157.0 (CC2), 159.1 (CD2), 159.3 (CB2), 
167.3 (CD4). 
 
MS (ESI) m/z = 1044.2 [M-2PF6]2+ (calc. 1044.0), 449.6 [M-4PF6]4+ (calc. 450.0). 
 
IR (solid, ν∼/cm-1): 3662w, 3086w, 2925w, 2868w, 2853w, 2833w, 1956w, 1700w, 
1668w, 1613m, 1603m, 1560w, 1547w, 1488w, 1467m, 1448m, 1439m, 1421m, 1388m, 
1347w, 1287w, 1245w, 1207m, 1162w, 1130w, 1115w, 1091m, 1061m, 1045m, 1027m, 
1017w, 985w, 964w, 923w, 877w, 824s, 764s, 750s, 741s, 735s, 725s, 698s, 673m, 
663m, 638m, 614w. 
 
Cyclic voltammetry data (CH3CN, 0.1 M [nBu4N][PF6], Fc/Fc+): +0.83 V, - 1.69 V, 
-1.92 V, -2.44V. 
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UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 241 (107 x 103), 269 (116 x 103), 305 (141 x 
103), 480 (41 x 103). 
 
Elemental Analysis . Found: C, 44.34; H, 4.30; N, 6.92. Calc. for 
C92H98F24N12O14P4Ru2·NaPF6: C, 44.89; H, 4.01; N, 6.83%. 
 
 
 
 [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 
 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4
Molecular formula: C76H66F24N12O6P4Ru2
Molecular weight: 2026.19
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Complex [(tpy)Ru(L4)(Ru)(tpy)][PF6]4 was synthesized according to general procedure 
for ruthenium(II) complexes with L4 (0.015 g, 0.019 mmol, 1.0 eq ) and [Ru(tpy)Cl3] 
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(0.017 g, 0.038 mmol, 2.0 eq). The product was collected as a red solid (0.035 g, 0.017 
mmol, 92%). 
 
1H NMR (500 MHz, CD3CN) δH 3.69 (m, 4H, HG4), 3.80 (m, 4H, HG3), 4.06 (m, 4H, 
HG2), 4.54 (s, 4H, HF), 4.67 (m, 4H, HG1), 7.11 (m, 4H, HC5), 7.17 (m, 4H, HA5), 7.29 (d, 
J 5.5 Hz, 4H, HC6), 7.35 (s, 4H, HP2, P3, P5, P6), 7.41 (d, J 5.4 Hz, 4H, HA6), 7.82-7.94 (m, 
8H, HC4 and HA4), 8.34 (s, 4H, HD3), 8.33-8.45 (m, 2H, HB4), 8.46 (d, J 8.0 Hz, 4H, HC3), 
8.47 (d, J 8.0 Hz, 4H, HA3), 8.72 (d, J 8.1 Hz, 4H, HB3). 
 
13C NMR (125 MHz, CD3CN) δC 70.0 (CG2), 70.6 (CG4), 70.9 (CG1), 71.6 (CG3), 73.5 
(CF), 112.2 (CD3), 124.7 (CB3), 125.3 (CA3), 125.5 (CC3), 128.5 (CA5 and CC5), 128.8 
(CP2,P3,P5,P6), 136.3 (C B4), 138.9 (CA4 and CC4), 139.0 (CP1/P4), 153.3 (CA6), 153.8 (CC6), 
156.9 (CA2), 157.0 (CC2), 159.1 (CD2), 159.3 (CB2), 167.3 (CD4). 
 
MS (ESI) m/z = 868.3 [M-2PF6]2+ (calc. 868.5), 530.5 [M-3PF6]3+ (calc. 530.5), 361.7 
[M-4PF6]4+ (calc. 362.0). 
 
IR (solid, ν∼/cm-1): 3662w, 3086w, 2922w, 2868w, 2851w, 2833w, 1956w, 1700w, 
1668w, 1613m, 1603m, 1560w, 1546w, 1488w, 1467m, 1448m, 1437m, 1420m, 1388m, 
1349w, 1285w, 1245w, 1207m, 1162w, 1130w, 1115w, 1090m, 1061m, 1045m, 1027m, 
1017w, 987w, 964w, 925w, 877w, 824s, 820s, 786s, 764s, 750s, 741s, 735s, 725s, 696s, 
673m, 663m, 645m, 638m, 614w. 
 
Cyclic voltammetry data (CH3CN, 0.1 M [nBu4N][PF6], Fc/Fc+): +0.83 V, - 1.69 V, 
-1.92 V, -2.44 V. 
 
UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 241 (108 x 103), 269 (116 x 103), 305 (140 x 
103), 480 (40 x 103). 
 
Elemental Analysis . Found: C, 42.34; H, 3.50; N, 7.92. Calc. for C76H66F24N12O6P4Ru2 
·2/3NaPF6: C, 42.71; H, 3.11; N, 7.86%. 
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 [(tpy)Ru(L6)(Ru)(tpy)][PF6]4 
 
[(tpy)Ru(L6)(Ru)(tpy)][PF6]4
Molecular formula: C76H66F24N12O6P4Ru2
Molecular weight: 2026.19
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Complex [(tpy)Ru(L6)(Ru)(tpy)][PF6]4 was synthesized according to general procedure 
for ruthenium(II) complexes with L6 (0.015 g, 0.019 mmol, 1.0 eq ) and [Ru(tpy)Cl3] 
(0.017 g, 0.038 mmol, 2.0 eq). The product was collected as a red solid (0.035 g, 0.017 
mmol, 90%). 
 
1H NMR (500 MHz, CD3CN) δH 3.75 (m, 4H, HG4), 3.83 (m, 4H, HG3), 4.06 (m, 4H, 
HG2), 4.67 (m, 4H, HG1), 4.70 (s, 4H, HF), 7.11 (m, 4H, HC5), 7.15 (m, 4H, HA5), 7.27 (m, 
2H, HP2/P5 or HP3/P4), 7.30 (d, J 5.3 Hz, 4H, HC6), 7.34 (m, 2H, HP2/P5 or HP3/P4), 7.43 (d, J 
5.6 Hz, 4H, HA6), 7.85-7.95 (m, 8H, HC4 and HA4), 8.34 (s, 4H, HD3), 8.35-8.45 (m, 2H, 
HB4), 8.46 (d, J 9.2 Hz, 4H, HC3), 8.47 (d, J 9.2 Hz, 4H, HA3), 8.73 (d, J 8.2 Hz, 4H, HB3). 
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13C NMR (125 MHz, CD3CN) δC 70.0 (CG2), 70.7 (CG4), 70.9 (CG1), 71.3 (CG3), 71.6 
(CF), 112.2 (CD3), 124.7 (CB3), 125.3 (CA3), 125.5 (CC3), 128.5 (CA5 and CC5), 128.7 
(CP2/P5 or CP3/P4), 129.6 (CP2/P5 or CP3/P4), 136.3 (CB4), 138.9 (CA4 and CC4), 139.0 (CP1/P6), 
153.3 (CA6), 153.7 (CC6), 156.9 (CA2), 157.0 (CC2), 159.1 (CD2), 159.3 (CB2), 167.3 (CD4). 
 
MS (ESI) m/z = 868.1 [M-2PF6]2+ (calc. 861.5), 530.4 [M-3PF6]3+ (calc.530.5). 
 
IR (solid, ν∼/cm-1): 3662w, 3086w, 2851w, 2833w, 1956w, 1705w, 1665w, 1613m, 
1603m, 1561w, 1545w, 1488w, 1467m, 1448m, 1437m, 1420m, 1385m, 1349w, 1285w, 
1246w, 1205m, 1162w, 1130w, 1065m, 1045m, 1027m, 1017w, 987w, 965w, 925w, 
877w, 824s, 825s, 786s, 764s, 750s, 741s, 735s, 725s, 696s, 673m, 663m, 645m, 635m, 
615w. 
 
Cyclic voltammetry data (CH3CN, 0.1 M [nBu4N][PF6], Fc/Fc+): +0.83 V, - 1.69 V, 
-1.92 V, -2.44 V. 
 
UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 241 (108 x 103), 269 (115 x 103), 305 (139 x 
103), 480 (39 x 103). 
 
Elemental Analysis . Found: C, 44.34; H, 3.75; N, 8.72. Calc. for C76H66F24N12O6P4Ru2 
·0.1NaPF6: C, 44.70; H, 3.26; N, 8.23%. 
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 [(tpy)Ru(L7)(Ru)(tpy)][PF6]4 
 
[(tpy)Ru(L7)(Ru)(tpy)][PF6]4
Molecular formula: C74H62F24N12O6P4Ru2
Molecular weight: 1998.16
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Complex [(tpy)Ru(L7)(Ru)(tpy)][PF6]4 was synthesized according to general procedure 
for ruthenium(II) complexes with L7 (0.015 g, 0.020 mmol, 1.0 eq ) and [Ru(tpy)Cl3] 
(0.018 g, 0.040 mmol, 2.0 eq). The product was collected as a red solid (0.036 g, 0.018 
mmol, 89%). 
 
1H NMR (500 MHz, CD3CN) δH 4.03 (m, 4H, HG3), 4.15 (m, 4H, HG2), 4.26 (m, 4H, 
HG4), 4.72 (m, 4H, HG1), 6.88-6.92 (m, 2H, HP3/P4), 7.00-7.06 (m, 2H, HP2/P5), 7.10 (m, 
4H, HC5), 7.16 (m, 4H, HA5), 7.29 (d, J 5.3 Hz, 4H, HC6), 7.42 (d, J 5.3 Hz, 4H, HA6), 
7.85-7.95 (m, 8H, HC4 and HA4), 8.34 (s, 4H, HD3), 8.35-8.43 (m, 2H, HB4), 8.43-8.51 (m, 
8H, HC3 and HA3), 8.72 (d, J 8.2 Hz, 4H, HB3). 
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13C NMR (125 MHz, CD3CN) δC 69.7 (CG4), 70.2 (CG2), 70.8 (CG1), 70.9 (CG3), 112.2 
(CD3), 115.7 (CP2/P5), 124.7 (CB3), 124.8 (CP3/P4), 125.3 (CA3), 125.4 (CC3), 128.5 (CA5 and 
CC5), 136.3 (CB4), 138.9 (CA4 or CC4), 139.0 (CA4 or CC4), 149.9 (CP1/P6), 153.3 (CA6), 
153.8 (CC6), 156.9 (CA2), 157.0 (CC2), 159.1 (CD2), 159.2 (CB2), 167.3 (CD4). 
 
MS (ESI) m/z = 854.1 [M-2PF6]2+ (calc. 854.2), 521.1 [M-3PF6]3+ (calc. 521.0), 354.6 
[M-4PF6]4+ (calc. 355.0). 
 
IR (solid, , ν∼/cm-1): 3662w, 3086w, 2923w, 2868w, 2853w, 2833w, 1956w, 1700w, 
1668w, 1613m, 1603m, 1560w, 1546w, 1448m, 1437m, 1423m, 1388m, 1349w, 1283w, 
1243w, 1162w, 1130w, 1115w, 1090m, 1061m, 1043m, 1027m, 1017w, 983w, 964w, 
925w, 877w, 824s, 820s, 786s, 764s, 750s, 741s, 733s, 725s, 696s, 673m, 663m, 645m, 
638m, 613w. 
 
Cyclic voltammetry data (CH3CN, 0.1 M [nBu4N][PF6], Fc/Fc+): +0.83 V, - 1.69 V, 
-1.92 V, -2.44 V. 
 
UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 241 (105 x 103), 269 (113 x 103), 305 (139 x 
103), 480 (38 x 103). 
 
Elemental Analysis . Found: C, 44.64; H, 3.50; N, 8.92. Calc. for  
C74H62F24N12O6P4Ru2·H2O·0.5CH3CN: C, 44.25; H, 3.24; N, 8.60%. 
 
 
 
 
 
 
 
 
 
 115 
CHAPTER 4 
 
Synthesis of a homoleptic mononuclear zinc(II) complex of a 
ditopic 4'-substituted- 2,2':6',2''-terpyridine ligand 
 
4.1   Introduction 
 
In contrast to typical octahedral ruthenium(II) complexes, zinc(II) can adopt different 
geometries in its complexes, depending on the type of coordinated ligand. Nevertheless, 
when tridentate tpy-based ligands react with zinc(II) ions octahedral complexes are 
usually formed (see Scheme 3.1). The zinc(II) ion with its d10 configuration has a filled 
electron shell and is a labile metal centre.  
 
 
 
Figure 4.1. Zinc(II)-hexagonal metallomacrocycles.155 
 
Zinc(II) has gained much interest as a template for the construction of photoluminescent 
PL) or electroluminescent (EL) metallopolymers with well-defined structures162-169 as 
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well as discrete molecular architectures such as hexagonal metallomacrocycles (Figure 
4.1).170-171 Depending on the nature of the π-conjugated system between the terpyridine 
units, the emission properties can be tuned, and materials with high PL quantum yields 
and EL performance are accessible. 
 
Studies of the homoleptic mononuclear Zn(II) complex of ditopic 4'-substituted- 
2,2':6',2''-terpyridine ligand L4 described in Chapter 2 will be fully presented in this 
chapter (Scheme 4.1). 
 
 
 
Scheme 4.1. Zn(II) complex of the ditopic 4'-substituted- 2,2':6',2''-terpyridine ligand L4 
studied in this chapter. 
 
 
 
 
4.2   Synthesis 
 
The homoleptic mononuclear Zn(II) complex of ligand L4 was easily prepared by 
reacting one equivalent of ligand L4 in CHCl3 with one equivalent of Zn(BF4)2·6H2O in 
acetonitrile at room temperature overnight. The solvent was removed in vacuo and the 
 117 
desired product was obtained in 89% yield (Scheme 4.2). No polymeric products were 
observed. 
 
 
Scheme 4.2. Synthesis of [Zn(L4)][BF4]2. 
 
 
 
 
 
4.3   Mass spectroscopic characterization 
 
Electrospray ionization mass spectroscopy (ESI-MS) was used to characterize the new 
homoleptic mononuclear zinc(II) complex of ligand L4 - [Zn(L4)][BF4]2. The peaks are 
observed as the ratio of mass to the charge of the species (m/z).  
 
In Figure 4.2 the ESI-MS spectrum of [Zn(L4)][BF4]2 is shown. The major peak 
envelope is a peak at m/z 420.3 and was assigned to [M-2BF4]2+. The other set of peaks at 
m/z 927.5 corresponds [M-BF4] +. Also shown are expansions of both peaks at m/z 420.3 
and 927.5. The peaks show the typical isotope distribution pattern of zinc(II), a 
separations of peaks in a given envelope confirm the charge on the ion. 
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Figure 4.2. ESI-MS spectrum of [Zn(L4)][BF4]2. 
 
 
 
 
4.4   1H NMR spectroscopy 
 
The Zn(II) complex of ligand L4 - [Zn(L4)][BF4]2, was characterized by 1H NMR 
spectroscopy in CH3CN solution.  
 
A comparison between the 1H NMR spectra obtained for the free ligand L4 in CHCl3 (not 
soluble in acetonitrile) and the zinc(II) complex [Zn(L4)][BF4]2 in acetonitrile is shown 
in Figure 4.3 as well as in Tables 4.1 and 4.2. 
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Scheme 4.3. Labeling for [Zn(L4)][BF4]2. 
 
 
 
Table 4.1. 1H NMR spectroscopic data, δH [ppm] for L4 (500 MHz, 295 K, CDCl3) and 
[Zn(L4)][BF4]2 (500 MHz, 295 K, CD3CN). 
 
In the aliphatic region of the 1H NMR spectra of ligand L4 and complex [Zn(L4)][BF4]2 
there are few significant differences. After complexation the HG1 and HG2 protons are 
both shifted downfield by 0.27 ppm for proton HG1 and 0.08 ppm for proton HG2, the 
signal assigned to proton HF is slightly shifted upfield (Table 4.1). 
 
 
 
 HG4 HG3 HG2 HG1 HF 
L4 3.62 (t) J 5.0 Hz 
3.73 (t) 
J 5.0 Hz 
3.91 (t) 
J 5.0 Hz 
4.38 (t) 
J 5.0 Hz 4.53 (s) 
[Zn(L4)][BF4]2 3.63 (m) 3.75 (m) 3.99 (m) 4.65 (m) 4.48 (s) 
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Table 4.2. 1H NMR spectroscopic data, δH [ppm] for L4 (500 MHz, 295 K, CDCl3) and 
[Zn(L4)][BF4]2 (500 MHz, 295 K, CD3CN). 
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Figure 4.3. 1H NMR spectrum (500 MHz, 295 K) of L4 (below) in CDCl3 and 
[Zn(L4)][BF4]2 (above) in CD3CN. The signal marked with * is the signal for CHCl3. 
Spectra exhibit some residues of the starting material, which could not be removed by 
column chromatography or other purification methods. 
 
 
HC5/HT5 
/HP H
C4/HT4 HD3/HT3' HC3/HT3 HC6/HT6 
L4 7.30 (m)/ 7.29 (s) 
7.81 (td) 
J 1.8, 7.7 
Hz 
8.02 (s) 8.58 (d) J 8.0 Hz 
8.66 (d) 
J 4.7 Hz 
[Zn(L4)][BF4]2 7.33 (m)/ 7.30 (s) 
8.08 (t) 
J 7.5 Hz 8.21 (s) 
8.52 (d) 
J 8.0 Hz 
7.73 (d) 
J 4.5 Hz 
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All of the terpyridine proton signals are influenced by the complexation of ligand L4 with 
zinc(II), but the signal for the HC6/HT6 proton of ligand is mostly affected and is shifted 
0.93 ppm upfield. It is important to notice that the signal for the HC6 proton of 
[(tpy)Ru(L4)(Ru)(tpy)][PF6]4 is shifted 1.37 ppm upfield. The signals for protons HC4 
and HD3 of complex [Zn(L4)][BF4]2 are shifted downfield, respectively 0.27 and 0.19 
ppm, in comparison to ligand L4. 
 
[M(tpy)2]
n+
N
N
N
N
N
N
M
36
45
3
4
n+
D
C
 
 
Scheme 4.4. Mononuclear metal complex of 2,2':6',2"-terpyridine [M(tpy)2]n+. 
 
It is generally observed in [M(bpy)3]n+, [M(tpy)2]n+ and [M(phen)3]n+ complexes that the 
protons adjacent to the nitrogen are significantly deshielded when compared to the free 
ligand. The degree of upfield shifting depends on both the metal ion and the precise 
ligand being studied.172-174 A number of factors contribute to the upfield shifting in these 
complexes, firstly, these protons are the ones closest to the metal centre and are likely to 
experience shielding from the t2g electron pair and, secondly, in the complexes (Scheme 
4.4) the protons lie above the aromatic plane of one of the other ligands present. The 
pyridine ring has a magnetic anisotropy and the precise position of the proton with 
respect to the ring will effect where exactly it lies with respect to the shielding or 
deshielding effects of the paired electrons in the pi* levels. naturally, the exact spatial 
relationship depends on the M-N bond lengths and the precise geometry of the complex 
and so a metal-dependent variation is expected. A possible third influence is a 
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temperature independent paramagnetism in the d6 complexes if there are suitable low 
lying states of T symmetry. 
 
All of the changes in the 1H NMR spectra of ligand L4 and complex [Zn(L4)][BF4]2 are 
also pictured in Figure 4.3.  
 
The assignment of the HG1, HG2, HG3 and HG4 protons of the complex [Zn(L4)][BF4]2 
was made using the 1H-1H COSY and NOESY techniques (Figures 4.4 and 4.5). The 
signal for HG1 gives a COSY cross peak to the signal HG2 at δ 3.99 ppm (Figure 4.4). 
The signal for HG3 gives a COSY cross peak to the signal at δ 3.63 ppm, and this signal is 
assigned to HG4 (Figure 4.4). 
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Figure 4.4. Part of the 1H-1H COSY spectrum (500 MHz, 295K) of [Zn(L4)][BF4]2 in 
CD3CN showing the aliphatic region. Spectrum exhibits some residues of the starting 
material, which could not be removed by column chromatography or other purification 
methods. 
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Figure 4.5. Part of the NOESY spectrum (500 MHz, 295K) of [Zn(L4)][BF4]2 in CD3CN 
showing the aliphatic region. 
 
 
 
 
4.5   13C NMR spectroscopy 
 
For comparison, the diethylene glycol CG, CF and phenyl CP carbon signals of zinc(II) 
complex [Zn(L4)][BF4]2 as well as the terpyridine carbon signals of this complex were 
put together with carbon signals of ligand L4 in Tables 4.3 and 4.4. The assignments 
were made using HMQC and HMBC techniques. 
 
Table 4.3 shows how the CG, CF and CP carbon signals of ligand L4 changes, after 
complexation with zinc(II). All of the signals are shifted downfield after complexation 
with zinc(II) but most changed are the carbon signals CG1 and CG4 of ligand L4, which 
are shifted by 3.3 and 2.4 ppm, respectively. 
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 CG1 CG2 CG3 CG4 CF 
CP/ 
(#)CP 
(quaternary) 
L4 67.7 69.7 71.2 68.0 73.3 128.0/ (#)137.7 
[Zn(L4)][BF4]2 71.0 69.8 71.5 70.5 73.4 128.8/ (#)139.0 
 
Table 4.3. 13C NMR spectroscopic data, δC [ppm], (125 MHz, 295 K) for L4 in CDCl3 
and [Zn(L4)][BF4]2 in CD3CN (see page 78 and 119 for scheme of labeling). 
 
 
In Figure 4.6 the cross peaks of the aliphatic protons HG and HF of the complex 
[Zn(L4)][BF4]2 to the signals for directly attached carbons are shown. All of the C-H 
signals could be easily assigned using the HMQC spectrum.  
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Figure 4.6. Part of the HMQC spectrum (500 MHz, 295 K) of [Zn(L4)][BF4]2 in CD3CN 
showing the aliphatic region. Spectrum exhibits some residues of the starting material, 
which could not be removed by column chromatography or other purification methods. 
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Table 4.4. 13C NMR spectroscopic data, δC [ppm], (125 MHz, 295 K) for L4 in CDCl3 
and [Zn(L4)][BF4]2 in CD3CN (see page 78 and 119 for scheme of labeling). 
 
Table 4.4 shows in comparison the terpyridine carbon signals of ligand L4 and zinc(II) 
complex [Zn(L4)][BF4]2. After complexation with zinc(II) almost all of the carbon 
signals are shifted downfield, accept carbons CC6, CC2 and CD2 which are shifted upfield.  
 
In the Figure 4.7 the cross peaks of the terpyridine protons HC3, HD3, HC4, HC6, HC5 and 
HP of the complex [Zn(L4)][BF4]2 to the direct carbons signal are shown. All of the 
signals were assigned using the HMQC spectrum.  
 
HC5HC4
HC3 HC6
HD3
HP2,P3,P5,P6
CD3
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CC6
*
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Figure 4.7. Part of the HMQC spectrum (500 MHz, 295 K) of [Zn(L4)][BF4]2 in CD3CN. 
 
CT2 
/CC2 
CT3 
/CC3 
CT4 
/CC4 
CT5 
/CC5 
CT6 
/CC6 
CT2' 
/CD2 
CT3' 
/CD3 
CT4' 
/CD4 
L4 156.3 121.5 137.0 124.0 149.2 157.3 107.6 167.1 
[Zn(L4)] 
[BF4]2 148.8 123.9 142.2 128.4 148.8 152.0 111.1 172.4 
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The three quaternary carbons CP1/P4, CC2 and CD2 could be only assigned using the 
HMBC technique, as they do not have any protons directly attached. In Figure 4.8, the 
cross peak of the benzene protons HP2,P3,P5,P6 of the complex [Zn(L4)][BF4]2 to the 
indirect carbon signal CP1/P4 is shown. The signal for proton HC3 couples with the signal 
for carbon CD2 and the signal for carbon CC2 couples with the signals for protons HC3, 
HD3, HC4, HC6 and HC5, giving the cross peaks. 
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Figure 4.8. Part of the HMBC spectrum (500 MHz, 295 K) of [Zn(L4)][BF4]2 in CD3CN 
showing the aromatic region. Spectrum exhibits some residues of the starting material, 
which could not be removed by column chromatography or other purification methods. 
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4.6   Absorption spectroscopic characterization 
 
The electronic spectra of the homoleptic mononuclear zinc(II) complex [Zn(L4)][BF4]2 
was recorded in HPLC grade acetonitrile solution. Although the 1H MR spectra show the 
presence of small amounts of other tpy containing species, it is assumed that the observed 
absorption spectra represent the major component. 
 
It is well-known from the literature that metal-to-ligand charge transfer (MLCT) 
processes do not occur for metal ions with filled electron shells, such as Zn(II) with its 
d10 configuration.175 Hence, only the ligand-centered (LC) pi* ← pi charge transitions are 
observed. 
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Figure 4.9. Absorption spectra of ligand L4 in CH2Cl2 (in red) and [Zn(L4)][BF4]2 in 
CH3CN (in blue). 
 
A comparison between the UV-vis spectra obtained for free ligand L4 (in red) and 
zinc(II) complex [Zn(L4)][BF4]2 (in blue) is shown in Figure 4.9. While the absorption 
spectrum of uncomplexed ligand L4 has only two bands in the high energy UV region, 
assigned to the ligand-centered (LC) pi* ← pi transitions with λmax at 241 and 279 nm 
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(εmax/103, M-1 cm-1 : 56.8 and 55.3, respectively), the electronic spectrum of zinc(II) 
complex [Zn(L4)][BF4]2 shows four bands: the most intense band with λmax at 243 nm 
(εmax/103, M-1 cm-1 : 76.0) and three others - λmax at 274, 310 and 323 nm (εmax/103, M-1 
cm-1 : 60.0, 34.0 and 35.0 respectively). 
 
 
 
 
4.7   DFT molecular modeling 
 
 
Figure 4.10. Calculated structure of [Zn(L4)]2+. 
 
The Zn(II) complex of the ditopic 4'-substituted- 2,2':6',2''-terpyridine ligand L4 
[Zn(L4)]2+ was also investigated by means of SCF performed with the PM3 method. The 
optimized bond distances of the metal coordination environment are given in Table 4.5, 
while the optimized geometry of [Zn(L4)]2+ is shown in Figure 4.10. The SCF 
calculations provide a minimum energy conformation in which the Zn(II) ion is six-
coordinate, directly bound to the six available donor atoms (nitrogen on tpy) of the 
ligand. All of the data were compared with another [Zn(4'-X-tpy)2]2+ system with 4'-(4'''-
benzo-15-crown-5)-methyloxy-2,2':6',2''-terpyridine ligand (4'-X-tpy) (Figure 4.11).176 
Molecular modeling shows that formation of a [1+1] metallomacrocyclic species is 
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possible with ligand L4. Both tpy moieties are almost flat, each is lying in one plane and 
they are coordinated to the zinc center in the characteristic perpendicular geometry, 
which means the planes on which tpy units are lying make a 90° angle.  
 
 
Figure 4.11. X-ray structure of [Zn(4'-X-tpy)2]2+, 4'-X-tpy = 4'-(4'''-benzo-15-crown-5)-
methyloxy-2,2':6',2''-terpyridine 
 
 
 
[Zn(L4)]2+ [Zn(4'-X-tpy)2] 
Zn-Nterm 2.027 2.262(4) 
Zn-Ncent 1.994 2.145(7) 
Zn-Nterm 2.023 2.246(3) 
 
Table 4.5. Values of the mean distances (Å) of calculated (for [Zn(L4)][BF4]2) and 
experimental (X-ray) structures (for [Zn(4'-X-tpy)2]2+). 
 
A comparison of the calculated bond distances of [Zn(L4)]2+ and experimental bond 
distances of [Zn(X-tpy)2] shows that coordination environment in these complexes affects 
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the bond length, namely the Zn-N bonds in the [Zn(L4)]2+ complex are shortened by 
0.150-0.235 Å.  
An analysis of bond length data for the IS independent [Zn(4'-X-tpy)2]) structures 
including tpy or 4'-X-tpy ligands in the CSD using VISTA gave average Zn-Nterm 2.185 
Å and Zn-Ncent 2.081 Å. 
 
 
 
 
4.8   Conclusion 
 
The homoleptic mononuclear zinc(II) complex of the ditopic 4'-substituted-2,2':6',2''-
terpyridine ligand L4, which is based on a benzene unit connected to two 4'-substituted- 
2,2':6',2''-terpyridine moieties through diethyleneoxy spacers, has been synthesized. The 
complex was characterized by 1H and 13C NMR spectroscopy, mass spectrometry (ESI-
MS), IR spectroscopy, UV-Vis spectroscopy and elemental analysis. Molecular modeling 
of [Zn(L4)]2+ using the SCF method showed that formation of a [1+1] 
metallomacrocyclic species is possible with this ligand.  
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4.9   Experimental 
 
Ligand L4 was prepared as described in Chapter 2. Zn(BF4)2·6H2O is a commercially 
available compound.  
 
 [Zn(L4)][BF4]2 
 
 
 
Compound L4 (0.10 g, 0.13 mmol) dissolved in 10 mL CHCl3 was added to a solution of 
Zn(BF4)2·6H2O (0.033 g, 0.13 mmol) in 30 mL CH3CN. The mixture was stirred 
overnight at room temperature. The solvent was removed in vacuo to give a white oil 
(0.12 g, 0.12 mmol, 89%). 
 
1H NMR (500 MHz, CD3CN) δH 3.63 (m, 4H, HG4), 3.75 (m, 4H, HG3), 3.99 (m, 4H, 
HG2), 4.48 (s, 4H, HF), 4.65 (m, 4H, HG1), 7.30 (s, 4H, HP2, P3, P5, P6), 7.33 (m, 4H, HC5), 
7.73 (d, J 4.5 Hz, 4H, HC6), 8.08 (t, J 7.5 Hz, 4H, HC4), 8.21 (s, 4H, HD3), 8.52 (d, J 8.0 
Hz, 4H, HC3). 
 
13C NMR (125 MHz, CD3CN) δC 69.8 (CG2), 70.5 (CG4), 71.0 (CG1), 71.5 (CG3), 73.4 
(CF), 111.1 (CD3), 123.9 (CC3), 128.4 (CC5), 128.8 (CP2,P3,P5,P6), 139.0 (CP1,P4), 142.2 (CC4), 
148.8 (CC6 and CC2), 152.0 (CD2), 172.4 (CD4). 
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MS (ESI) m/z = 927.5 [M-BF4]+ (calc. 927.5), 420.3 [M-2BF4]2+ (calc. 420.5). 
 
IR (solid, ν∼/cm-1): 3114w, 3083w, 2865w, 2359w, 1611w, 1600w, 1573w, 1558w, 
1478w, 1439w, 1429w, 1349w, 1224w, 1165w, 1053m, 1034m, 1030m, 1021m, 1012m, 
974w, 933w, 863w, 845w, 792w, 747w, 728w, 700w, 661w, 637w, 621w. 
 
UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 243 (76 x 103), 274 (60 x 103), 310 (34 x 
103), 323 (35 x 103). 
 
Elemental Analysis . Found: C, 53.63; H, 4.27; N, 8.92. Calc. for 
C46H44B2F8N6O6Zn·H2O·0.5CH3CN: C, 53.54; H, 4.54; N, 8.63%. 
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CHAPTER 5 
 
Synthesis of a tritopic 4'-substituted- 2,2':6',2''-terpyridine 
ligand and its heteroleptic trinuclear ruthenium(II) complex 
 
5.1   Introduction 
 
 
O O
O O
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N N
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Scheme 5.1. New tritopic ligand L5. 
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In the introduction it was shown that more than one or two 2,2':6',2"-terpyridine domains 
can be used to synthesize different groups of ligands (see Section 1.3). Bridged ligands 
containing three, four or six tpy domains can be used as the core for the synthesis of 
metallostars83,84 and metallodendrimers.85 
 
In this chapter the synthesis of new tritopic ligand L5 based on a mesitylene unit 
connected to three 4'-substituted-2,2':6',2''-terpyridine moieties through diethylene glycol 
spacers is discussed (Scheme 5.1). 
 
In Chapter 3, the interesting properties of the complexes of 2,2'-bipyridine and 2,2':6',2''-
terpyridine derivatives were discussed. The synthesis, as well as the photochemical and 
photophysical properties, of new dinuclear ruthenium(II) complexes of ditopic 4'-
substituted- 2,2':6',2''-terpyridine ligands have been described in this thesis in Chapter 3. 
In Chapter 5, a new tritopic 4'-substituted- 2,2':6',2''-terpyridine ligand L5 was introduced 
and characterized. In this chapter, a heteroleptic trinuclear ruthenium(II) complex of 
ligand L5 is discussed (Scheme 5.2). This ruthenium(II) complex [(L5)(Ru)3(tpy)3][PF6]6 
was designed such that one ruthenium ion goes to each binding site to create an M3L 
species. The monotopic tpy ligands "close" the complex at all three sites and prevent 
polymerization.  
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Scheme 5.2. Heteroleptic trinuclear ruthenium(II) complex of tritopic 4'-substituted- 
2,2':6',2''-terpyridine ligand. 
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5.2.1   Synthesis of a tritopic ligand L5 
 
Ligand L5 was prepared in three steps by nucleophilic substitution reactions. In the first 
step commercially accessible mesitylene was bromomethylated in reaction with para-
formaldehyde and potassium bromide (Scheme 5.3). The benzene ring functionalized 
with three diethylene glycol chains was obtained (L5a) by nucleophilic substitution of the 
tribromobenzene derivative (Scheme 5.3). In the last step, a nucleophile was generated 
by deprotonation of three terminal hydroxyl groups, these were then reacted further with 
Cl-tpy (Scheme 5.5). 4'-Chloro-2,2':6',2"-terpyridine (Cl-tpy) was prepared as previously 
reported in the literature.102 
 
 
 
 
 
Scheme 5.3. Synthesis of 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene. 
 
 
The conversion of mesitylene involves bromomethylation with para-formaldehyde and 
KBr in hot 1:1 mixture of concentrated sulfuric and acetic acids (Scheme 5.3). 
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1,3,5-tris(7-hydroxy-2,5-dioxaheptyl)-2,4,6-
trimethylbenzene (L5a)
 
 
Scheme 5.4. Synthesis of L5a. 
 
 
L5a was prepared from 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene, which was 
heated under reflux in the diethylene glycol with sodium hydroxide overnight (Scheme 
5.4). 
 
In the next step, after deprotonation of three terminal hydroxyl groups with potassium 
hydroxide in hot DMSO, intermediate product L5a was reacted further with Cl-tpy. After 
three days the desired product was obtained in 89% yield after work up (Scheme 5.5). 
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1. KOH, DMSO, 75 °C, 1 h
2. Cl-tpy, 75 °C, 3 days
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Scheme 5.5. Synthesis of ligand L5. 
 
 
 
 
5.2.2   Synthesis of ruthenium(II) complex of L5 (Ru3L5) 
 
A heteroleptic trinuclear ruthenium(II) complex of ligand L5 was prepared stepwise in a 
Biotage microwave reactor. First one equivalent of RuCl3·3H2O and one equivalent tpy 
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(Scheme 5.6) were heated under microwave conditions in ethanol at 135 °C for 15 
minutes. Then 0.3 equivalents of tritopic 4'-substituted- 2,2':6',2''-terpyridine ligand L5 
and the reducing agent N-ethylmorpholine (NEM) were added and the mixture was again 
heated under microwave conditions at 135 °C for 15 minutes (Scheme 5.6). The red 
ruthenium(II) complex was precipitated from solution with excess aqueous NH4PF6 and 
then filtered and collected, yielding [(L5)(Ru)3(tpy)3][PF6]6 in 90% yield, without further 
purification. 
 
 
 
 
Scheme 5.6. Synthesis of [(L5)(Ru)3(tpy)3][PF6]6. 
 
 
 
 
5.3.1   1H NMR spectroscopy of L5a and L5 
 
 
Table 5.1. 1H NMR spectroscopic data, δH [ppm], (400 MHz, 295 K, CDCl3) for L1a and 
L5a (see page 140 for scheme of labeling). 
L HG2-G4 HG1 HF HOH HP/HMe 
L1a 3.59–3.76 (m) 3.57 (m) 4.56 (s) 3.34 (br) 
7.18-7.39 
(m) 
L5a 3.65-3.85 (m) 3.55 (m) 4.59 (s) 1.71 (br) 2.41 (s) 
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Intermediate product L5a (Scheme 5.7) and ligand L5 (Scheme 5.8) were characterized 
by 1H NMR spectroscopy in CDCl3. In Table 5.1 the proton signals of intermediate L5a 
are compared with those of compound L1a.  
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Scheme 5.7. Labeling for L1a and L5a intermediates. 
 
All of HP protons on the benzene ring of L5a are substituted with CH3 groups, therefore a 
singlet for nine mesitylene protons HMe is observed at δ 2.41 ppm. All of the signals 
corresponding to the diethylene glycol chain HG1-G4 of L5a can be found, as expected in 
the aliphatic region at δ 3.55-3.85 ppm. The signal for HG1 is the strongest shifted 
downfield due to its close proximity to the tpy unit. The signals of the HG2, HG3 and HG4 
protons of ligand L5 overlap and give a multiplet. The signal at δ 4.59 ppm is assigned to 
HF from the -CH2- bridge connecting the benzene ring to the diethylene glycol chain. 
 
After the substitution of the three terminal hydroxyl groups on the diethylene glycol 
chains of L5a with Cl-tpy some of changes in chemical shifts can be observed (Tables 
5.2 and 5.3).  
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Scheme 5.8. Labeling for ligands L1 and L5. 
 
For comparison, Table 5.2 shows chemical shifts of the protons on diethylene glycol 
chains HG1-G4 and the -CH2-bridge HF of ligands L1 and L5. The aromatic protons from 
tpy of ligands L1 and L5 are shown in Table 5.3. 
 
All of the signals corresponding to the diethylene glycol chain HG1-G4 of L5 are slightly 
shifted upfield in comparison to the proton signals HG1-G4 of L1. The singlet at δ 4.54 
ppm is assigned to HF from the -CH2- bridge connecting the benzene ring to the ethylene 
glycol chain. The splitting of the methyl signal in the ligand L5 (and the complex) 
indicates that the two atropisomers only interconvert slowly in solution (see Figure5.1 
and 5.3). 
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Table 5.2. 1H NMR spectroscopic shift data, δH [ppm], (500 MHz, 295 K, CDCl3) for L1 
and L5 (see page 141 for scheme of labeling). 
 
The five signals in the aromatic region for both ligands L1 and L5: HT6, HT3, HT3', HT4, 
HT5 have almost the same chemical shifts in the two compounds. 
 
 
 
Table 5.3. 1H NMR spectroscopic shift data, δH [ppm], (500 MHz, 295 K, CDCl3) for L1 
and L5 (see page 141 for scheme of labeling).. 
 
The 1H NMR spectrum of ligand L5 (Figure 5.1) shows five signals in the aromatic 
region for the protons on tpy: HT5, HT3, HT3', HT4, HT5. In the aliphatic region, in the 1H 
NMR spectrum of ligand L5, there is one singlet for the HF proton at δ 4.54 ppm and 
four well separated multiplets from the HG protons on the diethylene glycol chains. The 
signal for HG1 is the strongest shifted downfield due to its close proximity to the tpy unit. 
The assignment of the HG1, HG2, HG3 and HG4 protons of the L5 ligand were made using 
the COSY technique (Figure 5.2). The signal for HG1 gives a COSY cross peak to the 
signal HG2 at δ 3.85 ppm (Figure 5.2). The signal for HG3 gives a COSY cross peak to 
L HG4 HG3 HG2 HG1 HF 
L1 3.63 (m) 3.75 (m) 3.91 (m) 4.37 (m) 4.54 (s) 
L5 3.61 (m) 3.68 (m) 3.85 (m) 4.34 (m) 4.54 (s) 
L HT5 HT4 HT3' HT3 HT6 
L1 7.27-7.31 (m) 7.81 (td) J 1.5, 7.8 Hz 8.02 (s) 
8.58 (d) 
J 8.0 Hz 
8.65 (d) 
J 4.1 Hz 
L5 7.27-7.32 (m) 7.79 (t) J 7.5 Hz 7.99 (s) 
8.56 (d) 
J 7.9 Hz 
8.65 (d) 
J 3.9 Hz 
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the signal at δ 3.61 ppm, and this signal is assigned to HG4 (Figure 5.2). The singlet for 
nine mesitylene protons HMe is observed at δ 2.38 ppm. 
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Figure 5.1. 1H NMR spectrum (500 MHz, 295 K) of L5 in CDCl3. The signal marked 
with * is the signal for CHCl3. Spectrum exhibits some residues of the starting material, 
which could not be removed by column chromatography or other purification methods. 
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Figure 5.2. Aliphatic region of the COSY spectrum (500 MHz, 295 K) of L5 in CDCl3. 
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5.3.2   1H NMR spectroscopy of Ru3L5 
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Scheme 5.9. Labeling for the ruthenium(II) complex of tritopic 4'-substituted- 2,2':6',2''-
terpyridine ligand [(L5)(Ru)3(tpy)3][PF6]6. 
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The complex [(L5)(Ru)3(tpy)3][PF6]6 was characterized by 1H NMR spectroscopy in 
CD3CN solution. Assignments have been made using COSY and NOESY experiments 
and by comparison with the spectra of heteroleptic dinuclear ruthenium(II) complexes of 
ditopic 4'-substituted- 2,2':6',2''-terpyridine ligands L1, L2, L4, L6 and L7 described in 
Chapter 3 in this thesis. 
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Figure 5.3. 1H NMR spectrum of [(L5)(Ru)3(tpy)3][PF6]6 in CD3CN. Spectrum exhibits 
some residues of the starting material, which could not be removed by column 
chromatography or other purification methods. 
 
 
In Figure 5.3 the 1H NMR spectrum of [(L5)(Ru)3(tpy)3][PF6]6 in CD3CN is shown. The 
proton signals from rings A and B of the unsubstituted tpy are highlighted in green, the 
proton signals from rings C and D of ligand L5 in red. 
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Table 5.4. 1H NMR spectroscopic data, δH [ppm] for L5 (500 MHz, 295 K, CDCl3) and 
[(L5)(Ru)3(tpy)3][PF6]6 (500 MHz, 295 K, CD3CN) (see page 144 for scheme of 
labeling). 
 
Tables 5.4 and 5.5 as well as Figure 5.3 show how the 1H NMR spectrum of ligand L5 
changes after complexation with ruthenium(II). All of the signals are influenced by 
addition of ruthenium(II) to the system.  
 
 
Table 5.5. 1H NMR spectroscopic data, δH [ppm] for L5 (500 MHz, 295 K, CDCl3) and 
[(L5)(Ru)3(tpy)3][PF6]6 (500 MHz, 295 K, CD3CN) (see page 144 for scheme of 
labeling). 
 
In the aliphatic region of the 1H NMR spectra of ligand L5 and complex 
[(L5)(Ru)3(tpy)3][PF6]6 there are a few significant differences. After complexation all of 
the proton signals HG and HF are shifted downfield, protons HG4, HG3 and HF by around 
0.10 ppm, and mostly affected signals assigned to the protons HG2 and HG1 by 0.18 and 
0.32 ppm, respectively (Table 5.4). The assignment of the HG1, HG2, HG3 and HG4 
protons of complex [(L5)(Ru)3(tpy)3][PF6]6 were made using the 1H-1H COSY technique 
(Figure 5.5). 
 HG4 HG3 HG2 HG1 HF 
L5 3.61 (m) 3.68 (m) 3.85 (m) 4.34 (m) 4.54 (s) 
Ru3L5 3.73 (m) 3.79 (m) 4.03 (m) 4.66 (m) 4.63 (s) 
 HT5/HC5 HT4/HC4 HT3'/HD3 HT3/HC3 HT6/HC6 
L5 7.27-7.32 (m) 7.79 (t) J 7.2 Hz 7.99 (s) 
8.56 (d) 
J 7.9 Hz 
8.65 (d) 
J 3.9 Hz 
Ru3L5 7.11 (m) 7.82-7.94 (m) 8.33 (s) 8.46 (m) 7.29 (d) J 5.2 Hz 
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Figure 5.4. 1H NMR spectrum (500 MHz, 295 K) of L5 (below) in CDCl3 and 
[(L5)(Ru)3(tpy)3][PF6]6 (above) in CD3CN. The signal marked with * is the signal for 
CHCl3. 
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Figure 5.5. Aliphatic region of the 1H-1H COSY spectrum (500 MHz, 295 K) of 
[(L5)(Ru)3(tpy)3][PF6]6 in CD3CN. Spectrum exhibits some residues of the starting 
material, which could not be removed by column chromatography or other purification 
methods. 
 148
For comparison, all of the terpyridine proton signals of ligand L5 and ruthenium(II) 
complex [(L5)(Ru)3(tpy)3][PF6]6 are shown in Table 5.5. The signals for the HT3, HT5 
and HT6 protons of ligand are all shifted upfield and the mostly affected signal assigned 
to the proton HT6 by 1.36 ppm. The signals for protons HC4/HT4 and HD3/HT3' of complex 
[(L5)(Ru)3(tpy)3][PF6]6 are shifted downfield, respectively by around 0.09 and 0.34 ppm, 
in comparison to ligand L5. 
 
 
 
 
5.4.1   13C NMR spectroscopy of L5a and L5 
 
Table 5.6 shows the ethylene glycol CG, CF and phenyl CP carbon signals for ligands L1 
and L5 in CDCl3 solution. All of the terpyridine carbon signals are shown in the Table 
5.7. The assignments were made using HMQC and HMBC techniques. 
 
 
L CG1 CG2 CG3 CG4 CF 
CP/ 
(#)CP 
(quaternary) 
L1 68.0 69.8 71.2 69.7 73.4 
127.3 
127.3 
128.7 
(#)138.6 
L5 68.0 69.6 71.3 69.6 68.1 
(#)132.5 
(#)138.5 
 
Table 5.6. 13C NMR spectroscopic shift data, δC [ppm], (125 MHz, 295 K, CDCl3) for 
L1 and L5 (see page 141 for scheme of labeling). 
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Almost all of the carbon signals in the aliphatic region of ligand L5 are shifted upfield, in 
comparison to the carbon signals of ligand L1, but most changed is the carbon signal CF 
of ligand L5, which is shifted by 5.3 ppm. 
 
 
 
Table 5.7. 13C NMR spectroscopic shift data, δC [ppm], (125 MHz, 295 K, CDCl3) for 
L1 and L5 (see page 141 for scheme of labeling). 
 
HG1 HG2 HG3 HG4
HF
CG1
CG3
CG4
CF
CG2
 
 
Figure 5.6. Part of the HMQC spectrum (500 MHz, 295 K) of L5 in CDCl3 showing the 
aliphatic region. Spectrum exhibits some residues of the starting material, which could 
not be removed by column chromatography or other purification methods. 
L CT3' CT3 CT5 CT4 CT6 CT2 CT2' CT4' 
L1 107.7 121.5 124.0 136.9 149.2 156.3 157.3 167.2 
L5 107.6 121.5 124.0 136.9 149.2 156.2 157.2 167.1 
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In Figure 5.6 the aliphatic region of HMQC spectrum of ligand L5 in CDCl3 is shown. 
The proton signals for HG2 and HG4 couple with the almost overlapping signals for 
carbons CG2 and CG4, giving the cross peaks. 
 
The signal for the quaternary carbon CP of ligand L5, to which the glycol chains are 
attached through a -CH2- bridge, is slightly shifted upfield. 
 
For the terpyridine carbon signals of ligands L1 and L5, almost no differences are 
observed, except the signal assigned to the carbon CT4' of ligand L5, which is shifted 
upfield by 0.1 ppm. 
 
 
 
 
5.4.2   13C NMR spectroscopy of Ru3L5 
 
Table 5.8 shows the ethylene glycol CG, CF and phenyl CP carbon signals for the 
heteroleptic trinuclear ruthenium(II) complex of ligand L5 in CD3CN solution. All of the 
terpyridine carbon signals, from both types of tpy units – from tritopic ligand L5 and 
monotopic tpy ligand - are shown in Tables 5.9 and 5.10. The assignments were made 
using HMQC and HMBC techniques. The terpyridine carbon signals are comparable to 
ruthenium(II) complexes described in Chapter 3 and other related terpyridine systems.  
 
In the aliphatic region of the 13C NMR spectrum after complexation, all of the carbon 
signals CG and CF as well as signals of carbons on the benzene ring CP are shifted 
downfield, in comparison to free ligand L5. The mostly affected signals assigned to the 
carbons CG1 and CG4 are shifted by around 3 and 1 ppm, respectively (Table 5.8). 
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 CG1 CG2 CG3 CG4 CF CP 
L5 68.0 69.60 71.3 69.6 68.1 132.5 138.5 
Ru3L5 70.9 70.0 71.7 70.6 68.4 
134.0 
139.0 
 
Table 5.8. 13C NMR spectroscopic data, δC [ppm], (125 MHz, 295 K) for L5 in CDCl3 
and [(L5)(Ru)3(tpy)3][PF6]6 in CD3CN (see page 144 for scheme of labeling). 
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Figure 5.7. Part of the HMQC spectrum (500 MHz, 295 K) of complex 
[(L5)(Ru)3(tpy)3][PF6]6 in CD3CN showing the aliphatic region. Spectrum exhibits some 
residues of the starting material, which could not be removed by column chromatography 
or other purification methods. 
 
In Figure 5.7 the aliphatic region of HMQC spectrum of complex 
[(L5)(Ru)3(tpy)3][PF6]6 in CD3CN is shown. Five cross peaks of proton signals for HG 
and HF to carbon signals CG and CF were found.  
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All of the terpyridine carbon signals of complex [(L5)(Ru)3(tpy)3][PF6]6 in comparison to 
tritopic ligand L5 are shifted downfield (Table 5.9). 
 
In Table 5.10 the terpyridine carbon signals of complex [(L5)(Ru)3(tpy)3][PF6]6 from 
monotopic tpy ligand (see aromatic rings A and B on Figure 5.3) are shown. 
 
 
 
Table 5.9. 13C NMR spectroscopic data, δC [ppm], (125 MHz, 295 K) for L5 in CDCl3 
and [(tpy)Ru(L5)(Ru)2(tpy)2][PF6]6 in CD3CN (see page 144 for scheme of labeling). 
 
 
 
 
Table 5.10. 13C NMR spectroscopic data, δC [ppm], (125 MHz, 295 K) for 
[(L5)(Ru)3(tpy)3][PF6]6 of monotopic tpy ligand in CD3CN (see page 144 for scheme of 
labeling). 
 
 
 
 
 
 
 
CT2 
/CC2 
CT3 
/CC3 
CT4 
/CC4 
CT5 
/CC5 
CT6 
/CC6 
CT2' 
/CD2 
CT3' 
/CD3 
CT4' 
/CD4 
L5 156.2 121.5 137.0 124.0 149.2 157.2 107.6 167.1 
Ru3L5 157.0 125.5 139.0 128.5 153.8 159.1 112.1 167.4 
 CA2 CA3 CA4 CA5 CA6 CB2 CB3 CB4 
Ru3L5 156.9 125.3 138.9 128.5 153.3 159.3 124.7 136.2 
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5.5.1   Mass spectrometric characterization of L5a and L5 
 
Electrospray ionization (ESI) and MALDI-TOF mass spectrometry, both in positive 
mode, were also used to characterize intermediate L5a and ligand L5. The [L+H]+ peak 
was found as the major peak: 475.5 [L5a+H]+ (calc. 475.5), 1169.3 [L5+H]+ (calc. 
1169.5). The simulated spectra match the experimental ones.  
 
 
 
 
5.5.2   Mass spectrometric characterization of Ru3L5 
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Figure 5.8. ESI-MS spectrum of [(L5)(Ru)3(tpy)3][PF6]6. 
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Electrospray ionization mass spectroscopy (ESI-MS) was used to characterize the new 
heteroleptic trinuclear ruthenium(II) complex of ligand L5 - [(L5)(Ru)3(tpy)3][PF6]6. The 
peaks are observed as the ratio of mass to the charge of the species (m/z), hence allowing 
one to distinguish between ions carrying different charges. 
 
In Figure 5.8 the ESI-MS spectrum of [(L5)(Ru)3(tpy)3][PF6]6 is shown. The second 
highest signal is a peak at m/z 615.5 and was assigned to [M-4BF6]4+. The other three 
signals at m/z 1375.8, 869.0 and 463.9 correspond to [M-2PF6]2+, [M-3PF6]3+ and [M-
5PF6]5+, respectively. Also shown are expansions of peaks at m/z 1375.8, 869.0 and 615.5 
(Figure 5.9). The peaks show the typical isotope pattern of three ruthenium ions. 
Confirming the nuclearity of the complex. 
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Figure 5.9. Measured (above) and simulated (below) isotopic pattern of +4, +3 and +2 
charged cations from [(L5)(Ru)3(tpy)3][PF6]6. The m/z ratio is also reflecting in the line 
spacing. 
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5.6.1   Absorption spectroscopic characterization of L5 
 
The electronic spectrum of the tritopic 4'-substituted-2,2':6',2''-terpyridine ligand L5 was 
recorded in HPLC grade dichloromethane solution. 
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Figure 5.10. Absorption spectra of ligand L4 in CH2Cl2 (in green) and ligand L5 in 
CH2Cl2 (in orange). 
 
In Figure 5.10 absorption spectra of ligand L4 (1,4-bis(8-(4'-(2,2':6',2''-terpyridyl))-
2,5,8-trioxaoctyl)benzene, see Section 2) (in green) and ligand L5 (in orange) are shown 
for comparison. The UV-Vis spectra of both ligands L4 and L5 look almost identical. 
There are two bands in the high energy UV region, assigned to ligand-centered (LC) pi* 
← pi transitions with λmax at 241 and 279 nm. Both bands have almost the same intensity, 
(εmax/103 M-1 cm-1 : 56.8 and 55.3 for ligand L4, 57.0 and 55.6 for ligand L5). 
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5.6.2   Absorption spectroscopic characterization of Ru3L5 
 
The electronic spectrum of the heteroleptic trinuclear ruthenium(II) complex 
[(L5)(Ru)3(tpy)3][PF6]6 was recorded in HPLC grade acetonitrile solution. The four very 
intense bands with λmax at 233, 241, 269 and 305 (εmax/103 M-1 cm-1 : 120.0, 122.0, 137.0 
and 173.0 respectively) nm in the UV region are assigned to the ligand-centered (LC) pi* 
← pi transitions. [(L5)(Ru)3(tpy)3][PF6]6 complex exhibits typical low energy metal-to-
ligand charge transfer (MLCT) transition for ruthenium(II) complexes with λmax at 481 
nm (εmax/103 M-1 cm-1 : 47.0).  
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Figure 5.11. Absorption spectra of ligand L5 in CH2Cl2 (in blue) and 
[(L5)(Ru)3(tpy)3][PF6]6 in CH3CN (in green). 
 
In Figure 5.11 absorption spectra of ligand L5 in CH2Cl2 (in blue) and 
[(L5)(Ru)3(tpy)3][PF6]6 in CH3CN (in green) are shown for comparison. The absorption 
spectrum of uncomplexed ligand L5, unlike complex [(L5)(Ru)3(tpy)3][PF6]6, shows only 
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two bands in the high energy UV region, assigned to ligand-centered (LC) pi* ← pi 
transitions with λmax at 241 and 279 nm (εmax/103 M-1 cm-1 : 57.0 and 55.6 respectively). 
 
 
 
 
5.7   Electrochemical studies of Ru3L5 
 
The redox properties of ruthenium(II) complex [(L5)(Ru)3(tpy)3][PF6]6 have been 
investigated using the cyclic voltammetry method (CV).  
 
 
Potential [V] vs Fc/Fc+ 
oxidation                       reduction 
0.78a -1.68a, -1.92a, -2.39b 
 
Table 5.11. Redox potentials measured for [(L5)(Ru)3(tpy)3][PF6]6 in argon-purged 
solutions of acetonitrile. E1/2 values are given for reversible processes (a) from the 
cyclovoltametry and for irreversible processes (b) from square wave. 
 
 
 
The oxidation of ruthenium(II) in this complex occurs at 0.78 V (Table 5.11). There are 
three reduction processes, two of them are reversible, at -1.68 and -1.92 V, one is 
irreversible, at -2.39 V (Table 5.11). The potentials were measured versus 
Ferrocene0/Ferrocenium+ (Fc/Fc+). 
 
In Figure 5.12 the cyclic voltammogram of [(L5)(Ru)3(tpy)3][PF6]6 in degassed 
acetonitrile is shown.  
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Figure 5.12. Cyclic voltammogram of [(L5)(Ru)3(tpy)3][PF6]6 (1 mM) in degassed 
acetonitrile containing 0.1 M [nBu4N][PF6], scan rate = 100 mVs-1. 
 
 
 
 
 
5.8   Conclusion 
 
In this chapter, new tritopic intermediate L5a, ligand L5 and the heteroleptic trinuclear 
ruthenium(II) complex of tritopic 4'-substituted-2,2':6',2''-terpyridine ligand L5 have been 
synthesized and characterized with 1H and 13C NMR spectroscopy, mass spectrometry 
(ESI-MS and MALDI-TOF), IR spectroscopy, UV-Vis spectroscopy and elemental 
analysis. To fully characterize the ruthenium(II) complex of ligand L5, 
[(L5)(Ru)3(tpy)3][PF6]6, also cyclic voltammetry has been used. The compounds are 
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based on a mesitylene ring substituted in position 1, 2 and 3 with three diethylene glycol 
chains connected to 4'-substituted-2,2':6',2''-terpyridine moieties. Experimental data of 
ligand L5 have been compared with those of ligand L1. Spectroscopic data of 
ruthenium(II) complex [(L5)(Ru)3(tpy)3][PF6]6 have been compared with those of ligand 
L5. 
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5.9.1   Experimental of L5a and L5 
 
 1,3,5-Tris(7-hydroxy-2,5-dioxaheptyl)-2,4,6-trimethylbenzene (L5a) 
 1,3,5-Tris(8-(4'-(2,2':6',2''-terpyridyl))2,5,8-trioxaoctyl)-2,4,6-trimethylbenzene (L5) 
 
 
 
4'-Chloro-2,2':6',2"-terpyridine102 and 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene106 
were prepared as previously reported in the literature.  
 
 
Schematic reaction for 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene is shown 
below.106 
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 1,3,5-Tris(7-hydroxy-2,5-dioxaheptyl)-2,4,6-trimethylbenzene (L5a) 
 
NaOH, reflux, overnight
Molecular formula: C24H42O9
Molecular weight: 474.58
3-oxapentane-1,5-diol
(diethyleneglycol)
Br Br
Br
1,3,5-tris(bromomethyl)-
2,4,6-trimethylbenzene
O O
O O
HO OH
O
O
HO
P3
P6
P4
P5
P2
P1
F
G1
G2
G3
G4
1,3,5-tris(7-hydroxy-2,5-dioxaheptyl)-2,4,6-
trimethylbenzene (L5a)
 
 
1,3,5-Tris(bromomethyl)-2,4,6-trimethylbenzene (1.0 g, 2.5 mmol) was added to a hot 
suspension of NaOH (0.28 g, 7.0 mmol) in 50 mL diethylene glycol. The reaction 
mixture was stirred overnight at 125 °C under nitrogen. After 10 h, the reaction mixture 
was cooled to room temperature and quenched with 100 mL water, then extracted with 
CHCl3 (4x100 mL). The organic layer was dried (MgSO4), filtered and the solvent was 
removed in vacuo yielding a yellow oil of L5a (0.71 g, 1.5 mmol, 60%). The product was 
used in the next step without further purification.  
 
The reaction could also be performed in a microwave reactor at 125 °C for 15 minutes 
but on a much smaller scale. 1,3,5-Tris(bromomethyl)-2,4,6-trimethylbenzene (0.10 g, 
0.25 mmol) was reacted with NaOH (0.041g, 0.88 mmol) in 10 mL diethylene glycol. 
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After work up, L5a was obtained in 50% yield (0.059 g, 0.13 mmol). Despite the lower 
yield, this method allowed the reaction time to be shortened from 10 hours to 15 minutes. 
 
1H NMR (400 MHz, CDCl3) δH 1.71 (br, 3H, HOH), 2.41 (s, 9H, HMe), 3.55 (m, 6H, HG1), 
3.65-3.85 (m, 18H, HG2-G4), 4.59 (s, 6H, HF), 
 
MS(MALDI-TOF, sinapinic acid): m/z = 475.5 [L5a+H]+ (calc. 475.5). 
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 1,3,5-Tris(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)-2,4,6-trimethylbenzene (L5) 
 
1. KOH, DMSO, 75 °C, 1 h
2. Cl-tpy, 75 °C, 3 days
L5a
Molecular formula: C69H69N9O9
Molecular weight: 1168.34
O O
O O
HO OH
O
O
HO
1,3,5-tris(8-(4'-(2,2':6',2''-terpyridyl))-2,5,8-trioxaoctyl)-2,4,6-
trimethylbenzene (L5)
O O
O O
O O
N N
N N
N
N
O
O
O
N
NN
P3
P6
P4
P5
P2
P1
F
G1
G2
G3
G4
T3
T2
T6
T4
T5
T3'
T2'
T4'
 
 
Compound L5a (0.71 g, 1.5 mmol, 1.0 eq) was added to a suspension of finely powdered 
potassium hydroxide (1.6 g, 29 mmol) in 30 mL dry DMSO and the mixture was stirred 
for 1 h at 70 °C under nitrogen. After 1 h, 4'-chloro-2,2':6',2''-terpyridine (Cl-tpy) (2.5 g, 
9.3 mmol, 6.0 eq) was added and the reaction mixture was heated to 70 °C for 3 days. 
The reaction mixture was cooled to room temperature and quenched with 70 mL of 
water. The product was then extracted with CHCl3. The organic layer was separated and 
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dried (MgSO4). The crude product was filtered and the solvent was removed in vacuo. 
The pure product L5 was obtained after column chromatography (Al2O3, CHCl3), 
isolated as a yellow oil (1.6 g, 1.3 mmol, 89%). 
 
1H NMR (500 MHz, CDCl3) δH 2.38 (s, 9H, HMe), 3.61 (m, 6H, HG4), 3.68 (m, 6H, HG3), 
3.85 (m, 6H, HG2), 4.32 (m, 6H, HG1), 4.54 (s, 6H, HF), 7.27-7.32 (m, 6H, HT5), 7.79 (t, J 
7.5 Hz, 6H, HT4), 7.99 (s, 6H, HT3'), 8.56 (d, J 7.9 Hz, 6H, HT3), 8.65 (d, J 3.9 Hz, 6H, 
HT6). 
 
13C NMR (125 MHz, CDCl3) δC 16.0 (CMe), 68.0 (CG1), 68.1 (CF), 69.6 (CG4), 69.6 (CG2), 
71.3 (CG3), 107.6 (CT3'), 121.5 (CT3), 124.0 (CT5), 132.5 (CP1,P3,P5), 136.9 (CT4), 138.5 
(CP2,P4,P6), 149.2 (CT6), 156.2 (CT2), 157.2 (CT2'), 167.1 (CT4'). 
 
MS (ESI) m/z = 1169.3 [L5+H]+ (calc. 1169.5). 
 
IR (oil, ν∼/cm-1): 2878w, 1599w, 1582s, 1560s, 1468m, 1441m, 1406m, 1346m, 1252w, 
1203m, 1134m, 1092m, 1057m, 1038m, 1013m, 968m, 883w, 868w, 793s, 743s, 698m, 
658m, 621m. 
 
UV/VIS (CH2Cl2):λmax/ nm (εmax, M-1 cm-1) 241 (57 x 103), 279 (55.6 x 103). 
 
Elemental Analysis. Found: C, 62.60; H, 5.80; N, 9.15. Calc. for 
C69H69N9O9·3H2O·CHCl3: C, 62.66; H, 5.71; N, 9.40%. 
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5.9.2   Experimental of Ru3L5 
 
[Ru(tpy)Cl3] was prepared as described in Section 3.9. In some cases NaPF6 can be 
captured in long ethylene glycol chains (see elemental analysis). 
 
 [(L5)(Ru)3(tpy)3][PF6]6 
 
O O
O O
O O
O
O
O
N
N
N
P3
P6
P4
P5
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F
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N N
N N
N
N
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N Ru
N
N
N
Ru
[PF6]6
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B
C D
2 23
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5 6
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N
N
Ru
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Compound L5 (0.014 g, 0.012 mmol, 1.0 eq ) and [Ru(tpy)Cl3] (0.016 g, 0.036 mmol, 3.0 
eq) with a few drops of N-ethylmorpholine (NEM) were heated at 135 °C in 15 mL 
ethanol in a microwave reactor for 30 minutes. Excess of solid ammonium 
hexafluorophosphate was added to give a red precipitate. This was collected by filtration 
through celite, washed with water and diethyl ether, then redissolved in acetonitrile. The 
solvent was removed in vacuo to give a red solid [(L5)(Ru)3(tpy)3][PF6]6 (0.032 g, 0.010 
mmol, 90%).
 
 
 
 
 
1H NMR (500 MHz, CD3CN) δH 2.47 (s, 9H, HMe), 3.73 (m, 6H, HG4), 3.79 (m, 6H, HG3), 
4.03 (m, 6H, HG2), 4.63 (s, 6H, HF), 4.66 (m, 6H, HG1), 7.11 (m, 6H, HC5), 7.16 (m, 6H, 
HA5), 7.29 (d, J 5.2 Hz, 6H, HC6), 7.42 (d, J 5.0 Hz, 6H, HA6), 7.82-7.94 (m, 12H, HC4 
and HA4), 8.33 (s, 6H, HD3), 8.37 (m, 3H, HB4), 8.46 (m, 12H, HC3 and HA3), 8.72 (d, J 8.2 
Hz, 6H, HB3). 
 
13C NMR (125 MHz, CD3CN) δC 16.1 (CMe), 68.4 (CF), 70.0 (CG2), 70.6 (CG4), 70.9 
(CG1), 71.7 (CG3), 112.1 (CD3), 124.7 (CB3), 125.3 (CA3), 125.5 (CC3), 128.5 (CA5 and 
CC5), 134.0 (CP1/P3/P5 or CP2/P4/P6), 136.2 (C B4), 138.9 (CA4 and CC4), 139.0 (CP1/P3/P5 or 
CP2/P4/P6), 153.30 (CA6), 153.8 (CC6), 156.9 (CA2), 157.0 (CC2), 159.1 (CD2), 159.3 (CB2), 
167.4 (CD4). 
 
MS (ESI) m/z = 463.9 [M-5PF6]5+ (calc. 464.0), 615.6 [M-4PF6]4+ (calc. 615.5), 869.0 
[M-3PF6]3+ (calc. 869.0), 1375.8 [M-2PF6]2+ (calc. 1375.5). 
 
 167 
IR (solid, ν∼/cm-1): 3651w, 3310w, 3121w, 3080w, 2870w, 1607m, 1468w, 1448m, 
1437m, 1418m, 1387m, 1348w, 1286w, 1248w, 1209m, 1163w, 1094w, 1061w, 1045w, 
1028w, 964w, 824s, 785s, 766s, 752s, 741s, 725s, 696m, 663m, 644m, 612w. 
 
Cyclic voltammetry data (CH3CN, 0.1 M [nBu4N][PF6], Fc/Fc+): +0.78 V, -1.68 V, 
-1.92 V, -2.39 V. 
 
UV/VIS (CH3CN):λmax/ nm (εmax, M-1 cm-1) 233 (120 x 103), 241 (122 x 103), 269 (137 x 
103), 305 (173 x 103), 481 (47 x 103). 
 
Elemental Analysis: Found: C, 40.83; H, 3.25; N, 7.66. Calc. for 
C114H102F36N18O9P6Ru3·2NaPF6: C, 40.54; H, 3.04; N, 7.47%. 
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CHAPTER 6 
 
Synthesis of homoleptic mononuclear europium(III) and 
terbium(III) complexes of a tritopic 4'-substituted- 2,2':6',2''-
terpyridine ligand 
 
6.1   Introduction 
 
Historical overview177 
Discovery and isolation of the lanthanides 
 
In 1752, the Swedish mineralogist Cronstedt discovered a new heavy mineral in a mine 
near Ryddarhyttan in his home country. Gadolin (Finnish), in 1794, isolated an oxide 
from a heavy black mineral at Ytterby (also in Sweden) and named the oxide ‘ytterbia’. 
Half a century later, in 1842, Mosander further separated ‘ytterbia’ by oxalate and 
hydroxide precipitation. He named the three fractions ‘yttria’, ‘erbia’ and ‘terbia’. The 
isolation of lanthanum, the lanthanides, yttrium, and scandium was not completed until 
1908–1909 owing to the difficulties in separating them by repetitive fractional 
crystallizations. Charles James, an early expert in the isolation of kilogram quantities of 
pure lanthanide salts, once performed many thousands of recrystallizations to obtain 
‘pure’ Tm(BrO3)3. Before the Second World War, a major advance in separating 
lanthanide ions was made by McCoy, who purified considerable quantities of Eu by 
reducing Eu3+ to Eu2+ with Zn amalgam followed by precipitation as EuSO4. The 
Manhattan project during the Second World War yielded the first large-scale separation 
methods for lanthanide ions. The ion exchange chromatographic methods developed 
during this project are based on the (small) differences in the stability of chelates (at the 
time citrate complexes). Together with the liquid-liquid extraction methods developed in 
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the early 1950s these methods are still used in the commercial production of 
lanthanides.177  
 
Over the past five years, the lanthanides have attracted great interest, due to their unique 
magnetic and photophysical properties such as their relatively long-lived luminescence. 
178-180Research in luminescence signaling has developed quickly due to its many possible 
applications.181-199 The metal-based complexes can be used as therapeutic drugs, 
biological probes and assays.200-212 Furthermore lanthanides have potential applications in 
medical diagnostics213,214, optical imaging215,216 and high technology.217,218 
 
Lanthanides have a characteristic 4f open-shell configuration and exhibit small and 
regular decreases in their ionic radii across the periodic series, (the lanthanide 
contraction).219,220 Their most stable oxidation state is +3, with configuration [Xe]4f n 
(Figure 6.3). They are coordinated by a variety of ligands with high coordination 
numbers, typically between eight and ten.  
 
Lanthanides are hard metals so they can coordinate to ligands with hard donors, like 
nitrogen or oxygen. For example, in [Eu(ClO4)(L)]2+, (Figure 6.1) the metal ion is 
coordinated to six oxygen atoms and two nitrogen atoms from cryptand(2.2.2). This type 
of complexes is very stable due to the chelate effect. The eight-coordinate geometry of 
the lanthanides allows the self-assembled helicate structure shown in Figure 6.1 to be 
formed.217 
 
       
Figure 6.1. Some examples of the structures of lanthanide complexes.217 
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For an f-orbital, the quantum numbers are n = 4 or 5, l = 3 and ml = +3, +2, +1, 0, -1, -2, -
3. A set of f-orbitals is therefore seven-fold degenerate, and the "cubic set" is the most 
commonly used to present the shapes of these orbitals. Figure 6.2 shows the three 
dimensional representation of f-orbitals: 4fxyz, 4fx(z2-y2), 4fy(z2-x2), 4fz(x2-y2), 4fx3, 4fy3 and 4fz3. 
In the cubic set of 4f orbitals, there are two distinct shapes, each of which possesses a 
number of planar and conical nodes. None of the 4f orbitals possesses radial nodes. 
The 4fxyz, 4fx(z2-y2), 4fy(z2-x2), and 4fz(x2-y2) (bottom two rows in Figure 6.2) each have eight 
lobes. The 4fx(z2-y2), 4fy(z2-x2), and 4fz(x2-y2) orbitals are related to each other by 45° rotations 
about the x, y, and z-axis respectively. Each orbital has three nodal planes, which for the 
4fxyz are the xy, xz, and yz planes. The 4fx3, 4fy3, and 4fz3 (top row in Figure 6.2) orbitals 
has a planar node in the xy plane and two conical nodes orientated along the z-axis. The 
other two orbitals are related through 90° rotations. 
The lanthanides have 4f orbitals and the ground state electronic configuration of e.g. 
europium is [Xe]4f 76s2.  
 
 
Figure 6.2. The three dimensional representations of the f orbitals.221 
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Figure 6.3. The place of the lanthanides in the Periodic Table.177 
 
The most interesting spectroscopic properties of lanthanides are an effect of the shielding 
of the 4f orbitals. The characteristic narrow emission bands in the visible and near 
infrared ranges, as well as very low extinction coefficients in the absorption spectra (εmax, 
0.1 M-1 cm-1)222 are a result of the spin forbidden f-f electronic transitions. The intensity 
of these transitions is very low due to very little f-d mixing. 
 
    
 
 
Figure 6.4. Characteristic transitions and emission spectrum of Eu3+ complexes.210 
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Most of the lanthanide ions' complexes are luminescent. The exceptions are La(III) 
(configuration: [Xe]) and Lu(III) (configuration: [Xe]4f 14 ) which have no f-f transitions. 
The "f –f" electronic transitions are easily recognizable and almost independent of the 
chemical environment of the ion. They can be either fluorescent (e.g. Pr(III), Nd(III), 
Ho(III), Er(III) and Yb(III)) or phosphorescent (e.g. orange Sm(III), red Eu(III), Gd(III) 
UV, green Tb(III), yellow Dy(III) and blue Tm(III)). Fluorescence occurs when the 
processes undergo without change in spin, typically S1 →S0 transitions and 
phosphorescence refers to transitions involving a change in spin, typically T1 →S0.222  
 
As their emissions occur in the visible region, Eu(III) and Tb(III) are especially 
interesting, Eu(III) emits in the red (550–750 nm) (Figure 6.4) and Tb(III) emits in the 
green (450–650 nm) (Figure 6.5); the energy gaps: Eu(III) (∆E = 12300 cm–1, 5D0 → 7F6 
and Tb(III) (∆E = 14800 cm–1, 5D4 → 7F0).218 
 
                      
 
Figure 6.5. Characteristic transitions and emission spectrum of Tb3+ complexes.210 
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One of the strongly investigated type of ligands for Ln(III) complexation are receptors 
bearing the β-diketonate structural motif.223 Suitable diketonate complexes can be 
advantageously used for fluoroimmunologic assays223 and for responsive systems based 
on luminescence quenching.224 For example, Zebret and Haamcek from the University of 
Geneva have prepared a new ligand by introducing terminal carboxylate groups on the 
Hbpca ((bis(2-pyridylcarbonyl)amine) backbone to achieve Ln(III) coordination in the 
pentacoordinate cavity (Figure 6.6).225-228 The structure of this coordination site can be 
compared to some pentadentate ligands, namely derivatized dicarbazone229,230 and 
terpyridine ligands231used for fluorimetric assays.223  
 
                 
 
Figure 6.6. View of the coordination environment around Eu(III) cations with the atomic 
numbering scheme (O1' and O2' – amidic carbonyl groups, O1 and O2.– water 
molecules).218 
 
The X-ray crystal structure of this Eu(III) complex shows that it is formed by three 
molecules of the ligand shown in Figure 6.6, interconnected with three europium cations 
around a crystallographic threefold axis. Each europium cation in the crystal structure is 
nine-coordinate with five donor atoms of one ligand (pentacoordinated cavity), two 
oxygen atoms of the amidic carbonyl groups of the neighboring ligand, and the two 
remaining positions are occupied by water molecules (Figure 6.6). The coordination 
sphere of Eu(III) can be described as a distorted mono-capped square antiprismatic site, 
in which one water molecule caps the rectangular face formed by two carbonyl and two 
carboxylate oxygens. 
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Recently a new approach in lanthanide chemistry has generated great interest. Scientists 
are trying to control the luminescent properties of multimetallic assemblies exactly by 
controlling intermetallic communication between two (or more) metal ions inserted into 
polymetallic edifices, such that directional energy transfer occurs. One may control the 
properties of one metal ion by tuning the physicochemical properties of the other ion. 
This strategy is being mostly used for sensitizing Near-IR emitting Ln(III) ions and there 
are two possibilities : through-bond or through-space directional energy transfer.206  
 
 
Figure 6.7. Tetrametallic complex exhibiting Ru(II)-to-Ln(III) directional energy 
transfer.232 
 
An example of the first process is given by the tetrametallic square Ru2Ln2 complex 
proposed by Guo et al. (Figure 6.7).232 An example of the through-space strategy is 
shown in Figure 6.8 for a trimetallic RuLn2, the d- and f-transition metal ions are not 
directly linked.233  
 
 
Figure 6.8. Trimetallic complex exhibiting Ru(II)-to-Ln(III) through-space energy 
transfer.233 
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Following on from these examples of chelating ligands with hard donor atoms and the 
known Eu(tpy)3 complex234, ligand L5 was designed to act as a chelating ligand for one 
Ln(III) ion. Studies of new homoleptic mononuclear europium(III) and terbium(III) 
complexes of tritopic 4'-substituted- 2,2':6',2''-terpyridine ligand L5 described in Chapter 
5 will be fully presented in this chapter (Scheme 6.1). 
 
[CF3SO3]3Ln
Ln = Eu(III) or Tb(III)
 
 
Scheme 6.1. Homoleptic mononuclear lanthanide(III) complex of a tritopic 4'-
substituted- 2,2':6',2''-terpyridine ligand. 
 
 
 
 
6.2   Synthesis of [Eu(L5)3]3+ 
 
The homoleptic mononuclear europium(III) complex of ligand L5 (Scheme 6.3) was 
easily prepared by reacting one equivalent of ligand L5 in CHCl3 with one equivalent of 
Eu(CF3SO3)3 in acetonitrile at room temperature for few minutes. 1H NMR spectrum 
shows that the reaction occurs almost instantly. The solvent was removed in vacuo and 
the desired product was obtained in 90% yield (Scheme 6.2). 
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Scheme 6.2. Synthesis of [Eu(L5)][CF3SO3]3. 
 
 
 
 
6.3   1H NMR spectroscopy of [Eu(L5)3]3+ 
 
Europium(III) has a [Xe]4f 6 configuration so it has six unpaired electrons and therefore 
shows paramagnetic properties. The Eu(III) complex of ligand L5 - [Eu(L5)][CF3SO3]3, 
was characterized by 1H NMR spectroscopy in CD3CN solution (Scheme 6.3) and the 
spectrum is shown in Figure 6.9. 
-3.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
HC4 HC3
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HMe
HG1-4
HF (4H)
*
HF (2H)
 
 
Figure 6.9. 1H NMR spectrum (600 MHz, 295 K) of [Eu(L5)][CF3SO3]3 in CD3CN. The 
signal marked with * is the signal for CD3CN. 
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Scheme 6.3. Labeling for [Eu(L5)][CF3SO3]3. 
 
The assignment of all of the protons of the europium(III) complex were made using the 
COSY, NOESY and ROESY (Figure 6.11) techniques. Both NOESY and ROESY are 
very useful for identifying protons that are close in space but ROESY has the advantage 
that cross peaks are always positive and cannot be zero.235 
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All of the signals corresponding to the diethylene glycol chain HG1-G4 of 
[Eu(L5)][CF3SO3]3 can be found, as expected, in the aliphatic region between δ 2.85-3.15 
ppm. The signals at δ 4.08 and 3.63 ppm are assigned to HF from the -CH2- bridge 
connecting the benzene ring to the diethylene glycol chain. A singlet for the nine 
mesitylene protons HMe is observed at δ 1.83 ppm (Figure 6.9). 
 
 
Table 6.1. 1H NMR spectroscopic data, δH [ppm] for L5 (600 MHz, 295 K, CDCl3) and 
[Eu(L5)][CF3SO3]3 (500 MHz, 295 K, CD3CN) (see pages 141 and 178 for scheme of 
labeling). 
HC4 HC3
HC6
HC5
HC4
HC3
HC6
HC5
 
Figure 6.10. Part of the COSY spectrum (600 MHz, 295K) of [Eu(L5)][CF3SO3]3 in 
CD3CN.  
 HC5/HT5 HC4/HT4 HD3/HT3' HC3/HT3 HC6/HT6 
L5 7.27-7.32 (m) 
7.79 (t) 
J 7.2 Hz 7.99 (s) 
8.56 (d) 
J 7.9 Hz 
8.65 (d) 
J 3.9 Hz 
[Eu(L5)]3+ 6.72 (d) J 7.2 Hz 
7.44 (t) 
J 7.4 Hz 1.96 (s) 3.20 (m) 8.58 (br) 
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A comparison between the chemical shifts of tpy protons of free ligand L5 in CHCl3 and 
the europium(III) complex [Eu(L5)][CF3SO3]3 in acetonitrile is shown in Table 6.1. All 
of the terpyridine proton signals of ligand L5 after complexation with europium(III) are 
shifted upfield. The signals for protons HC4/HT4 and HC6/HT6 of complex 
[Eu(L5)][CF3SO3]3 are not so strongly affected and respectively shifted by 0.35 and 0.07 
ppm, in comparison to ligand L5. The signals for protons HC3/HT3, HC5/HT5 and 
HD3/HT3' are the most shifted upfield by 5.36, 0.57 and more than 6.03 ppm for signal 
HD3/HT3'. The signals, especially the signal for proton HC6/HT6 are broadened due to the 
paramagnetic contribution of Eu(III) cation. This very strong upfield shifting is also a 
result of the paramagnetic metal center. 
 
In Figure 6.10 the COSY spectrum of complex [Eu(L5)][CF3SO3]3 is shown. The signal 
for HC4 gives a COSY cross peak to the signal HC3 at δ 3.20 ppm and HC5 at δ 6.72 ppm.  
Due to broadening of the signal and the short relaxation time, the COSY cross peaks of 
proton HC6 can not be found.  
 
HF
HG4
HMe
HG3
HG2
 
 
Figure 6.11. Part of the ROESY spectrum (600 MHz, 295K) of [Eu(L5)][CF3SO3]3 in 
CD3CN.  
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6.4   13C NMR spectroscopy of [Eu(L5)3]3+ 
 
For comparison, the diethylene glycol CG, CF and phenyl CP carbon signals of 
europium(III) complex [Eu(L5)][CF3SO3]3 as well as the terpyridine carbon signals of 
this complex were put together with carbon signals of ligand L5 in Tables 6.2 and 6.3. 
The assignments were made using HMQC and HMBC techniques. 
 
 CG1 CG2 CG3 CG4 CF CP 
L5 68.0 69.6 71.3 69.6 68.1 132.5, 138.5 
[Eu(L5)]3+ 68.9 69.0 71.1 70.0 68.1 68.9 
133.5 
138.7 
 
Table 6.2. 13C NMR spectroscopic data, δC [ppm], (151 MHz, 295 K) for L5 in CDCl3 
and [Eu(L5)][CF3SO3]3 in CD3CN (see pages 141 and 178 for scheme of labeling). 
 
 
Table 6.2 shows how the CG, CF and CP carbon signals of ligand L5 changes, after 
complexation with europium(III). The signals CG1, CG4, CF and CP are slightly shifted 
downfield after complexation with europium(III) and the carbon signals CG2 and CG3 of 
europium(III) complex [Eu(L5)][CF3SO3]3 are shifted upfield by 0.6 and 0.2 ppm, 
respectively. 
 
In Figure 6.12 the cross peaks of the aliphatic protons HF (4H) at δ 4.08 ppm and HF 
(2H) at δ 3.63 ppm of the complex [Eu(L5)][CF3SO3]3 to the signals for directly attached 
carbons at δ 68.1 and δ 68.9 ppm are shown. All of the C-H signals could be easily 
assigned using the HMQC spectrum.  
 
Table 6.3 shows in comparison the terpyridine carbon signals of ligand L5 and 
europium(III) complex [Eu(L5)][CF3SO3]3. The signals CT4/CC4, CT6/CC6 and CT4'/CD4 
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are strongly shifted downfield after complexation with europium(III) and the carbon 
signals CT2/CC2, CT3/CC3, CT5/CC5, CT2'/CD2 and CT3'/CD3 of europium(II) complex 
[Eu(L5)][CF3SO3]3 are shifted upfield. The signals for carbons CC3/CT3, CC6/CT6 and 
CD3/CT3' are the most shifted, by more than 30 ppm for all three signals. These very 
strong chemical shifts are a result of the paramagnetic metal center. 
 
 
 
Table 6.3. 13C NMR spectroscopic data, δC [ppm], (151 MHz, 295 K) for L5 in CDCl3 
and [Eu(L5)][CF3SO3]3 in CD3CN (see pages 141 and 178 for scheme of labeling). 
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Figure 6.12. Part of the HMQC spectrum (600 MHz, 295 K) of [Eu(L5)][CF3SO3]3 in 
CD3CN. 
 
CT2 
/CC2 
CT3 
/CC3 
CT4 
/CC4 
CT5 
/CC5 
CT6 
/CC6 
CT2' 
/CD2 
CT3' 
/CD3 
CT4' 
/CD4 
L5 156.2 121.5 137.0 124.0 149.2 157.2 107.6 167.1 
[Eu(L5)]3+ 153.6 90.7 151.1 105.1 184.1 144.3 72.6 175.2 
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In the Figure 6.12 the cross peaks of the terpyridine protons HC3 and HD3 of the complex 
[Eu(L5)][CF3SO3]3 in CD3CN to the directly bound carbon signals are shown. 
 
HC4 HC5
CC3
CC2
CC6
HF
CG4
CP2,P4,P6
CP1,P3,P5
 
 
Figure 6.13. Part of the HMBC spectrum (600 MHz, 295 K) of [Eu(L5)][CF3SO3]3 in 
CD3CN 
 
In Figure 6.13, the cross peaks of the protons HC4, HC5 and HF of the europium(III) 
complex to the carbon signals separated by 2-3 bonds are shown. The signal for proton 
HC4 couples with the signals for carbons CC2 and CC6, the signal for proton HC5 couples 
with a signal for a carbon CC3 and the signal for proton HF couples with the signals for 
carbons CG4, CP1,P3,P5 and CP2,P4,P6, giving the cross peaks. 
 
The complex [Tb(L5)][CF3SO3]3 could not be studied in the solid state.  However, 
preliminary NMR studies suggesting the presence of a paramagnetic species and 
photochemical investigation (see section 6.5) of the complex in solution confirm the 
existence of the proposed terbium(III) complex. 
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6.5    Photochemical characterization 
 
In order to determine conditional stability constants, spectrophotometer titrations of 
ligand L5 10-5 M with europium(III) and terbium(III) trifluoromethanesulfonate solutions 
5×10-3 M were performed. UV-vis spectra were recorded after each addition of Ln(III) 
starting from 0.01 eq/0.05 eq up to a total concentration ratio R = Ln(III)/L5 = 5. All of 
the titrations were conducted in acetonitrile solution (Figures 6.14 and 6.15).  
 
Addition of the Ln(III) salt results in the appearance of a new band at around 320 nm 
with a increase in the insentity of two bands of ligand L5 at 241 and 279 nm. The band at 
241 nm is additionally red shifted. After R = Ln(III)/L5 = 1 further addition of Ln(III) 
does not significantly modify the shape of the spectrum. UV-vis spectra recorded during 
the titration of L5 with Ln(III) display only one well defined isosbestic point at 300 nm 
(Figures 6.14 and 6.15). 
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Figure 6.14. UV-vis spectra of ligand L5 10-5 M in acetonitrile and 298 K in the presence 
of increasing amounts of Eu(CF3SO3)3, double arrows denote isosbestic point. The inset 
shows relation between ε [105 cm-1 M-1] and added amount of metal [eq]. 
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Figure 6.15. Absorption spectra of ligand L5 10-5 M in acetonitrile and 298 K in the 
presence of increasing amounts of Tb(CF3SO3)3, double arrows denote isosbestic point. 
The inset shows relation between ε [105 cm-1 M-1] and added amount of metal [eq]. 
 
 
Emission (fluorescence and phosphorescence) spectra were also recorded after each 
addition of Ln(III) starting from 0.01 eq/0.05 eq up to a total concentration ratio R = 
Ln(III)/L5 = 5. The titrations were performed in acetonitrile solution. 
 
In Figures 6.16 and 6.17 the emission spectra of ligand L5 titrated with a solution of 
Eu(CF3SO3)3 are shown. In red, the spectrum of ligand L5 is shown, before addition of 
the metal salt, the ligand exhibits no emission. Increasing the amount of europium(III) 
salt in the solution causes the appearance of an emission spectrum typical for this 
lanthanide (see Figure 6.4). The five bands at 591, 615, 650, 690 and 700 nm correspond 
to five transition processes: 5D1 → 7F1, 5D0 → 7F0, 5D0 → 7F1, 5D0 → 7F2 and 5D0 → 7F4, 
respectively. 
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Figure 6.16. Emission (fluorescence) spectra of ligand L5 10-5 M in acetonitrile and 298 
K in the presence of increasing amounts of Eu(CF3SO3)3. 
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Figure 6.17. Emission (phosphorescence) spectra of ligand L5 10-5 M in acetonitrile and 
298 K in the presence of increasing amounts of Eu(CF3SO3)3. 
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In both Figures 6.16 and 6.17 the spectra of the species with R = 1 and R = 5 are 
highlighted, in blue for R = 1 and in green for R = 5. None of the spectra, neither R = 1 
nor R = 5, have maximum emission intensity, especially in the fluorescence  spectra 
(Figure 6.16), but these data can not be treated as quantitative and the above observation 
suggests only that an intermediate has a stronger emission that dominates the 1:1 species.  
 
In Figures 6.18 and 6.19 the emission spectra of ligand L5 titrated with a solution of 
Tb(CF3SO3)3 are shown. The spectrum of ligand L5 before addition of the metal salt 
exhibits no emission and is shown in red. Upon addition of terbium(III) salt, the typical 
emission spectrum appears (see Figure 6.5). The four bands at 490, 544, 584 and 621 nm 
correspond to four transition processes: 5D4 → 7F6, 5D4 → 7F5, 5D4 → 7F4 and 5D4 → 7F3, 
respectively. 
 
In the case of titration of ligand L5 with the terbium(III) salt, the spectra with R = 1 and 
R = 5 almost overlap with each other and are very close to the spectrum with the 
maximum emission intensity, especially in the fluorescence spectra (Figure 6.18). 
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Figure 6.18. Emission (fluorescence) spectra of ligand L5 10-5 M in acetonitrile and 298 
K in presence of increasing amounts of Tb(CF3SO3)3. 
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Figure 6.19. Emission (phosphorescence) spectra of ligand L5 10-5 M in acetonitrile and 
298 K in presence of increasing amounts of Tb(CF3SO3)3. 
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Mathematical treatments of the data with SPECFIT®236,237 allowed the determination of 
conditional stability constants corresponding to the following general equation: 
 
 
 
The model used for SPECFIT approximation suggests that in solution are four absorbing 
species, nevertheless only three could be defined: ligand and the 1:2 and 1:1 Ln:L5 
species. Data were fitted by non-linear least-squares techniques to the following set of 
equations: 
 
 
 
In Table 6.2 conditional stability constants of 1:2 and 1:1 Eu:L5 species are shown. Data 
fitted based on UV-vis and phosphorescence titrations give comparable values for 
stability constants logβ21 (around 16), for logβ11 (around 25), whereas stability constants 
fitted by treating fluorescence data are by two orders of magnitude smaller. 
 
 UV-Vis Luminescence Fluor./Phosp. 
logβ21 16.04 13.88/16.02 
logβ11 24.63 22.07/25.08 
 
Table 6.2. Conditional stability constants for [Eu(L)2]3+ and [EuL]3+. Estimated errors ± 
2 log K units. 
 
In Table 6.3 conditional stability constants of 1:2 and 1:1 Tb:L5 species are shown. Data 
could be fitted only based on UV-vis and fluorescence titrations. The observations made 
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during interpretation of data for europium(III) complexes (see above) suggest that values 
for stability constants logβ21 (around 14) and logβ11 (around 22), fitted by treating UV-
vis data are more credible. 
 
 UV-Vis Luminescence (Fluorescence) 
logβ21 13.80 15.92 
logβ11 21.52 24.42 
 
Table 6.3. Conditional stability constants for [Tb(L)2]3+ and [TbL]3+. Estimated errors ± 
2 log K units. 
 
Recalculated spectra of the ligand and 1:2 and 1:1 Ln:L5 species match satisfyingly the 
experimental ones. 
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Figure 6.20. Distribution diagram for europium(III). 
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Distribution diagrams drawn from the conditional stability constants are presented in 
Figures 6.20 and 6.21. When the ratio R reaches a value 0.5, the 1:2 Ln(III)/L5 complex 
become predominant. For europium(III) 1:2 Eu(III)/L5 species at R = 0.5 is present in 
solution in 90%, for terbium, around 70%. Furthermore, when R is larger than 1.5 for 
[EuL]3+ and 1 for [TbL]3+, the 1:1 complexes represent the most abundant species in 
solution. 
 
In the distribution diagram for europium(III) at R = 1, the 1:1 Eu(III)/L5 species 
represents only 70% of the total solution species and the 1:2 Eu(III)/L5 species is present 
in solution, comprising 30% of the total solution species. Significant excess of 
europium(III) salt is needed to shift an equilibrium towards 1:1 Eu(III)/L5 complex, at R 
= 2.5, 1:1 complex represents the most abundant species in solution (95%) (Figure 6.20). 
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Figure 6.21. Distribution diagram for terbium(III). 
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In the distribution diagram for terbium(III) at R = 1, the 1:1 Tb(III)/L5 species comprises 
80% of the total solution species and there is only a trace amount of free ligand left. The 
1:2 Tb(III)/L5 complex represents only 20% of the solution species. At R = 1.5, the 1:1 
complex becomes completely predominant in solution (95%) (Figure 6.21). 
 
 
 
 
6.6   Conclusion 
 
The homoleptic mononuclear europium(III) and terbium(III) complexes of tritopic 4'-
substituted- 2,2':6',2''-terpyridine ligand L5 have been synthesized. The photophysical 
properties of both complexes [Eu(L5)][CF3SO3]3 and [Tb(L5)][CF3SO3]3 were fully 
investigated. The absorption and emission spectra of both complexes have been recorded. 
The europium(III) complex [Eu(L5)][CF3SO3]3 was characterized by 1H and 13C NMR 
spectroscopy.  
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6.7   Experimental 
 
 [Eu(L5)][CF3SO3]3 
 [Tb(L5)][CF3SO3]3 
 
Ligand L5 was prepared as described in Chapter 5. Eu(CF3SO3)3 and Tb(CF3SO3)3 are 
commercially available compounds and were used as received (Sigma Aldrich, 98%) 
 
 [Eu(L5)][CF3SO3]3 
 
        
 
Compound L5 (0.14 g, 0.12 mmol) dissolved in 10 mL CHCl3 was added to a solution of 
Eu(CF3SO3)3 (0.072 g, 0.12 mmol) in 30 mL CH3CN. The mixture was stirred 10 minutes 
at room temperature. The solvent was removed in vacuo to give a yellowish oil (0.19 g, 
0.11 mmol, 90%).  
 
1H NMR (600 MHz, CD3CN) δH 1.83 (s, 9H, HMe), 1.96 (s, 6H, HD3), 2.88 (m, 4H, HG2), 
2.95 (m, 4H, HG1), 3.05 (m, 4H, HG3), 3.12 (m, 4H, HG4), 3.20 (m, 6H, HC3), 3.63 (s, 2H, 
HF), 4.08 (s, 4H, HF), 6.72 (d, J 7.2 Hz, 6H, HC5), 7.44 (t, J 7.4 Hz, 6H, HC4), 8.58 (br, 
6H, HC6). 
 
13C NMR (151 MHz, CD3CN) δC 15.7 (CMe), 68.1 (CF), 68.9 (CG1 and CF), 60.0 (CG2), 
70.0 (CG4), 71.1 (CG3), 72.6 (CD3), 90.7 (CC3), 105.1 (CC5), 133.5 (CP1,P3,P5), 138.7 
(CP2,P4,P6), 144.3 (CD2), 151.1 (CC4), 153.6 (CC2), 175.2 (CD4), 184.1 (CC6). 
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  [Tb(L5)][CF3SO3]3 
 
          
 
Complex [Tb(L5)][CF3SO3]3 was synthesized according to the same procedure as for 
[Eu(L5)][CF3SO3]3 with ligand L5 (0.14 g, 0.12 mmol) and Tb(CF3SO3)3 (0.073 g, 0.12 
mmol). The mixture was stirred 10 minutes at room temperature. The solvent was 
removed in vacuo to give a yellowish oil (0.20 g).   
 
1H NMR (400 MHz, CD3CN): Preliminary results show the presence of a paramagnetic 
species. 
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